Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chloride channel activity (GO:0005254),-0.5711640676661263,-2.0207087200863536,0.0,0.0394986511081566,0.029,21/59,13.96%,SLC26A7;CLIC4;GABRG3;ANO1;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;TTYH2;GLRA2;CLIC1;GABRB2;CLCN5;GABRA3;ANO3;ANO2;CFTR;SLC1A4
prerank,metalloendopeptidase activity (GO:0004222),0.6537110812601392,1.9770537438827607,0.0,0.02019682197707305,0.021,19/76,8.80%,ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;MMEL1;ADAMTS9;SPRTN;PMPCB;ECE2;EEF1AKMT4-ECE2
prerank,anion channel activity (GO:0005253),-0.5309055917324716,-1.9346881997050573,0.0,0.06970350195557047,0.099,22/61,13.96%,SLC26A7;LRRC8C;CLIC4;GABRG3;ANO1;LRRC8D;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;GLRA2;CLIC1;GABRB2;CLCN5;GABRA3;ANO3;ANO2;CFTR;SLC1A4
prerank,metallopeptidase activity (GO:0008237),0.6000614670148802,1.9064279900542345,0.0,0.04773794285489994,0.092,21/113,8.80%,PAPPA;ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;MMEL1;ADAMTS9;SPRTN;DPEP1;PMPCB;ECE2;EEF1AKMT4-ECE2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6974116428501524,-1.8672573469497478,0.00516795865633075,0.08219204605594352,0.231,6/16,5.91%,PTPRB;PTPRG;PTPRE;PTPRD;PTPRK;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6974116428501524,-1.8672573469497478,0.00516795865633075,0.08219204605594352,0.231,6/16,5.91%,PTPRB;PTPRG;PTPRE;PTPRD;PTPRK;PTPRT
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5968730515009761,-1.8624368187522111,0.0,0.07063288198164475,0.244,14/29,9.66%,GRID2;GRIA4;GABRG3;GRIK1;GRIK2;GABRA2;GABRB3;GABRB1;GABRG2;GLRA2;GABRB2;GRIA2;GABRA3;GRID1
prerank,retinoid binding (GO:0005501),0.7603605159347269,1.8494628133930369,0.001579778830963665,0.11444865787008063,0.291,5/22,6.07%,RBP4;CYP26B1;NR2F2;RBP1;ALDH1A2
prerank,protease binding (GO:0002020),0.5791844763153496,1.8406660101295582,0.0,0.10373822197314794,0.336,37/99,14.41%,CCBE1;COL1A2;COL1A1;TIMP3;SERPINE1;BCL2;ITGA3;CFLAR;ATP9A;STIM1;INSL3;RFFL;LDLR;BFAR;CST3;DERL1;BDKRB2;DERL3;CD28;POLG;TIMP2;RNF139;SLC2A13;PRKN;ITGB3;ITGAV;LONP2;ADAMTSL4;SELENOS;RIPK2;NOL3;TRIP4;PTEN;COL3A1;ADRM1;RIOK3;AMFR
prerank,glutamate receptor activity (GO:0008066),-0.6572347057272164,-1.8328435157697505,0.0,0.08964644834841425,0.347,10/19,10.96%,GRM7;GRID2;GRM3;GRIA4;GRIK1;GRIK2;GRM5;GRIA2;GRID1;GRM8
prerank,chloride transmembrane transporter activity (GO:0015108),-0.68699446153823,-1.8240692880146285,0.0051813471502590676,0.08596765241187025,0.383,7/16,14.00%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR;SLC12A5
prerank,platelet-derived growth factor binding (GO:0048407),0.8485870920462388,1.80958935929094,0.0,0.13935807164180408,0.484,5/11,3.57%,COL1A2;COL1A1;COL5A1;PDGFRA;PDGFRB
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.8068336545005633,1.7846232775796487,0.00510204081632653,0.16968390585283344,0.618,6/12,5.70%,LTBP1;TGFBR3;BMPR1A;TGFBR1;ACVR1;ENG
prerank,ligand-gated anion channel activity (GO:0099095),-0.643075712109801,-1.7736006690865302,0.004866180048661801,0.1434730415252159,0.592,13/17,23.06%,GABRG3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;GLRA2;GABRB2;GABRA3;CFTR;GABRA4;GABRG1;GLRA3
prerank,amino acid binding (GO:0016597),-0.5421609343460185,-1.7584495042952233,0.006329113924050633,0.1456028707516361,0.637,9/31,7.48%,GRM7;NOS3;GLRA1;GLRA2;DDAH1;NOS1;DDAH2;GRIN2B;GRIN3A
prerank,ligand-gated channel activity (GO:0022834),-0.5624184717749751,-1.7516914418933904,0.005952380952380952,0.14091724645351164,0.663,10/29,9.66%,GRID2;GRIA4;GRIK1;GRIK2;GRIN2A;GABRB1;GRIN2B;GRIN3A;GRIA2;GRID1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7850812813981839,1.750009106895909,0.007961783439490446,0.2356733057974044,0.781,5/15,8.59%,ALDH1A1;ALDH1A2;ALDH1L1;ALDH7A1;ALDH2
prerank,retinoic acid binding (GO:0001972),0.7965352904280277,1.7483912931996122,0.006837606837606838,0.21046006537472714,0.791,2/12,1.88%,CYP26B1;NR2F2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6557268277121824,-1.7407265758704458,0.007614213197969543,0.14458196087450903,0.7,6/15,13.10%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.7375319215548244,1.7390243913455792,0.004878048780487805,0.21431072209005297,0.827,6/18,5.70%,LTBP1;TGFBR3;BMPR1A;TGFBR1;ACVR1;ENG
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8005093471917787,1.7390040884532747,0.008130081300813009,0.19287964988104767,0.827,5/13,8.59%,ALDH1A1;ALDH1A2;ALDH1L1;ALDH7A1;ALDH2
prerank,ligand-gated ion channel activity (GO:0015276),-0.558204498911141,-1.7384960152564795,0.009202453987730062,0.1359218288133624,0.707,10/30,9.66%,GRID2;GRIA4;GRIK1;GRIK2;GRIN2A;GABRB1;GRIN2B;GRIN3A;GRIA2;GRID1
prerank,ephrin receptor activity (GO:0005003),0.7251611220663904,1.7238927822398253,0.008726003490401396,0.19645999559516514,0.876,4/17,2.61%,EPHA3;EPHA7;EPHA4;EPHA8
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.7251611220663904,1.7238927822398253,0.008726003490401396,0.19645999559516514,0.876,4/17,2.61%,EPHA3;EPHA7;EPHA4;EPHA8
prerank,insulin-like growth factor receptor binding (GO:0005159),0.7942339207988561,1.7100327247353653,0.0074211502782931356,0.21241972205257253,0.911,4/12,3.30%,IGF1;IGF2;PIK3R1;GNAS
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.6360225269132198,-1.7089909820888762,0.010498687664041995,0.16880758358214437,0.807,8/17,8.47%,GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;GRIN2B;GRIN3A;GRIA2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.5790208428650344,1.7067489720820563,0.001314060446780552,0.20511577644248216,0.917,20/60,10.18%,EPHA3;NRP1;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2;IGF2R;RYK
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.6686238214118791,-1.7050884226759084,0.007228915662650603,0.1627244849224687,0.82,4/14,5.44%,KCNJ2;KCNJ3;KCND3;KCNQ1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6927488614280315,-1.6999298162374952,0.011547344110854504,0.1602406061623059,0.839,7/12,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5984820629838432,-1.6933304990572533,0.015151515151515152,0.15901111383614513,0.853,8/19,9.66%,GRID2;GABRG3;GRIK1;GRIK2;GABRA2;GABRG2;GABRA3;GRID1
prerank,anion transmembrane transporter activity (GO:0008509),-0.6838383398357334,-1.686091491960491,0.012531328320802004,0.15819961473249575,0.87,4/12,4.23%,ABCG2;SLCO2B1;SLC22A6;SLC39A8
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.7059422193586907,-1.6726476803034256,0.018823529411764704,0.16941823391978933,0.911,4/11,11.84%,PPP1R1A;PPP1R14C;PPP1R14B;PPP1R14A
prerank,BMP binding (GO:0036122),0.7769254360933646,1.6660375989023046,0.015254237288135594,0.3045435944179258,0.978,2/11,5.70%,GREM2;ENG
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5343600660169494,-1.6556567639368729,0.017699115044247787,0.18807716843450417,0.937,8/28,9.66%,GRID2;GABRG3;GRIK1;GRIK2;GABRA2;GABRG2;GABRA3;GRID1
prerank,endopeptidase inhibitor activity (GO:0004866),0.5402220559286172,1.6552167341036175,0.004975124378109453,0.31913273817181903,0.989,16/82,7.14%,COL4A3;TIMP3;AHSG;SERPINE1;SERPING1;RECK;FETUB;CAST;SERPIND1;WFDC3;TFPI;SERPINF1;CST3;SERPINH1;CRB2;TIMP2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.7491600007984474,1.6547522743750902,0.006944444444444444,0.3012782615243063,0.989,2/14,0.18%,SLC7A11;SLC1A3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.7823410306949967,1.6485716010091322,0.025089605734767026,0.3029013275803961,0.991,3/11,4.73%,ITPR1;TRPA1;RASA3
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.7321403793598799,1.6482107928466152,0.018581081081081082,0.2881670963427361,0.991,6/13,15.58%,BMP6;CDH5;SRC;BMP2;BMP4;BMP5
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.6598092360101655,-1.6469508907764703,0.023696682464454975,0.19296252791367094,0.947,7/13,18.89%,SH3BP4;CCDC88A;GDI1;ARHGDIA;ARHGDIB;GPSM2;ITGB1BP1
prerank,lipase activator activity (GO:0060229),0.796531814915117,1.6458477490089256,0.014705882352941176,0.28114894229448284,0.992,3/10,6.32%,PDPK1;ARHGAP6;SRC
prerank,diacylglycerol kinase activity (GO:0004143),-0.6756628411707033,-1.6457819403414067,0.023060796645702306,0.18571004449591275,0.948,7/11,20.81%,DGKB;DGKH;DGKK;DGKG;DGKQ;DGKZ;DGKI
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6805944199218592,-1.6399788737382504,0.017897091722595078,0.18693211888084807,0.953,3/11,5.44%,KCNJ3;KCND3;KCNQ1
prerank,phospholipase activator activity (GO:0016004),0.7967948103546452,1.638976934940159,0.02389705882352941,0.28808886759504637,0.994,3/10,6.32%,PDPK1;ARHGAP6;SRC
prerank,acid-thiol ligase activity (GO:0016878),0.7289419302248563,1.6177479761720643,0.026223776223776224,0.3401745718121891,0.998,7/13,15.45%,SLC27A5;ACSL1;ACSS3;AASDH;ACSF3;ACSS2;AACS
prerank,BMP receptor binding (GO:0070700),0.7321501436907789,1.616994271394919,0.029411764705882353,0.32805865578965104,0.998,6/12,15.58%,BMP6;CDH5;SRC;BMP2;BMP4;BMP5
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6473774232930738,-1.615283985160304,0.01990049751243781,0.22123285403289758,0.976,8/12,13.22%,PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE8B;PDE7A;PDE4C
prerank,metallocarboxypeptidase activity (GO:0004181),0.6369470226053148,1.614406017796408,0.022222222222222223,0.3220781080434756,0.999,7/26,11.70%,CPXM2;AEBP1;VASH2;CPXM1;AGBL2;PEPD;CPA2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.705723781359392,1.6106104183710332,0.022653721682847898,0.3205052040288975,0.999,6/18,9.93%,ALDH1A1;AKR1B1;ALDH1A2;ALDH2;ALDH18A1;AKR1B10
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6691896226031937,-1.6010576044077451,0.021739130434782608,0.23810522647184107,0.983,4/11,7.23%,ATP8A1;ATP8B1;ATP11C;ATP11A
prerank,CoA-ligase activity (GO:0016405),0.7093625086255245,1.5994127311944468,0.02735042735042735,0.34062717065178977,1.0,6/14,15.45%,SLC27A5;ACSL1;ACSS3;ACSF3;ACSS2;AACS
prerank,transforming growth factor beta binding (GO:0050431),0.6409017990156188,1.5977277029693564,0.031818181818181815,0.33280554463230816,1.0,7/23,6.88%,LTBP1;TGFBR3;TGFBR1;TWSG1;ACVR1;ENG;LTBP3
prerank,GABA-A receptor activity (GO:0004890),-0.5803409629102145,-1.589557761705812,0.034210526315789476,0.25004969601528315,0.988,7/18,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,mannose binding (GO:0005537),0.7205917014827182,1.5882435163454671,0.029411764705882353,0.3490509200777917,1.0,3/12,5.97%,LMAN2L;LMAN1;COLEC11
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6010575828799835,-1.5828718903782895,0.019230769230769232,0.25289860324905694,0.991,8/15,12.99%,HS3ST1;HS3ST3A1;NDST3;HS3ST4;HS6ST3;HS3ST5;HS6ST2;HS3ST2
prerank,anion:anion antiporter activity (GO:0015301),-0.5815686895641935,-1.5775316604175387,0.033942558746736295,0.2549341043745401,0.994,5/17,13.83%,SLC26A7;SLC26A2;SLC26A6;SLC25A4;SLC25A11
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.6128663822306925,-1.5766175584312363,0.036585365853658534,0.24723998104359787,0.994,5/14,13.83%,SLC26A7;SLC26A2;SLC25A30;SLC26A6;SLC25A11
prerank,cation:chloride symporter activity (GO:0015377),-0.6770523101794595,-1.574545871258035,0.02947845804988662,0.2418391041987235,0.995,5/10,17.73%,SLC12A2;SLC12A7;SLC12A6;SLC12A5;SLC12A8
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.5325119737847098,1.5682052211323896,0.013089005235602094,0.4002959465518633,1.0,18/60,8.62%,EPHA3;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;ACVR1;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2
prerank,phospholipid transfer activity (GO:0120014),-0.5519591897241075,-1.5655607134239018,0.036011080332409975,0.2507002620335351,0.996,7/21,8.99%,PITPNC1;CERT1;PLTP;PITPNA;TNFAIP8L3;PLEKHA3;OSBPL2
prerank,monocarboxylic acid binding (GO:0033293),0.6499883989800976,1.563649861053937,0.030844155844155844,0.4009069162449001,1.0,4/18,15.03%,CYP26B1;NR2F2;NAPEPLD;RXRA
prerank,translation elongation factor activity (GO:0003746),-0.6070839596944234,-1.5631732006685004,0.02669902912621359,0.2465105569159906,0.997,7/14,13.99%,EEF2;GTPBP1;EIF5A;EIF5AL1;GFM2;EEF1A1;EEF1B2
prerank,GABA receptor activity (GO:0016917),-0.5531320256286599,-1.5630643871481344,0.031914893617021274,0.2390975332705141,0.997,7/21,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,E-box binding (GO:0070888),0.5941418734051122,1.5615728987792306,0.025714285714285714,0.39525950575952207,1.0,6/34,6.06%,TCF4;MITF;ZEB1;ASCL1;NEUROD1;ATOH8
prerank,calcium:sodium antiporter activity (GO:0005432),0.7757670731467345,1.5575204269205725,0.02877697841726619,0.39518639592923477,1.0,5/10,6.53%,SLC24A3;SLC8A1;SLC8A3;SLC24A1;SLC24A5
prerank,alanine transmembrane transporter activity (GO:0022858),-0.6438019651049527,-1.5561863771776574,0.04318181818181818,0.24297655075623606,0.998,5/12,13.96%,SLC6A6;SLC38A5;SLC36A4;SLC3A2;SLC1A4
prerank,poly(U) RNA binding (GO:0008266),0.6506345284723206,1.5510667829578062,0.044850498338870434,0.4044928258218212,1.0,3/20,1.36%,RBMS1;ATXN1;RBMS3
prerank,alpha-actinin binding (GO:0051393),0.6178409397908818,1.54851050520679,0.04354587869362364,0.4008853153657802,1.0,6/24,6.67%,PDLIM5;DAG1;PDLIM2;PALLD;SYNPO2;CACNA1C
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6557207673880556,-1.5478599188839957,0.046228710462287104,0.25202599530602343,0.998,4/10,3.99%,SLCO2A1;SLCO1C1;SLCO2B1;SLC22A6
prerank,voltage-gated chloride channel activity (GO:0005247),-0.6702274546894195,-1.5466282888168803,0.04367816091954023,0.24671720477893114,0.998,5/10,21.21%,ANO1;CLCN3;CLCN5;ANO6;CLCN4
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.6674082067066437,-1.5413967960108095,0.04700854700854701,0.2488027778136335,0.998,4/10,11.81%,DPP10;FAP;PRCP;DPP6
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5952743607706822,-1.5410797453443457,0.04449648711943794,0.24242375612565747,0.998,9/13,23.06%,GABRG3;GABRA2;GLRA1;GABRG2;GLRA2;GABRA3;GABRA4;GABRG1;GLRA3
prerank,semaphorin receptor activity (GO:0017154),0.7208474303524222,1.5391567315077803,0.05745062836624776,0.4207496380964011,1.0,2/11,0.18%,NRP1;PLXNA2
prerank,receptor ligand activity (GO:0048018),0.4541107949442145,1.5371139505556184,0.0010869565217391304,0.41510589411969084,1.0,28/245,7.08%,IGF1;GREM2;EPHA7;BMP6;IGF2;GDNF;AREG;TGFA;SEMA3D;IL34;IL17D;EPGN;WNT8B;INHBE;WNT4;GAS6;SEMA5A;WNT6;CSF1;APOA1;ENDOU;NTF3;VIP;FAM3B;CCL4;WNT5B;IL12B;TSLP
prerank,wide pore channel activity (GO:0022829),0.6120649184303041,1.534548276622741,0.03255813953488372,0.41190103395748123,1.0,4/23,7.01%,GJA1;GJB6;GJB2;PANX1
prerank,gap junction channel activity (GO:0005243),0.6172935282009426,1.5259073818682094,0.0327613104524181,0.42937573803650647,1.0,4/22,7.01%,GJA1;GJB6;GJB2;PANX1
prerank,muscle alpha-actinin binding (GO:0051371),0.6775840327139385,1.5232665853261045,0.053082191780821915,0.4262753486979206,1.0,4/15,4.66%,PDLIM5;PDLIM2;PALLD;SYNPO2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5481192736791228,-1.5203888083617132,0.04696132596685083,0.2738002471553022,0.999,7/19,12.76%,EFNA5;AFAP1L2;NRG3;GRM5;DGKQ;PAK2;ERBB3
prerank,acylglycerol lipase activity (GO:0047372),-0.6295298608456299,-1.520056796996409,0.05057471264367816,0.26725633313905056,0.999,3/11,5.02%,MGLL;ABHD2;LIPE
prerank,poly-pyrimidine tract binding (GO:0008187),0.622361301823029,1.5187778607416966,0.05362776025236593,0.43019230811165604,1.0,3/23,1.36%,RBMS1;ATXN1;RBMS3
prerank,NAD binding (GO:0051287),0.5945500178000364,1.514116170170084,0.04606240713224369,0.43369428478262523,1.0,5/26,8.59%,ALDH1A1;CRYL1;SIRT2;NNT;ALDH2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.6369205539722425,-1.5132906914327768,0.04187192118226601,0.27332485704328074,1.0,8/11,27.35%,SGMS1;SGMS2;PTDSS1;SAMD8;PIGO;GNPTAB;PIGN;AASDHPPT
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5645859326059048,-1.5076753770170739,0.05063291139240506,0.2702117105571301,1.0,7/16,21.77%,ANO1;ANO4;TTYH2;ANO3;ANO2;ANO6;NMUR2
prerank,intracellular chloride channel activity (GO:0061778),-0.5645859326059048,-1.5076753770170739,0.05063291139240506,0.2702117105571301,1.0,7/16,21.77%,ANO1;ANO4;TTYH2;ANO3;ANO2;ANO6;NMUR2
prerank,phosphatidylglycerol binding (GO:1901611),-0.6027721839117335,-1.5020872766454538,0.05693069306930693,0.2730864332429869,1.0,3/13,3.60%,PITPNC1;PLTP;PITPNA
prerank,transcription coactivator binding (GO:0001223),0.6270169731027104,1.499438806728263,0.039619651347068144,0.472111642730304,1.0,4/20,3.07%,RORA;SMAD3;AR;THRB
prerank,5'-nucleotidase activity (GO:0008253),-0.6101240157613864,-1.4989625092407053,0.034653465346534656,0.2725037286679708,1.0,5/13,19.08%,NT5E;NT5C2;NT5C1A;NT5C;ACP3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.6493014407524157,1.4966048604384141,0.06535947712418301,0.47073966994977146,1.0,3/16,7.63%,SLC44A1;SLC22A2;SLC22A4
prerank,inward rectifier potassium channel activity (GO:0005242),-0.500251887838741,-1.4957859942716216,0.05234159779614325,0.27230834763976197,1.0,12/24,26.86%,KCNJ2;KCNJ3;ABCC9;KCNN2;KCNJ15;KCNJ10;KCNJ8;KCNJ6;ABCC8;KCNJ13;KCNJ16;KCNN1
prerank,nuclear export signal receptor activity (GO:0005049),0.7003324262562761,1.4935710008641307,0.07521367521367521,0.4699725361917051,1.0,5/11,14.44%,RANBP17;NUP42;XPO7;CSE1L;NUP214
prerank,endopeptidase regulator activity (GO:0061135),0.5309406379459967,1.491957433313802,0.046153846153846156,0.4650573270599569,1.0,12/40,15.33%,AHSG;RECK;FETUB;CAST;SERPIND1;TFPI;CST3;RENBP;APH1B;ITIH2;ADRM1;NLRC4
prerank,protein kinase C binding (GO:0005080),0.5369776753027079,1.4912936180952634,0.04207573632538569,0.45702294790017084,1.0,9/43,9.63%,NELL1;PDLIM5;PRKCSH;GRK5;DACT1;TOP2B;PARD6G;PARD6B;ITGAV
prerank,ion channel activity (GO:0005216),-0.3872356314822123,-1.4847790542377193,0.01951219512195122,0.28616318139803226,1.0,18/80,9.66%,TRPM3;PIEZO2;GRID2;GRIA4;PIEZO1;GRIK1;GRIK2;GRIN2A;ABCC9;MCUB;GABRB1;TRPC1;UNC80;GRIN2B;GRIN3A;TRPM7;GRIA2;GRID1
prerank,calcium-release channel activity (GO:0015278),0.6391486918422701,1.4805832953761155,0.07178631051752922,0.4815203630355947,1.0,3/17,4.73%,ITPR1;TRPA1;RASA3
prerank,amino acid:sodium symporter activity (GO:0005283),0.7002182525826082,1.477663754707182,0.0807899461400359,0.48061168509646657,1.0,2/11,3.80%,SLC1A3;SLC6A13
prerank,endopeptidase activity (GO:0004175),0.4344158570593946,1.4768057317892191,0.003157894736842105,0.47338877634017146,1.0,47/257,14.58%,ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;USP11;RHBDL3;SFRP1;CTSH;MMP11;CTSF;USP47;USP20;MMEL1;ADAMTS9;SPRTN;PRSS48;USP35;USP24;USP48;PMPCB;ECE2;EEF1AKMT4-ECE2;APEH;MASP1;CAPN7;CLPP;CASP7;ADAMTSL4;F2;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;JMJD7;HPN;THOP1
prerank,"DNA binding, bending (GO:0008301)",-0.5622895757217274,-1.4763446853789508,0.05623471882640587,0.29621516575728957,1.0,6/14,20.17%,LEF1;FOXD1;HHEX;TOP2A;HMGB2;HMGA2
prerank,carboxypeptidase activity (GO:0004180),0.5489458720686202,1.4755827635670327,0.05635838150289017,0.4682908586593166,1.0,9/35,12.71%,CPXM2;AEBP1;VASH2;CPXM1;AGBL2;NAALADL1;PEPD;CPA2;CTSZ
prerank,neuropeptide receptor activity (GO:0008188),-0.46949496769718996,-1.4696692868125742,0.04519774011299435,0.30301661266796603,1.0,18/29,40.36%,SORCS2;HCRTR2;NPY1R;SORCS1;GPR37;NPSR1;SORCS3;NPY5R;NMUR2;TACR1;SSTR2;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.6507694456248735,1.4622217831279032,0.08277027027027027,0.5031924790972372,1.0,5/14,7.14%,COL4A3;TIMP3;RECK;FETUB;TIMP2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5138571482779662,1.4611686465363891,0.050143266475644696,0.49692303163345736,1.0,8/53,6.40%,SLC7A11;SLC1A3;SLC7A2;SLC1A5;SLC6A9;SLC22A2;SLC7A13;SLC38A6
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.44222506143767054,-1.4603427708577283,0.03859649122807018,0.31432960167583446,1.0,14/37,22.19%,WARS1;WARS2;LARS1;TARS3;YARS1;YARS2;QARS1;TARS2;KARS1;FARS2;NARS2;MARS2;AARS2;TARS1
prerank,nucleotidase activity (GO:0008252),-0.5624100836499901,-1.4596340059575696,0.0549738219895288,0.3093906106801255,1.0,6/15,22.12%,NT5E;NT5C2;NT5C1A;NT5C;ACP3;BPNT2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.64549646118781,1.4595920137253715,0.09149277688603531,0.4927262418180275,1.0,8/15,20.55%,SETD1A;WDR82;SETD4;KMT2A;WDR5;SETD1B;CXXC1;RBBP5
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6504003526029369,1.4573718531510664,0.07534246575342465,0.4897559322521216,1.0,2/15,1.08%,SLC1A3;SLC1A5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.6807698086286348,1.4561603133453649,0.09722222222222222,0.4847571106265749,1.0,3/11,15.81%,SLC25A24;SLC35B3;LRRC8A
prerank,phospholipase binding (GO:0043274),0.6596148041021637,1.451250668379896,0.07773851590106007,0.49092047964726426,1.0,4/13,9.33%,PDPK1;ARHGAP6;SRC;PRKN
prerank,rRNA binding (GO:0019843),-0.42180460094363886,-1.4499979050769445,0.030927835051546393,0.32195728648367095,1.0,16/42,21.54%,RPS14;RPS13;RPS3;RPL11;RPS9;CAVIN1;RPS5;MRPS18A;PPAN;RPL5;FASTKD2;RPLP0;MRPS7;RPL23;RRS1;RPF2
prerank,insulin-like growth factor binding (GO:0005520),0.6490339837346809,1.448885772959091,0.08080808080808081,0.48984540957791056,1.0,8/15,12.56%,IGFBP2;IGFBP4;IGFBP5;IGF2R;ITGB3;ITGAV;IGFBP3;INSR
prerank,leak channel activity (GO:0022840),0.6155706791908869,1.4463448049850223,0.08064516129032258,0.4888074108902587,1.0,4/18,7.01%,KCNK2;NALCN;KCNK7;PANX1
prerank,actin binding (GO:0003779),0.4398766579100252,1.4445844289439103,0.014176663031624863,0.4856573247676457,1.0,31/170,10.14%,PHACTR1;PLEKHH2;MTSS1;PDLIM5;MICAL3;NCALD;CALD1;GSN;SYNE2;DAG1;TLN2;TPM1;PDLIM2;PARVA;SHROOM2;MACF1;VASH2;MYH10;PHACTR2;SYNPO2;IQGAP2;LIMA1;SMTN;LRRK2;VCL;MYL4;CAPZB;ACTN4;PRKN;SYNPO2L;TNNT3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5332050023675219,1.440513749533468,0.06428571428571428,0.4905685653249365,1.0,7/38,6.33%,SERPINE1;SERPING1;SERPIND1;WFDC3;TFPI;SERPINF1;SERPINH1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5759980810114154,-1.439216545050425,0.07766990291262135,0.33765984889631157,1.0,8/13,13.99%,KCNQ1;PRKAR1A;GSK3A;PRKAR2B;PRKAR1B;CSK;PRKAR2A;RYR2
prerank,growth factor receptor binding (GO:0070851),0.4614818547860717,1.4350847371779145,0.044359949302915085,0.49906618001618436,1.0,21/95,13.94%,ESM1;PDGFD;AREG;TGFA;IL6R;EPGN;KL;PDGFRA;PDGFRB;FRS2;PIBF1;SRC;IL12B;TSLP;ITGB3;FGF2;TRIP6;HBEGF;EGF;GLMN;ARF4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.43178927041573817,1.432051174212981,0.018579234972677595,0.5001970991257367,1.0,42/188,15.07%,TCF7L2;ZBTB20;TBL1XR1;PBX1;SMAD3;AR;SOX5;RUNX1;ARID5B;NKX2-1;ARID4A;PRDM5;YAP1;IRF1;CREB3L2;KLF15;BCOR;TCF7;CEBPA;NFE2L2;RNF10;NR1D1;FOXC2;NCOR1;NONO;MZF1;GLIS2;FOXA1;TFAM;CEBPB;REST;PER3;GLI1;ZNF513;HDAC4;TAF9;ETS1;TCF12;GATA6;NR1H3;RXRA;FOXK2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.4446102438427563,-1.4297570386036327,0.05757575757575758,0.3513670240087404,1.0,9/32,22.20%,KCNB2;KCNQ5;KCNQ1;KCNC2;KCNQ3;KCNA2;KCNS3;KCNC1;KCNC4
prerank,insulin-like growth factor I binding (GO:0031994),0.6534837473900622,1.428178496846439,0.1111111111111111,0.5037985037614334,1.0,7/13,12.56%,IGFBP2;IGFBP4;IGFBP5;ITGB3;ITGAV;IGFBP3;INSR
prerank,nuclease activity (GO:0004518),0.4927535377717629,1.423797893399548,0.05459387483355526,0.509955410587304,1.0,10/52,11.57%,ENPP1;REXO5;SND1;OGG1;REXO4;RNASE12;RNASEL;PARN;DNASE1L1;RNASE7
prerank,cadherin binding (GO:0045296),-0.3067127129076605,-1.4232533584926403,0.0,0.3585857933936569,1.0,88/315,15.10%,PKP4;PTPRB;DOCK9;COBLL1;MRTFB;STXBP6;MPP7;FNBP1L;PTPRJ;CTNND2;ESYT2;CDH2;BAIAP2L1;ITGA6;NOTCH3;PROM1;F11R;CDH1;ANK3;KDR;BSG;TJP2;EPN2;CTNNA3;CEMIP2;TJP1;STK38;HSPA8;IQGAP1;RPL34;CBL;TRPC4;SPTBN1;CDH12;CDH6;RDX;PAICS;UBAP2;EEF2;CDH8;DIAPH3;LRRFIP1;TES;PTPRT;TMOD3;CDH9;FMNL2;HSP90AB1;TAGLN2;CLIC1;HNRNPK;EHD4;EPS8L2;CDH13;ANLN;WASF2;SNX1;PACSIN2;PFKP;LASP1;TRIM25;PCBP1;CLINT1;ABCF3;ALDOA;JUP;CDH10;SH3GLB2;SCRIB;RANGAP1;RPL6;RPL29;BZW2;GLOD4;CCT8;RPL7A;GAPVD1;PAK2;SLC3A2;PPME1;RPL14;PLEC;RUVBL1;EMD;NUMB;GIPC1;MB21D2;PDLIM1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6096736245976679,-1.4159300037646796,0.08705882352941176,0.3678443898655333,1.0,6/10,20.74%,GABRG3;GABRA2;GABRG2;GABRA3;GABRA4;GABRG1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.448899683125552,-1.411237173468448,0.08359133126934984,0.37023761886936496,1.0,16/31,28.98%,SLC12A2;SLC12A7;KCNK5;ABCC9;SLC12A6;KCNK10;KCNA2;SLC12A5;SLC12A8;HCN1;TMEM38B;KCNC4;ABCC8;KCNK4;SLC12A9;AQP1
prerank,nucleotide diphosphatase activity (GO:0004551),0.6336708003050056,1.4069284376044444,0.12048192771084337,0.5561187869561199,1.0,3/14,6.82%,CILP;ENPP1;NUDT13
prerank,actinin binding (GO:0042805),0.5779644963110859,1.406642261017475,0.09902597402597403,0.5484716855220162,1.0,6/21,9.67%,PDLIM5;DAG1;SYNPO2;CSRP2;CACNA1C;CSRP3
prerank,metalloexopeptidase activity (GO:0008235),0.49801257926909903,1.4038967069298145,0.07586206896551724,0.5488356202792817,1.0,8/51,8.29%,CPXM2;CPQ;AEBP1;VASH2;CPXM1;AGBL2;DPEP1;PEPD
prerank,store-operated calcium channel activity (GO:0015279),-0.6012171074915329,-1.4022028028500726,0.10185185185185185,0.3836749778694778,1.0,5/10,13.40%,TRPC3;TRPC4;TRPC5;TRPC1;TRPC6
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5920587162260481,1.400910515873774,0.11692307692307692,0.5502283933807415,1.0,4/18,5.70%,TGFBR3;SMAD3;TGFBR1;ENG
prerank,lipoprotein particle receptor binding (GO:0070325),0.5376680112468233,1.4007836137148792,0.09090909090909091,0.5426931301863194,1.0,5/27,9.04%,LRP1;HSPG2;APOE;APOA1;PICALM
prerank,P-type ion transporter activity (GO:0015662),-0.5580921978367863,-1.3979923379348698,0.07894736842105263,0.38651393024041475,1.0,5/12,11.80%,ATP2C1;ATP2A3;ATP2B2;ATP2B4;ATP7A
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.6387720444521283,1.3977336405804852,0.13518197573656845,0.5448945191580722,1.0,3/12,15.81%,SLC25A24;SLC35B3;LRRC8A
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.44957723211541295,-1.3938820504085467,0.0967741935483871,0.38935509821170916,1.0,10/27,15.86%,SLC26A7;SLC26A2;ANO1;SLC22A8;SLC22A6;SLC39A8;SLC25A30;SLC26A6;SLC25A11;XPR1
prerank,hormone activity (GO:0005179),0.49015533177758497,1.3882767475404083,0.07539682539682539,0.5675798319498071,1.0,3/54,8.45%,IGF1;VIP;NPFF
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4584124673237818,1.3844133777261263,0.05926860025220681,0.5713507530256589,1.0,16/72,12.45%,FRMPD4;SVIL;ACTN2;GSN;MARK1;TULP1;PLCD1;MYO1B;ADAP2;TULP3;SNX18;PICALM;COMMD1;GSDME;SNX21;SYTL2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.596448305115615,1.3810413088031215,0.12519809825673534,0.5659452222187319,1.0,1/16,0.20%,ATP6V0A4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.596448305115615,1.3810413088031215,0.12519809825673534,0.5659452222187319,1.0,1/16,0.20%,ATP6V0A4
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.4587066464177677,-1.3795166937251233,0.08284023668639054,0.4150456299776691,1.0,12/26,28.28%,PPP1R1A;PPP1R14C;PTN;PPP1R14B;MGAT5;PPP1R14A;PPME1;LMTK2;CABIN1;PPP1R11;PPP1R1B;SET
prerank,growth factor activity (GO:0008083),0.45582287117089665,1.3789580458345345,0.06958762886597938,0.5647031424789625,1.0,16/74,14.21%,IGF2;GDNF;AREG;TGFA;EPGN;CSF1;ENDOU;NTF3;IL12B;CSPG5;FGF2;HBEGF;F2;EGF;NRTN;MDK
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.39978720034802356,-1.3783468410696003,0.05714285714285714,0.4108126340665603,1.0,10/48,7.91%,TRPM3;PIEZO2;SLC12A2;SLC12A7;PIEZO1;ABCC9;TRPC1;UNC80;SLC12A6;TRPM7
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4780647863652504,-1.3764558625660683,0.1069364161849711,0.4083088739553323,1.0,12/21,15.16%,PDE5A;PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE1C;PDE8B;PDE9A;PDE7A;PDE4C;PDE6A
prerank,cell adhesion mediator activity (GO:0098631),-0.46522365926185194,-1.3752731908396583,0.08797653958944282,0.4045015923008978,1.0,9/24,10.50%,ESAM;BSG;CNTN4;NTNG1;SIRPA;CNTN6;LRRC4C;ROBO4;EMB
prerank,sulfuric ester hydrolase activity (GO:0008484),0.631396144538847,1.3742243091781428,0.12609457092819615,0.5724083750164838,1.0,3/12,4.24%,SULF2;SULF1;GALNS
prerank,O-methyltransferase activity (GO:0008171),0.6494232482702569,1.3739502004965247,0.13756613756613756,0.5659044599420144,1.0,5/10,15.39%,COMT;FTSJ3;LRTOMT;BCDIN3D;CMTR2
prerank,copper ion binding (GO:0005507),0.4971474728493876,1.371752226047415,0.0944206008583691,0.5657346398438056,1.0,4/42,5.00%,PAM;MOXD1;MT3;HEPH
prerank,peptidase inhibitor activity (GO:0030414),0.5100342471584881,1.3674205971493476,0.101620029455081,0.5715421722085063,1.0,10/33,12.58%,AHSG;RECK;FETUB;CAST;SERPIND1;TFPI;CST3;TIMP2;RENBP;ITIH2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.47637852592923474,1.3669683469196463,0.09241379310344827,0.5654192116217861,1.0,16/60,17.47%,LRRK1;PPM1H;PPM1E;CTDSPL;PPP3CA;LRRK2;MTMR3;RPAP2;CTDSP2;PPP1R3C;PHLPP2;PTEN;PPP1R3D;PPM1G;UBLCP1;DUSP4
prerank,poly-purine tract binding (GO:0070717),0.5477500355430751,1.366799129340987,0.13601236476043277,0.5589147469008869,1.0,6/27,11.00%,RBMS1;ATXN1;RBMS3;RBMS2;RBPMS;DDX3X
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4482892296428511,-1.3667200184652062,0.0926517571884984,0.41593386557550566,1.0,8/26,9.96%,SLC6A6;ABCG2;SLC16A6;SLC5A6;SLC16A9;SLC16A1;SLC16A4;SLC26A6
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.46404901088262235,-1.3631100825506506,0.09880239520958084,0.41718439555049386,1.0,12/23,15.16%,PDE5A;PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE1C;PDE8B;PDE9A;PDE7A;PDE4C;PDE6A
prerank,protein heterodimerization activity (GO:0046982),0.4072104106269842,1.3584910658642397,0.036026200873362446,0.5780164755289937,1.0,39/178,13.52%,TCF4;BMP6;ADRA1B;ARNT2;ATP1A2;BCL2;TPM1;ITGA3;IRAK2;ZHX2;NEUROD1;MIGA2;EPAS1;ADRA2C;BDKRB2;BUD23;IL12B;AGTR1;ATP1B2;TLR6;TOP2B;IRAK3;ZBTB1;KATNB1;KRT10;ARNT;MICU2;EXT1;BHLHE41;ADRA2A;KATNA1;RRAGD;NR4A1;YWHAE;MTTP;TUBB2B;TPM2;TRMT112;P4HB
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5571998477700165,-1.3545627846167962,0.1378504672897196,0.42962703932615254,1.0,4/12,16.68%,ENTPD1;ENTPD2;ENTPD6;ENTPD3
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4179636335115173,-1.35215855224016,0.09539473684210527,0.42836443179412154,1.0,18/35,28.13%,TAF1B;RRN3;TAF1;BAZ2A;TBP;FOXP1;TAF1C;UBTF;H3-3A;AGO1;NPM1;GTF2B;TAF4;SMARCA4;RUVBL2;PIH1D1;FOS;TBPL1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6122343654355762,1.3497159381078665,0.14942528735632185,0.5984829355736286,1.0,4/14,8.25%,PYCR1;MTHFR;PYCR3;ALDH1L1
prerank,CoA hydrolase activity (GO:0016289),0.5889970338044468,1.3494397485350615,0.1390728476821192,0.5921231698570568,1.0,4/16,5.15%,ACOT11;ACOT6;ACOT2;NUDT7
prerank,LRR domain binding (GO:0030275),0.6156375698669202,1.3476175718864623,0.14332247557003258,0.5908488465656462,1.0,2/14,7.37%,ROBO1;PMF1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.39959797433437805,-1.3467363909455168,0.08280254777070063,0.4350318563227075,1.0,18/37,25.88%,SLCO2A1;SLCO1C1;SLC22A8;SLCO2B1;SLC22A6;COX4I1;UQCRH;COX6A1;COX5B;SLCO4A1;COX5A;SLCO1B1;UQCR10;COX8A;UQCR11;UQCRQ;UQCRC1;UQCRFS1
prerank,lipid phosphatase activity (GO:0042577),0.5980082332516576,1.3466508807059858,0.16134453781512606,0.5866365495507662,1.0,3/14,3.04%,PLPP3;EPHX2;PLPP7
prerank,pyridoxal phosphate binding (GO:0030170),0.5525324140840838,1.3465495379374637,0.13658536585365855,0.5801996131595532,1.0,5/20,15.80%,ABAT;ACCS;PDXK;PYGM;PYGB
prerank,GDP binding (GO:0019003),-0.3588202905972404,-1.3460843352618836,0.046218487394957986,0.42995611822207813,1.0,16/63,14.29%,RAP1A;RIT2;RAB27A;KRAS;RAB21;RAP1B;RAB5B;RAB12;RAB8B;RAB27B;ARL3;RASL12;DIRAS2;RALB;RIT1;RAB4A
prerank,pseudouridine synthase activity (GO:0009982),0.6195100446204893,1.3420965506316969,0.1453287197231834,0.5878568793430096,1.0,6/13,18.90%,PUS3;RPUSD4;RPUSD2;TRUB2;PUSL1;TRUB1
prerank,cyclic nucleotide binding (GO:0030551),-0.4602384064137075,-1.3398465871918677,0.13315926892950392,0.4380699137188663,1.0,4/21,4.96%,PDE5A;PDE4D;PDE4B;PDE2A
prerank,DNA-binding transcription factor binding (GO:0140297),0.3986333421745658,1.339246320292209,0.03433001107419712,0.5901226686968076,1.0,28/189,10.63%,TCF7L2;LDB2;FHL2;RUNX1T1;SMAD3;AR;BCL2;DACT1;PRRX1;PRDM5;ASCL1;YAP1;TLE1;CRTC3;NEUROD1;TBX3;SKI;SIK1;NFE2L2;MTA2;RERE;RBPJ;NCOR1;MTA3;IFI27;CXXC5;RBL2;NEK6
prerank,heme binding (GO:0020037),0.461356203549167,1.3337510560348935,0.0963855421686747,0.6002638297398071,1.0,16/65,13.13%,PTGIS;CYP26B1;CYB5B;TDO2;FLVCR2;CYP1B1;SRC;HEBP1;CYP27A1;NR1D1;CYB5A;SDHC;PGRMC2;SLC48A1;CYB5R4;NOX4
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5339760431257444,-1.3327351012361843,0.1315136476426799,0.4487858337176965,1.0,2/12,1.56%,PIEZO2;PIEZO1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5248854446305167,-1.3326012230890463,0.1480637813211845,0.44274631797704944,1.0,5/12,8.53%,SLC9A2;SLC9B2;SLC9A6;LETM1;SLC9A7
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.4870626133256064,-1.3315263123316574,0.10852713178294573,0.4391002342370092,1.0,9/17,17.76%,PITPNC1;ATP8B1;PLTP;PITPNA;ABCG1;PCTP;PITPNB;ATP10A;ABCB4
prerank,poly(A) binding (GO:0008143),0.5506791076858427,1.329237555404701,0.17384615384615384,0.6075389675840627,1.0,5/21,11.00%,RBMS1;RBMS3;RBMS2;RBPMS;DDX3X
prerank,cytokine receptor activity (GO:0004896),0.4407411098323921,1.328363502896753,0.08472400513478819,0.6035397152368129,1.0,14/83,10.11%,GHR;IL31RA;IL6R;LEPR;GFRA2;OSMR;XCR1;ACKR2;CCR9;IL12B;IL13RA1;IL15RA;CNTFR;GFRA4
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5181628170546376,-1.3273187724001942,0.1411764705882353,0.44238175261396856,1.0,5/13,8.53%,SLC9A2;SLC9B2;SLC9A6;LETM1;SLC9A7
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.5020742265884521,1.3261922917829392,0.13412816691505217,0.6033677173531947,1.0,16/34,21.73%,IGF2;PARP16;MAP2K1;CKS1B;ALS2;STK4;SPRY2;CCNK;DDX3X;STRADA;CCNT2;RICTOR;ETAA1;MLST8;TAOK1;CCNT1
prerank,fatty acid synthase activity (GO:0004312),-0.5761598122308472,-1.3250388692122586,0.1536697247706422,0.4412231673787611,1.0,2/10,5.34%,ELOVL7;ELOVL5
prerank,ligand-gated calcium channel activity (GO:0099604),0.5563882994935061,1.3202711702456276,0.1696,0.6151533974225823,1.0,4/19,9.41%,ITPR1;TRPA1;RASA3;TRPM4
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6036701630030411,1.3196899495775645,0.19055944055944055,0.6102822479990883,1.0,5/11,18.27%,CASP12;CFLAR;CASP7;CASP9;CASP1
prerank,calcium channel inhibitor activity (GO:0019855),0.6209346086799459,1.317149799544593,0.178752107925801,0.6117953990555045,1.0,1/11,0.27%,ITPR1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.6150383064357586,1.316542635210297,0.20930232558139536,0.6072675189020222,1.0,5/10,18.27%,CASP12;CFLAR;CASP7;CASP9;CASP1
prerank,potassium channel activity (GO:0005267),-0.3333748414869772,-1.3137375950426513,0.07446808510638298,0.4611742662279739,1.0,18/89,9.58%,KCNB2;KCNK5;KCNQ5;KCND2;GRIK1;GRIK2;KCNMA1;KCND3;ABCC9;KCNK13;KCNN2;KCNQ1;KCNH7;KCNH5;KCNC2;KCNMB2;KCNK10;KCNQ3
prerank,tRNA methyltransferase activity (GO:0008175),0.5751686082639035,1.3135699221144164,0.1835016835016835,0.6098953115210195,1.0,6/16,15.14%,TRMT44;BCDIN3D;TRMT9B;TRMT13;THUMPD3;THUMPD2
prerank,protein kinase activator activity (GO:0030295),0.44786335155579293,1.312794748906498,0.11964735516372796,0.606368314545825,1.0,19/60,14.25%,IGF2;PRKAG2;GAS6;MT3;GPRC5D;PARP16;MAP2K1;ALS2;STK4;SPRY2;STK11;FGF13;DDX3X;RGCC;STRADA;DUSP19;WNK1;MARK2;GPRC5A
prerank,glycine binding (GO:0016594),-0.5393065367284464,-1.3127654722937225,0.16009280742459397,0.45729721737518203,1.0,4/11,7.48%,GLRA1;GLRA2;GRIN2B;GRIN3A
prerank,amino acid transmembrane transporter activity (GO:0015171),0.46738732119857673,1.3071736262159932,0.11571428571428571,0.6176830786742755,1.0,11/47,9.73%,SLC7A11;SLC7A2;SLC1A5;SLC6A13;SLC22A2;SLC7A13;PDPN;SLC38A6;SLC22A4;SLC38A9;SLC43A1
prerank,calcium channel activity (GO:0005262),0.4220137241794937,1.3068444142273332,0.11166253101736973,0.6125308893847776,1.0,13/84,10.49%,CACNA2D3;SLC24A3;SLC24A1;MCU;CACNB1;SLC24A5;CACNA1C;PANX1;CUL5;ORAI2;TRPM4;ITGAV;ANXA6
prerank,fibroblast growth factor binding (GO:0017134),0.5438192133276418,1.3067805367782321,0.1872146118721461,0.6067146922791865,1.0,9/21,15.82%,FGFR1;KL;FGFR2;FGFR4;GLG1;ITGB3;ITGAV;CXCL13;FIBP
prerank,FAD binding (GO:0071949),0.5187312107809045,1.3064145700856769,0.15512048192771086,0.6018938164659061,1.0,5/24,8.95%,MICAL3;MTHFR;DDO;SQOR;AIFM1
prerank,bHLH transcription factor binding (GO:0043425),0.5487860579430222,1.3030023721817545,0.15203761755485892,0.6059487957238547,1.0,3/19,3.21%,FHL2;SMAD3;ASCL1
prerank,protein tyrosine kinase activity (GO:0004713),0.4067900749548249,1.3001896987806,0.09773539928486293,0.6083002996679137,1.0,22/108,10.44%,EPHA3;EPHA7;DDR2;LYN;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;AXL;MUSK;ROR1;SRC;NTRK3;EGFR;EPHB2;RYK;BAZ1B;TTBK1
prerank,kinase inhibitor activity (GO:0019210),0.4846592748878943,1.2999499947057525,0.1537313432835821,0.6032804581719458,1.0,7/33,12.37%,RHOH;AHSG;PARVA;ITPRIP;DNAJC3;TAOK3;DUSP19
prerank,voltage-gated calcium channel activity (GO:0005245),0.4788093151312395,1.2983301788365655,0.16279069767441862,0.6022410896502501,1.0,5/37,11.34%,CACNA2D3;CACNB1;CACNA1C;ITGAV;CACNA1G
prerank,kinase activator activity (GO:0019209),0.49928924360576227,1.2973675573300685,0.13656387665198239,0.5993848939685825,1.0,12/30,16.25%,PRKAG2;MT3;GPRC5D;STK11;FGF13;RGCC;STRADA;DUSP19;WNK1;MARK2;GPRC5A;AGAP2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.513287675757357,1.2972560187173823,0.1582089552238806,0.594197577348834,1.0,11/27,22.65%,POLR2D;POLR3A;POLR2C;POLRMT;PRIMPOL;POLR2L;POLR1F;MED21;POLR1H;POLR1D;POLR1C
prerank,transcription cis-regulatory region binding (GO:0000976),0.3726558872360727,1.2924919674871498,0.03278688524590164,0.6021907808907876,1.0,78/406,15.86%,TCF7L2;ZBTB20;RORA;TBL1XR1;TRPS1;TEAD1;PBX1;SMAD3;AR;SOX5;RUNX1;GLI3;AEBP1;ARID5B;NKX2-1;ARID4A;PRDM5;ASCL1;YAP1;MLXIP;MXI1;MSC;IRF1;RFX5;CREB3L2;KLF15;ETV6;EPAS1;CUX2;ZBTB8B;BCOR;TCF7;NR5A1;CEBPA;NFE2L2;RNF10;SREBF1;DR1;NR1D1;OSR1;BBX;FOXC2;NCOR1;ZBTB4;NONO;MZF1;ACTN4;GLIS2;ARNT;CREB3;FOXA1;TFAM;RBL2;ZBTB8A;ZNF177;CEBPB;POLRMT;NFE2;REST;PER3;GLI1;STAT6;ZNF513;HOXC8;HDAC4;TAF9;ETS1;TWIST2;TCF12;GATA6;NR1H3;ZNF25;RXRA;FOXK2;PSPC1;MTF1;TFCP2;ZBTB17
prerank,neuropeptide binding (GO:0042923),-0.46904942104129765,-1.2892371309438322,0.15577889447236182,0.506407856835759,1.0,11/18,44.51%,SORL1;GPR37;NMUR2;SSTR2;MC4R;SSTR1;OPRD1;NMUR1;GPR149;OPRM1;SSTR3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.6059542556961528,1.2891471531072094,0.22240802675585283,0.6061775893389089,1.0,2/11,9.93%,AKR1B1;AKR1B10
prerank,glutathione transferase activity (GO:0004364),0.5207287759027918,1.286655668262443,0.19213313161875945,0.6076505696535539,1.0,6/23,13.90%,PTGES;GSTM4;GSTM2;MGST1;GSTT1;GSTK1
prerank,sulfotransferase activity (GO:0008146),0.488296830681754,1.2864421087064053,0.16167664670658682,0.6028905720420813,1.0,5/33,4.61%,UST;GAL3ST3;GAL3ST2;TPST1;HS6ST1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5854687264375628,1.2854387302164156,0.20490367775831875,0.6007588183060713,1.0,2/12,5.05%,PIK3R1;FRS2
prerank,receptor tyrosine kinase binding (GO:0030971),0.4420184974594784,1.2844368186690855,0.15374149659863945,0.5983288553373922,1.0,7/56,5.05%,ANGPT1;CBLB;PIK3R1;DOCK4;GAS6;ANGPT2;FRS2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.41153855267912676,1.2772413440633352,0.11858190709046455,0.6123625773111304,1.0,22/91,15.77%,FRMPD4;SVIL;ACTN2;GSN;MARK1;TULP1;PLCD1;MYO1B;SH3PXD2B;ADAP2;TULP3;SNX18;PICALM;COMMD1;GSDME;SNX21;SYTL2;WIPI1;PIRT;PARD3;GSDMD;LAPTM4B
prerank,steroid hydroxylase activity (GO:0008395),0.5578260161599281,1.2767787221582663,0.1946624803767661,0.6084312236776218,1.0,5/16,18.28%,CYP7B1;CYP1B1;CYP27A1;CYP2R1;CYP1A1
prerank,ATPase binding (GO:0051117),0.4222361927636558,1.2764313245563914,0.13474240422721268,0.6042786439835289,1.0,17/71,13.84%,ATP6V0A4;AR;ABCA1;TMTC4;PPP3CA;ANK1;DERL1;SRC;ATP1B2;SLC2A13;EGFR;ATP6V1E1;CLPP;TOR1AIP1;SELENOS;PTPN3;TAF9
prerank,tau-protein kinase activity (GO:0050321),0.5340599092562033,1.274020494099848,0.18679549114331723,0.6061052389040189,1.0,6/20,15.27%,ROCK2;MARK1;BRSK1;TTBK1;MARK2;DYRK1A
prerank,SH3 domain binding (GO:0017124),-0.3383391876987174,-1.2706543949183853,0.08,0.5462313460210264,1.0,14/62,10.26%,AFAP1L1;SHANK3;SGIP1;ELMO1;AFAP1L2;ENAH;ADAM12;ADAM15;CBL;ARHGAP27;PTPN12;WASF2;SHANK1;SKAP1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6173477760263302,1.268321886530673,0.24324324324324326,0.6168599051724827,1.0,3/10,11.22%,DSE;RENBP;GALM
prerank,histone demethylase activity (GO:0032452),0.4906974786389121,1.2652695900524145,0.17573872472783825,0.6197662647788003,1.0,13/27,23.23%,FBXL19;KDM5B;PHF2;KDM5C;KDM7A;PHF8;RIOX1;KDM3B;KDM4A;KDM5A;KDM4C;JARID2;KDM3A
prerank,pentosyltransferase activity (GO:0016763),0.46300213986163397,1.2640873981469385,0.17851959361393324,0.6180648919183578,1.0,12/36,19.43%,ART4;PARP11;LARGE1;LARGE2;PARP16;SIRT2;PARP14;TNKS2;UPP2;LACC1;SIRT5;PPAT
prerank,calcium activated cation channel activity (GO:0005227),-0.4647564228321103,-1.2632432148058126,0.1896551724137931,0.5582524428495824,1.0,7/17,16.55%,ANO1;KCNMA1;KCNN2;KCNMB2;TMEM63C;TMEM63B;ANO6
prerank,mRNA 3'-UTR binding (GO:0003730),0.42083242468395904,1.2630054593726263,0.14852752880921896,0.6157343764385055,1.0,13/79,12.76%,CELF2;RBMS1;RBMS3;CSDC2;IGF2BP2;CPEB1;ZFP36L1;CPEB3;RBMS2;PARN;SERBP1;LARP1;UTP23
prerank,ligand-gated cation channel activity (GO:0099094),-0.33015595251574686,-1.261163514194939,0.1,0.556925243711267,1.0,12/75,8.47%,KCNJ2;GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;KCNJ3;P2RX7;KCNN2;GRIN2B;GRIN3A;GRIA2
prerank,MHC class II protein complex binding (GO:0023026),-0.5185887221274328,-1.2605515089148829,0.19002375296912113,0.5515218755342282,1.0,4/11,12.70%,HSPA8;ATP1B1;HSP90AB1;CD81
prerank,pre-mRNA binding (GO:0036002),0.5005605988830317,1.2570538802972606,0.21376281112737922,0.6275969937670391,1.0,11/28,23.08%,CELF2;U2AF1L4;RBM22;HNRNPA1;ERI1;RNPC3;RBM41;HNRNPU;RBM4;ZRSR2;PRPF8
prerank,ubiquitin protein ligase activity (GO:0061630),0.37054755395006356,1.2543271984149469,0.08845738942826321,0.6301922557769845,1.0,60/228,18.74%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;BFAR;CDC42;ZNRF3;KCMF1;UBE4B;RNF10;TRIP12;DTX4;RNF185;RNF139;RNF145;UBR4;UBOX5;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;RNFT1;RNF217;MUL1;RNF19A;RC3H2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;RNF2;NHLRC3;UBR5;MSL2;UBR3;UBE3B;RNF138;UBE3A;RNF135;DTX3;RC3H1;RNF34;TRIM41;TRIM32
prerank,magnesium ion binding (GO:0000287),0.3835217795513084,1.2522634638017611,0.1350407450523865,0.6306989541130501,1.0,42/135,22.18%,EYA2;ADCY2;MARK1;CIB4;EPHX2;MVK;MAP3K20;PDXK;LRRK2;ADPRH;SIK1;BRSK1;DXO;OXSR1;MAST2;STK4;IRAK3;CLYBL;IDH2;STK11;NEK6;TDP2;RAP2A;MARK2;PSPH;CERK;FOXK2;NLRC4;RP2;DYRK3;GNAI1;ENDOV;RHEB;FAN1;EXD2;OPA1;NUDT5;NUDT12;PGM1;PPA1;PAPOLA;PPA2
prerank,GTPase regulator activity (GO:0030695),0.3697018214805907,1.2500357738313874,0.10822510822510822,0.6318627078875922,1.0,36/212,9.82%,ALDH1A1;NRP1;ASAP1;RIN2;ERRFI1;RHOH;RABGAP1L;TBC1D4;SYDE2;DLC1;ARHGAP28;USP6NL;ARHGEF10L;ARHGAP18;NPRL3;ARHGAP29;ASAP3;RAPGEF2;IQGAP2;ARHGAP19;SMAP2;ARHGAP32;ARHGAP10;ACAP2;ARFGAP3;LRRK2;ADPRH;ARHGAP35;ALS2;ARHGAP9;ARRB1;ARL2;RUNDC3A;SYDE1;SEC23B;TBC1D2B
prerank,carboxylic acid binding (GO:0031406),-0.36941894695354405,-1.2490270502879521,0.1152542372881356,0.574815947452082,1.0,15/38,25.35%,GRM7;NOS3;GLRA1;GLRA2;NOS1;GRIN2B;GRIN3A;GLUD1;MAG;GCLC;RTN4R;GRIN1;GLRA3;EPDR1;SHMT1
prerank,gated channel activity (GO:0022836),-0.4828454239535525,-1.2452112903973358,0.19035532994923857,0.5772252105396121,1.0,2/14,1.56%,PIEZO2;PIEZO1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.48848875898868915,1.2423274369094284,0.2038404726735598,0.6487081513431475,1.0,10/27,22.65%,POLR2D;POLR3A;POLR2C;POLRMT;POLR2L;POLR1F;MED21;POLR1H;POLR1D;POLR1C
prerank,lipase activity (GO:0016298),-0.36053947074073944,-1.2409951089913007,0.1237785016286645,0.5811085286562637,1.0,16/43,27.50%,MGLL;ABHD2;LIPE;PLA1A;PNPLA8;PNPLA3;PNPLA2;ABHD6;PITPNM3;DAGLB;LYPLA1;LIPH;LIPC;LIPA;FAAH;LPL
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.562079591947816,1.2398903535806949,0.22705314009661837,0.6506109438999198,1.0,2/14,7.29%,DHRS3;ADH1A
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4042022800003749,1.2383698997930273,0.19143576826196473,0.6497585979407313,1.0,27/78,21.19%,CASP12;CFLAR;USP11;SFRP1;CTSH;CTSF;USP47;USP20;USP35;USP24;USP48;CASP7;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;CASP9;CASP1;USP49;CAPN15;USP46;USP37;PIGK;UCHL1
prerank,FMN binding (GO:0010181),-0.527822129536606,-1.2378009719964758,0.22037914691943128,0.5824970364004174,1.0,8/11,37.61%,NOS3;NOS1;MTRR;NOS2;PPCDC;NDOR1;HAO1;DUS2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3489924983184511,1.236743928280639,0.022132796780684104,0.6493397400248561,1.0,150/731,17.26%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;CREB3L2;KLF15;RARG;TBX3;SP4;HLF;BCL6;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;ZNF697;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;SP5;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,channel activity (GO:0015267),0.4498646781264023,1.2353325696471642,0.19322990126939352,0.6482873842186252,1.0,8/41,13.14%,TRPA1;BCL2;PDPN;PANX1;AQP6;P2RX5;KCNK3;TMEM120B
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5909341714225042,1.23435414168977,0.26523297491039427,0.6458151257070776,1.0,6/10,23.04%,KAT2B;HEXIM2;INCA1;CDKN2C;CDKN1B;HEXIM1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.570104402400025,1.2340949790584674,0.2525597269624573,0.6418382859301522,1.0,7/12,24.05%,TENT5A;TENT5D;TENT4A;TENT4B;PAPOLG;PAPOLA;PAPOLB
prerank,MAP-kinase scaffold activity (GO:0005078),0.5767278925644018,1.2335601378082106,0.23943661971830985,0.6384915855459067,1.0,6/11,16.85%,KSR1;SH3RF1;MAP2K1;DUSP19;AKAP13;MAPK8IP3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3480567447374856,1.233284801114711,0.023138832997987926,0.6345663257943613,1.0,149/732,17.26%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;KLF15;RARG;TBX3;SP4;HLF;BCL6;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;ZNF697;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;SP5;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,outward rectifier potassium channel activity (GO:0015271),0.5740612301044721,1.232457804214017,0.25678119349005424,0.6322798057294974,1.0,2/11,2.60%,KCNK2;KCNT2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3638051370978564,1.232188990074795,0.10010764262648009,0.6284364893636891,1.0,59/232,18.74%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;BFAR;CDC42;ZNRF3;KCMF1;RNF10;TRIP12;DTX4;RNF185;RNF139;RNF145;UBR4;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;UFL1;RNFT1;RNF217;MUL1;RNF19A;RC3H2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;RNF2;NHLRC3;UBR5;MSL2;UBR3;UBE3B;RNF138;UBE3A;RNF135;DTX3;RC3H1;RNF34;TRIM41;TRIM32
prerank,protein serine/threonine kinase activity (GO:0004674),0.35410557314377783,1.2278859751076334,0.08220603537981269,0.63575738505986,1.0,71/334,16.02%,STK17B;DAPK2;PDPK1;NRK;ROCK2;CDK14;CAMK1D;CDK8;DAPK1;GRK3;GRK5;BMPR1A;DMPK;MARK1;MYLK;TGFBR1;IRAK2;MAPK4;ACVR1;CDK16;SBK3;PRKAA2;MAP3K20;CASK;NUAK1;ULK2;LRRK2;AKT3;SIK1;EIF2AK3;BRSK1;MAP2K1;ARAF;OXSR1;MAST2;STK4;IRAK3;EGFR;MAP3K8;MAP4K4;CCNK;CAMK2B;VRK3;STK11;TTBK1;NEK6;BRAF;TAOK3;IKBKE;TBK1;TLK1;WNK1;MAP3K13;RIPK2;MAP3K15;MAP4K5;ACVR1B;STK16;MARK2;MOK;PIK3R4;CDK12;RIOK3;CLK4;PLK2;CLK3;DYRK1A;PIKFYVE;DYRK1B;MAPKAPK2;TRIO
prerank,potassium channel regulator activity (GO:0015459),-0.34876011135365603,-1.2276312522649775,0.15331010452961671,0.6034160057222747,1.0,10/49,11.81%,DPP10;KCNIP4;KCNAB1;NEDD4L;ABCC9;KCNMB2;SGK1;WNK2;ADRB2;DPP6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5858872383295284,1.227500390193783,0.2690166975881262,0.6321342982434552,1.0,5/10,21.13%,KDM7A;PHF8;RIOX1;KDM4A;KDM4C
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.503991446451082,1.2227148948881443,0.24878048780487805,0.6405817301857863,1.0,4/22,6.71%,RBMS3;CPEB1;ZFP36L1;CPEB3
prerank,DNA binding (GO:0003677),0.34549023564633513,1.2207804726297204,0.03636363636363636,0.6411068666313857,1.0,136/694,15.71%,TCF7L2;TCF4;POLR2D;RBMS1;RORA;TEAD1;PBX1;SMAD3;ZEB2;C1D;BCL2;NR2F2;GLI2;SP7;ARID5B;NKX2-1;ARID4A;THRB;PRDM5;FOXP2;NFIB;DNMT3A;PDS5B;NUPR1;RARB;ZIC4;OGG1;MEOX2;RLF;APLP2;IRF1;ZIC2;RFX5;NEUROD1;RARG;LIG4;DENND4A;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;COLEC11;GTF3C1;HES7;SHOC1;INO80;SMARCA1;RAD51B;DMC1;CUL4B;NR5A1;SPRTN;BATF;CEBPA;NFE2L2;POLG;DDX60;SREBF1;SNAPC1;REXO4;DCLRE1C;TSHZ2;TET1;POLL;RBPJ;LIN9;TCF7L1;FOXC2;SAFB2;CHD2;KDM5B;HIVEP2;NHEJ1;EGFR;MLH1;ZBTB4;AIFM1;HNRNPA1;SPATA24;SMC6;ARNT;FOXA1;ZKSCAN3;PHF1;TFAM;CXXC5;DNASE1L1;MBD1;CENPC;DNASE2;DDX3X;CEBPB;POLRMT;NFE2;TDP2;CCDC25;SPDEF;NKX2-8;DCLRE1A;RAD18;NR4A1;MBD4;MCM2;GLI1;CAMTA1;ZNF513;MYCN;NPAS2;HDAC4;TAF9;RC3H2;ETS1;HMCES;ZNF148;RAD51D;ZNF219;POGK;YAF2;SNAPC4;NR1H3;FUBP3;RBM5;RXRA;FOXK2;HUWE1;RBM6;SAP30L;SMARCB1;TSHZ1;HDGFL3;CAMTA2;MTF1;TFCP2;RTF2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3434843532633132,1.2191386309643761,0.018036072144288578,0.6410019338667555,1.0,166/831,17.26%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TRPS1;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;AEBP1;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;KLF15;RARG;ETV6;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;ZBTB8B;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;ZNF697;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;OSR1;BBX;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;ACTN4;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;RBL2;SP5;ZBTB8A;ZNF177;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;HOXC8;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TWIST2;TCF12;HOXD1;GATA6;NR1H3;ZNF25;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;ATF5;TFDP1;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,calcium ion binding (GO:0005509),0.34908289376090834,1.218754160523634,0.09883103081827843,0.6376024493595425,1.0,46/323,10.64%,ITPR1;FBN1;PAM;CLEC3B;ENPP1;CDH11;SLC8A1;GSN;PLSCR2;ADGRV1;SPARC;LRP1;GJB2;MAN1C1;PPP3CA;CIB4;ASPH;MCTP2;STIM1;FBLN1;RAPGEF2;SLC25A24;PLA2G4A;BAIAP3;SMOC2;CDH5;COLEC11;TNNC1;CABCOCO1;DCHS1;SCUBE1;RCN1;SYT9;NAALADL1;FKBP9;PLSCR4;ANXA3;TRPM4;S100A11;MICU2;MASP1;SLIT3;SLIT1;ANXA6;PCDHB8;BRAF
prerank,dynactin binding (GO:0034452),-0.505142893350607,-1.2144625205167985,0.2324455205811138,0.6308562969603875,1.0,6/12,26.85%,BICD1;PAFAH1B1;BICDL1;BICD2;GSK3B;SPTBN5
prerank,disordered domain specific binding (GO:0097718),-0.41296750113062514,-1.212586843263023,0.17941952506596306,0.6286890389865349,1.0,4/23,10.37%,FN1;HSP90AB1;CALM1;CALM3
prerank,solute:anion antiporter activity (GO:0140323),0.544242552987332,1.2124497444380358,0.26461038961038963,0.6500021091774938,1.0,1/14,0.10%,SLC7A11
prerank,phosphotyrosine residue binding (GO:0001784),-0.3671167580489772,-1.2121118435416702,0.17725752508361203,0.6230718591472939,1.0,12/37,19.02%,YES1;PLCG2;SHE;SHC3;BCAR3;SHB;PIK3R3;PTPN6;RASA1;NCK2;PTPN5;FGR
prerank,myosin V binding (GO:0031489),-0.45492751075813465,-1.2086057354567843,0.21662468513853905,0.625365521391131,1.0,8/15,25.55%,RAB6A;RAB3C;RAB11A;RAB27B;RAB6B;RAB3A;RAB14;RAB39B
prerank,RNA cap binding (GO:0000339),-0.44988587991734963,-1.2081373436548462,0.20924574209245742,0.6198055597802936,1.0,7/16,21.58%,EIF4E;EIF4A1;CYFIP2;EIF4E2;SNUPN;EIF3D;DCPS
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4658905407115629,1.2079623100545,0.21861152141802068,0.6575411169945465,1.0,4/27,3.90%,SLC8A1;SLC8A3;SLC41A1;SLC9A9
prerank,cytokine receptor binding (GO:0005126),0.39177169513138654,1.2078471817612901,0.18453865336658354,0.6534177766905378,1.0,11/83,7.34%,TGFBR3;SMAD3;IL6R;IL34;OSMR;CCL19;CSF1;PIBF1;IL12B;TSLP;IL13RA1
prerank,cation transmembrane transporter activity (GO:0008324),0.42875061084030053,1.207418292197474,0.23032904148783978,0.6502061650125158,1.0,7/48,6.40%,SLC7A2;SLC1A5;SLC41A1;SLC6A9;SLC22A2;SFXN2;SLC38A6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.45825280571146143,-1.2072596039818808,0.2433734939759036,0.6156018422710517,1.0,5/14,15.80%,OTUD7B;MINDY2;MINDY1;YOD1;USP15
prerank,cytokine activity (GO:0005125),0.37638274461125365,1.20713929223227,0.16267942583732056,0.6464831430037727,1.0,19/131,11.12%,BMP6;IL34;IL17D;WNT8B;INHBE;WNT4;WNT6;CCL19;CSF1;CXCL16;FAM3B;CCL4;WNT5B;IL12B;TSLP;BMP2;FGF2;BMP15;IFNK
prerank,transcription coregulator binding (GO:0001221),0.4279243035729952,1.205879402786346,0.2273972602739726,0.6453986266509952,1.0,11/50,12.01%,RORA;SMAD3;AR;THRB;CHD6;USP11;NR1D1;FAM89B;PHF1;NEK6;PER3
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5039698005900566,-1.2045557554741328,0.23148148148148148,0.6160479542516527,1.0,3/11,7.52%,KCNMA1;KCNN2;KCNMB2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.34141883663308537,1.2012276570292097,0.0625,0.6533264568501718,1.0,101/597,15.07%,TCF7L2;TCF4;ZBTB20;TBL1XR1;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;SOX5;GLI2;RUNX1;ZIC1;MAF;GLI3;ARID5B;NKX2-1;ARID4A;THRB;PRDM5;NFIB;ASCL1;YAP1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;MEOX2;MSC;TSPYL2;IRF1;RFX5;NEUROD1;CREB3L2;KLF15;RARG;TBX3;HLF;BCL6;CUX2;BCOR;TCF7;HES7;ZNF23;ZW10;NR5A1;BATF;CEBPA;NFE2L2;MBD2;RNF10;SREBF1;NR1D1;OSR1;BBX;TCF7L1;FOXC2;NCOR1;KDM5B;NONO;MZF1;GMEB1;GLIS2;ARNT;CREB3L4;CREB3;FOXA1;TFAM;NR1D2;CENPC;ZNF177;CEBPB;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;REST;NR4A1;PER3;MBD4;MCM2;GLI1;ZNF513;MYCN;NPAS2;HOXC8;HDAC4;TAF9;HIVEP1;ETS1;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3384252028520468,-1.2006237239245683,0.1659919028340081,0.6198842487069864,1.0,11/51,9.35%,SLCO2A1;SLCO1C1;SLC7A5;SLC22A8;SLCO2B1;CLCN3;SLC5A6;SLC22A6;MFSD2A;SLC35E4;SLC25A30
prerank,cGMP binding (GO:0030553),-0.5060178084542606,-1.1979345941905297,0.2334152334152334,0.620675801267571,1.0,2/11,4.96%,PDE5A;PDE2A
prerank,ATP binding (GO:0005524),0.3530405538660328,1.1976272907286425,0.1285563751317176,0.6585528941130725,1.0,48/266,14.38%,STK17B;DAPK2;ENPP1;DAPK1;KSR1;ABCA1;ATP1A2;BMPR1A;DMPK;MARK1;MLKL;PRKAG2;TGFBR1;MYO18A;MYH10;MYO1B;ACVR1;LIG4;MVK;OAS2;RHOBTB3;MAP3K20;PDXK;AKT3;SIK1;BRSK1;OXSR1;CLPX;MAST2;STK4;IRAK3;MAP4K4;ABCB9;STK11;NEK6;PEX6;ABCE1;P2RX5;TLK1;WNK1;INSR;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ABCD2;RTEL1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.49735744249571395,-1.1974905748806712,0.23389021479713604,0.6153909005125563,1.0,5/12,14.26%,PIK3R6;IPMK;PIK3R3;PIK3C2B;PIK3CA
prerank,sodium:proton antiporter activity (GO:0015385),-0.48438969462149994,-1.1973290344223653,0.2645739910313901,0.609621138021627,1.0,4/11,8.53%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,protein tyrosine kinase binding (GO:1990782),0.39944199801157476,1.1956082887794484,0.2156084656084656,0.6597388502742533,1.0,10/71,6.47%,ANGPT1;CBLB;DOCK4;NEDD9;EPHA4;GAS6;ANGPT2;ACVR1;CDH5;CD247
prerank,sequence-specific mRNA binding (GO:1990825),-0.5151246377020979,-1.195205951997445,0.2553191489361702,0.6089316706192699,1.0,5/10,25.42%,DHFR;TYMS;DHX9;RBM24;FMR1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.40624302739249074,1.1942834402752485,0.22691292875989447,0.6590256394295758,1.0,7/55,7.31%,ITPR1;SLC24A3;SLC24A1;MCU;SLC24A5;PANX1;CUL5
prerank,GTPase activator activity (GO:0005096),0.34608371653695225,1.1896845892080001,0.12989690721649486,0.6670933302345206,1.0,53/313,9.82%,ALDH1A1;NRP1;ASAP1;RIN2;MYCBP2;ERRFI1;RABGAP1L;TBC1D4;FARP1;RAPGEF4;SYDE2;DLC1;DOCK4;ARHGAP28;DOCK10;RCBTB2;USP6NL;ARHGEF10L;DOCK11;ARHGAP18;IQSEC2;DENND2A;NPRL3;ARHGAP29;ASAP3;FGD1;RAPGEF2;IQGAP2;FGD4;ARHGAP19;DENND4A;SMAP2;ARHGAP32;ARHGAP10;ARFGEF2;ACAP2;ARFGAP3;LRRK2;ADPRH;ARHGEF17;DOCK5;DENND5A;ARHGEF18;ARHGAP35;ALS2;ARHGAP9;RGL1;ARRB1;ARHGEF11;SYDE1;RAPGEF1;SEC23B;TBC1D2B
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.46828055988796335,1.1889919268065419,0.2372611464968153,0.664682589937776,1.0,6/25,13.40%,ART4;PARP11;PARP16;SIRT2;PARP14;TNKS2
prerank,metal ion binding (GO:0046872),0.3344354926355543,1.1880574621847533,0.08784473953013279,0.6629925495733856,1.0,69/477,10.64%,ITPR1;FBN1;PAM;CLEC3B;ENPP1;EYA2;ADCY2;CDH11;SLC8A1;GSN;PLSCR2;ADGRV1;SPARC;LRP1;GJB2;MARK1;MAN1C1;PPP3CA;CIB4;EPHX2;ASPH;HMGCLL1;APOE;MCTP2;STIM1;FBLN1;RAPGEF2;MT3;SLC25A24;MVK;PLA2G4A;BAIAP3;SMOC2;MAP3K20;CDH5;COLEC11;PDXK;TNNC1;LRRK2;ADPRH;SIK1;CABCOCO1;DCHS1;BRSK1;SCUBE1;RCN1;DXO;SYT9;OXSR1;NAALADL1;FKBP9;MAST2;STK4;IRAK3;PLSCR4;ANXA3;CLYBL;TRPM4;IDH2;S100A11;STK11;MICU2;MASP1;SLIT3;SLIT1;ANXA6;PCDHB8;NEK6;BRAF
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5098178148865754,-1.18754670457601,0.25721153846153844,0.6217320029430368,1.0,3/10,10.35%,MECOM;PRDM16;SUV39H1
prerank,chemokine binding (GO:0019956),0.4648030903931767,1.187366597112472,0.26905829596412556,0.6605395031126571,1.0,8/30,12.80%,XCR1;ACKR2;CCR9;PDPN;ITGB3;ITGAV;FGF2;CXCR6
prerank,voltage-gated potassium channel activity (GO:0005249),-0.30914627047052595,-1.184372777904894,0.15306122448979592,0.6237658269060374,1.0,12/80,6.21%,KCNB2;KCNJ2;KCNQ5;KCND2;KCNJ3;KCNMA1;KCND3;KCNN2;KCNQ1;KCNH7;KCNH5;KCNC2
prerank,adenyl ribonucleotide binding (GO:0032559),0.3444341150221939,1.1749796772366456,0.1470281543274244,0.6892324279723169,1.0,52/291,14.38%,STK17B;DAPK2;ENPP1;DAPK1;KSR1;RAPGEF4;ABCA1;ATP1A2;BMPR1A;MPPED2;DMPK;MARK1;MLKL;PRKAG2;TGFBR1;MYO18A;MYH10;MYO1B;RAPGEF2;ACVR1;LIG4;MVK;OAS2;RHOBTB3;MAP3K20;PDXK;AKT3;SIK1;BRSK1;OXSR1;CLPX;MAST2;STK4;IRAK3;MAP4K4;ABCB9;STK11;NEK6;PEX6;ABCE1;P2RX5;TLK1;WNK1;INSR;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ABCD2;ACSS2;RTEL1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4905222194325885,-1.174466832066258,0.2938388625592417,0.6435728891342263,1.0,10/11,50.98%,DDAH1;DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.36888858886043524,-1.1714389680035737,0.21981424148606812,0.6450168074166932,1.0,12/31,21.28%,UBE2G1;UBE2J1;UBE2H;TAF1;UBE2D3;UBE2K;UBE2B;UBE2G2;AKTIP;UBE2S;UBE2QL1;UBE2O
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.45751746935001664,-1.1704152501867273,0.2733644859813084,0.6413727518882996,1.0,4/14,6.54%,NOD1;MAL;BCL2L13;ATP2A3
prerank,potassium ion leak channel activity (GO:0022841),0.5090628360499234,1.1697549164331311,0.2652733118971061,0.6990797138819898,1.0,2/15,6.18%,KCNK2;KCNK7
prerank,R-SMAD binding (GO:0070412),0.4989666034015625,1.1682056611714762,0.2739273927392739,0.6988545167510023,1.0,3/18,3.17%,SMAD3;LDLRAD4;PMEPA1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.361105403294669,-1.1671760659200072,0.2098360655737705,0.6434297073374923,1.0,9/35,11.94%,TEC;YES1;PTK2B;BMX;CLK1;PKDCC;CSK;PEAK1;FES
prerank,sequence-specific DNA binding (GO:0043565),0.3295730197728209,1.1635443111330344,0.11557788944723618,0.7069907733489562,1.0,80/590,11.69%,TCF7L2;TCF4;ZBTB20;RORA;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;ZEB2;BCL2;NR2F2;GLI2;ZIC1;MAF;GLI3;THRB;PRDM5;FOXP2;NFIB;ASCL1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;FBXL19;MEOX2;MSC;RFX5;NEUROD1;KLF15;RARG;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;TCF7;HES7;ZNF23;NR5A1;BATF;NFE2L2;MBD2;SREBF1;SNAPC1;ZBTB38;NR1D1;OSR1;BBX;TET1;RBPJ;TCF7L1;FOXC2;SAFB2;KDM5B;ZBTB4;GMEB1;GLIS2;ARNT;TELO2;CREB3L4;CREB3;FOXA1;ZKSCAN3;TFAM;CXXC5;NR1D2;MBD1;ZNF177;CEBPB;POLRMT;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37
prerank,adrenergic receptor binding (GO:0031690),0.5037082854303501,1.1615742801270887,0.3228995057660626,0.7081053095062707,1.0,6/16,14.00%,GNAS;NEDD4;RAPGEF2;ADRA2C;ADRA2A;DLG4
prerank,alkali metal ion binding (GO:0031420),0.533992880614641,1.1614352993694974,0.31475409836065577,0.7041962327865334,1.0,4/13,13.79%,ATP1A2;PDXK;ADPRH;HDAC4
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.30384539480542766,-1.1587532296761107,0.1759656652360515,0.6590159239135862,1.0,25/71,18.01%,PTPRB;PTPRG;PTPRJ;UBASH3B;PTPN14;PTPRE;PTPRD;PTPRK;PTPN12;DUSP22;PTPN2;ACP1;PTPRT;PTP4A2;CDC14A;PTPN22;MTMR6;HACD2;DUSP11;PTPN6;PTPRN;PTPRC;PALD1;DUSP23;PTPN5
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5170496799031965,1.1531343999546166,0.3210702341137124,0.7218889433160662,1.0,3/15,5.28%,XCR1;ACKR2;CCR9
prerank,iron ion binding (GO:0005506),0.4047366958870441,1.151078158638641,0.2899728997289973,0.7233691989597906,1.0,19/48,20.14%,AGMO;HEPH;TET1;PHF2;CDO1;ABCE1;NFU1;KDM7A;PHF8;EGLN1;CYP2R1;MELTF;RIOX1;AOX1;PHYH;ALKBH1;FDX1;SCD;FTO
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4674249467449224,1.1506664037262195,0.2954898911353033,0.7200161537596826,1.0,1/22,0.20%,ATP6V0A4
prerank,transition metal ion binding (GO:0046914),0.3306407866808343,1.150626101495741,0.1459403905447071,0.71583416897474,1.0,96/397,19.72%,PAPPA;MYCBP2;PAM;MOXD1;AGMO;ENPP1;ADAM33;ADCY2;CBLB;SEC24D;SMAD3;GLI2;MSRB3;MPPED2;ZEB1;SLC30A8;FBXL19;IKZF4;LARGE1;MT3;ENDOU;HPF1;HEPH;SKI;LARGE2;PDXK;SLC11A2;RBSN;B4GALT1;DPEP1;TIMP2;ADH1A;SIRT2;TRAF7;NAALADL1;TET1;KDM5B;COMMD1;BBOX1;PRKN;NSD1;TIMM9;BAZ1B;PHF2;CXXC5;MBD1;KDM5C;ABCE1;TDP2;CPA2;NAPEPLD;MNAT1;CDA;KMT2A;SEC23A;HDAC4;NFU1;KDM7A;PHF8;CXXC4;RXRA;SAP30L;CYP2R1;RASSF1;DPP3;MYT1;MELTF;RNF2;RIOX1;COA6;SORD;AOX1;ZDHHC20;SHH;PIM1;PRIMPOL;GLO1;LACC1;DUSP12;SEC24A;HHIP;DHX58;RC3H1;POLR2L;KPNB1;SOD3;RABIF;SMPDL3B;FDX1;SIRT5;KDM4A;SCD;TET3;MDM4;CDADC1;IDE
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.31085830785250046,-1.1486512908114914,0.22745098039215686,0.6799674330955557,1.0,27/57,28.83%,COX4I1;NDUFC1;UQCRH;COX6A1;COX5B;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;CYB561D2;UQCRFS1;NDUFB4;NDUFV2;NDUFV3
prerank,metalloaminopeptidase activity (GO:0070006),-0.4248558717991482,-1.148309163874492,0.26636568848758463,0.6745319754058507,1.0,7/16,25.66%,XPNPEP3;MMP15;RNPEPL1;MMP16;TRHDE;LNPEP;NPEPPS
prerank,death receptor activity (GO:0005035),-0.4779360825140436,-1.1479754469176517,0.30303030303030304,0.6691429607456545,1.0,2/11,3.04%,TNFRSF11A;TNFRSF19
prerank,semaphorin receptor binding (GO:0030215),-0.39860322015423066,-1.146507541871315,0.25217391304347825,0.6664288455152133,1.0,8/23,12.61%,SEMA6D;SEMA6A;SEMA7A;RIT2;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,TBP-class protein binding (GO:0017025),-0.4091714489585112,-1.1462279172824217,0.2849604221635884,0.6610948054843191,1.0,10/21,26.07%,ESR1;TAF1B;TAF1;HHEX;GTF2A2;RUVBL1;YEATS2;GTF2B;THRA;RUVBL2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5231887008462397,1.1444370628410359,0.3248730964467005,0.7284056093942181,1.0,3/13,9.34%,HSD3B2;ECI1;IDI1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.43201044463088,1.1415556886722278,0.3033033033033033,0.7318161837018802,1.0,15/32,21.13%,PHYHD1;TET1;BBOX1;P4HTM;JMJD7;KDM7A;PHF8;EGLN1;RIOX1;PHYH;ALKBH1;KDM4A;TET3;FTO;KDM4C
prerank,frizzled binding (GO:0005109),0.4383452629496011,1.139869528101288,0.3136966126656848,0.7322072733027871,1.0,8/34,10.18%,WNT8B;WNT4;WNT6;FZD1;SFRP1;ZNRF3;WNT5B;RYK
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.4740762987226256,-1.1371546025327195,0.32207207207207206,0.6784370464892854,1.0,3/10,11.50%,OTUD4;YOD1;TNFAIP3
prerank,adenylate cyclase binding (GO:0008179),0.5391405123606621,1.135966166426848,0.3363148479427549,0.7386517944580119,1.0,2/10,2.63%,ADCY2;ADCY5
prerank,potassium ion antiporter activity (GO:0022821),0.49224135116525736,1.1352331442731036,0.3257328990228013,0.7362500450775215,1.0,5/15,9.13%,SLC24A3;SLC9A9;SLC24A1;SLC24A5;SLC9A5
prerank,carbohydrate:cation symporter activity (GO:0005402),0.5243392039276024,1.1351166124840777,0.34458259325044405,0.7324091526623172,1.0,2/11,9.30%,SLC2A10;SLC5A3
prerank,epidermal growth factor receptor binding (GO:0005154),0.4486220775112571,1.1344562449858027,0.30864197530864196,0.730033802590504,1.0,6/25,13.94%,AREG;TGFA;EPGN;HBEGF;EGF;ARF4
prerank,zinc ion binding (GO:0008270),0.328701309511519,1.1297105951577058,0.21593291404612158,0.7383732778374362,1.0,72/293,19.72%,PAPPA;MYCBP2;PAM;ENPP1;ADAM33;CBLB;SEC24D;SMAD3;GLI2;MSRB3;ZEB1;SLC30A8;FBXL19;IKZF4;MT3;HPF1;SKI;PDXK;RBSN;DPEP1;TIMP2;ADH1A;SIRT2;TRAF7;NAALADL1;TET1;KDM5B;BBOX1;PRKN;NSD1;TIMM9;BAZ1B;PHF2;CXXC5;MBD1;KDM5C;CPA2;NAPEPLD;MNAT1;CDA;KMT2A;SEC23A;HDAC4;KDM7A;PHF8;CXXC4;RXRA;SAP30L;RASSF1;DPP3;MYT1;RNF2;SORD;ZDHHC20;SHH;PRIMPOL;GLO1;DUSP12;SEC24A;HHIP;DHX58;RC3H1;POLR2L;KPNB1;RABIF;SMPDL3B;SIRT5;KDM4A;TET3;MDM4;CDADC1;IDE
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4984206134737962,1.1290791971620133,0.35855263157894735,0.7357836061863278,1.0,3/16,10.39%,TDO2;ALOXE3;CDO1
prerank,estrogen receptor binding (GO:0030331),-0.34773965477102975,-1.1287557073302343,0.29276315789473684,0.6945367966980052,1.0,12/32,23.07%,LEF1;ESR1;MED1;NRIP1;STRN;TAF10;PPARGC1B;ARID5A;SRARP;PPID;PADI2;DCAF1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.44754736359720426,-1.121487626429486,0.331002331002331,0.7080917885062593,1.0,5/13,17.20%,LPCAT1;AGPAT1;PNPLA3;AGPAT5;LPCAT2
prerank,small GTPase binding (GO:0031267),0.34045435242154426,1.1211427545331407,0.251131221719457,0.7533012311412954,1.0,40/169,15.15%,MYCBP2;RHOH;RABGAP1L;RAPGEF4;ABCA1;DOCK4;USP6NL;OPTN;CDC42EP4;FGD1;IQGAP2;GOLGA4;FGD4;RHOBTB3;STRN3;NDRG1;RANBP9;LRRK2;SPHK2;AFDN;MYO1C;ALS2;TRIP11;PICALM;ARFIP2;FMNL1;GGA2;BRAF;RNF152;FGD3;GOLGA5;WASF1;TNFAIP1;RAB3GAP1;TSC2;FLNA;AKAP13;RAPGEF6;TBC1D20;HACE1
prerank,N-methyltransferase activity (GO:0008170),0.4627946683566785,1.120566190039205,0.32102728731942215,0.7507186423859943,1.0,4/20,9.50%,NNMT;HNMT;TRMO;DIMT1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.34973361129027275,1.1204271413295468,0.27102803738317754,0.7469355990369451,1.0,15/134,6.40%,SLC1A3;SLC7A2;GJA1;SLC1A5;SLC16A12;SLC13A3;SLC6A9;SLC6A13;SLC2A10;SLC25A24;SFXN2;PDPN;SLCO3A1;SLC35A3;SLC38A6
prerank,Notch binding (GO:0005112),-0.3907201371994028,-1.1196938797557272,0.32564102564102565,0.7066520824342124,1.0,12/22,21.91%,CCN3;DNER;JAG2;NOTCH4;SNW1;GALNT11;KCTD10;DLL4;CUL3;DLL1;MEGF10;DTX1
prerank,ubiquitin-specific protease binding (GO:1990381),0.4690529588334751,1.1188398835855948,0.34507042253521125,0.7470338836999509,1.0,9/19,25.33%,DERL1;DERL3;PRKN;SELENOS;PTEN;AMFR;SUMO1;BAG6;LCOR
prerank,SH2 domain binding (GO:0042169),0.4336741679975101,1.118790163950357,0.32554744525547447,0.7431008034066995,1.0,5/31,6.32%,DAG1;AFAP1;DLC1;SH3PXD2B;SRC
prerank,sterol binding (GO:0032934),0.38740887261969104,1.11778172162208,0.3026315789473684,0.741658807231112,1.0,19/56,18.96%,RORA;ABCA1;INSIG2;APOA1;OSBPL8;STAR;SIDT1;ANXA6;TSPO;VDAC1;GRAMD1A;OSBPL9;NR1H3;OSBPL5;GRAMD1C;NPC1;INSIG1;ERLIN1;OSBP2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.46650094087438854,-1.1170721032677076,0.3295964125560538,0.7071700689779802,1.0,2/11,4.78%,LEF1;GATA2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3543250011780427,-1.1169565096305143,0.2740112994350282,0.7014039000201564,1.0,9/29,13.96%,SLC26A7;SLC26A2;SLC25A13;SLC25A12;SLC1A1;SLC25A30;SLC26A6;SLC25A11;SLC1A4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.36438417491806846,-1.1162141848734024,0.3096590909090909,0.6972614574857864,1.0,6/27,10.96%,RNF144B;RNF144A;RNF125;SIAH1;SIAH3;DCUN1D4
prerank,I-SMAD binding (GO:0070411),0.5136063698907527,1.1159794674201982,0.36316695352839934,0.7424976423325297,1.0,3/13,9.24%,SMAD3;TGFBR1;SMAD1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3281741691591055,-1.1135999974109514,0.28776978417266186,0.69815769500737,1.0,12/42,10.50%,STXBP6;BAIAP2L1;ESAM;BSG;CNTN4;NTNG1;TMOD3;SIRPA;CNTN6;LRRC4C;ROBO4;EMB
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.33316380031398696,1.1123844323139778,0.2733333333333333,0.7478481226616259,1.0,32/181,15.37%,TCF7L2;LDB2;SMAD3;ARNT2;AR;DACT1;PRRX1;CDK5RAP3;NEUROD1;NCOA2;TBX3;TACC1;NFE2L2;MTA2;RERE;RBPJ;NCOR1;MTA3;ACTN4;ARNT;IFI27;RBL2;NCOR2;BHLHE41;TEAD3;TRIP4;NCOA3;HDAC4;TCERG1;TADA3;RXRA;SMARCB1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.44418630833597517,1.1093670309515318,0.3292307692307692,0.751981185029067,1.0,2/24,1.22%,CAMK1D;DAPK1
prerank,RNA methyltransferase activity (GO:0008173),0.4721611904859072,1.1092363021872769,0.3449419568822554,0.7482888177470602,1.0,9/19,28.00%,FTSJ3;BCDIN3D;TRMT9B;TRMT13;METTL4;METTL3;TRMT12;TYW3;MEPCE
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.336551760953397,1.1088863524099806,0.28083700440528636,0.7452510113280902,1.0,27/173,11.95%,ZBTB20;TRPS1;ZEB2;MITF;KCNIP3;AEBP1;ZEB1;PRDM5;FOXP2;ASCL1;JDP2;MXI1;ETV6;TBX3;BCL6;SKI;NR1D1;ZBTB4;ZBTB1;MZF1;GTF2IRD1;ZKSCAN3;ZNF177;CEBPB;BHLHE41;ZBTB37;REST
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.28563520267890286,-1.1077284123507334,0.21287128712871287,0.7074421396393489,1.0,33/85,28.63%,ENPP2;MGLL;ABHD2;NDST3;PLA2G7;LIPE;PNPLA7;BCHE;PAFAH1B2;PLAAT3;PNPLA3;PLA2G4C;TARS2;PNPLA2;ABHD6;PNPLA6;LYPLA2;DAGLB;AARS2;PLA2G4F;LYPLA1;PLA2G4E;AOAH;GDPD1;ABHD4;PLAAT1;LIPC;PLA2G4B;LIPA;FAAH;LPL;PGAP1;PON3
prerank,chemorepellent activity (GO:0045499),0.44117236171838725,1.1073205578910714,0.33965244865718797,0.7453006182102297,1.0,4/25,4.31%,EPHA7;SEMA3D;SEMA5A;APOA1
prerank,ATP hydrolysis activity (GO:0140603),0.40560809702147144,1.105485168992527,0.3413940256045519,0.7459053571078116,1.0,14/41,17.81%,MYO18A;RNF213;RHOBTB3;SHOC1;CLPX;DDX3X;MYO1E;ABCA3;ABCD2;TOR1B;SMCHD1;ABCB6;DDX4;TOR3A
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.4477356604935402,-1.1043355554567151,0.3225058004640371,0.7103708548472043,1.0,7/12,28.13%,TAF1;TBP;H3-3A;GTF2B;RUVBL2;FOS;TBPL1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.3738273530728007,-1.1041229098967382,0.31896551724137934,0.705014737402531,1.0,4/23,5.85%,PLCE1;EDNRA;PLCG2;CHRM3
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4063764637010572,1.1039067934069648,0.3380281690140845,0.7460615676538028,1.0,19/42,24.01%,CCNA2;CKS1B;KAT2B;CCNK;HEXIM2;INCA1;CCNL2;CCNL1;CNPPD1;CCNQ;CDKN2C;CCNT2;CDKN1B;CCND2;CCNT1;CCNG2;HEXIM1;CCNY;CCNE2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5322798882124828,1.1035715173919367,0.3723404255319149,0.7431129934632541,1.0,4/11,12.70%,MAP3K20;EGFR;MAP3K13;MAP3K15
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3764876246045904,-1.1016575987737447,0.32571428571428573,0.7056771204079197,1.0,9/21,20.66%,REV3L;POLM;POLH;POLE4;POLB;POLN;POLD4;POLQ;POLK
prerank,protein kinase regulator activity (GO:0019887),0.35174192754382116,1.097060846800782,0.3234932349323493,0.7564247334154652,1.0,37/95,24.19%,PARVA;CCNA2;PRKAG2;MT3;ITPRIP;GPRC5D;DNAJC3;CCNK;STK11;FGF13;TAOK3;CCNL2;RGCC;STRADA;CCNL1;DUSP19;WNK1;CNPPD1;MARK2;GPRC5A;CDKN1C;AGAP2;CCNQ;CCNT2;CDKN1B;PRKAG1;ELP4;MADD;CCND2;TRIB1;CCNT1;CCNG2;NCKAP1L;HEXIM1;CCNY;CCNE2;MBIP
prerank,phosphatase inhibitor activity (GO:0019212),-0.39174900310305844,-1.096072040251468,0.3324468085106383,0.7148262763048483,1.0,12/20,34.54%,PTN;MGAT5;PPME1;LMTK2;URI1;ANP32E;STYX;CABIN1;PPP1R1B;SET;SAG;ENSA
prerank,single-stranded DNA binding (GO:0003697),0.3533717028675596,1.0948980161164221,0.3281061519903498,0.7580243967243261,1.0,15/93,14.99%,POLR2D;RBMS1;SHOC1;RAD51B;DMC1;SPRTN;REXO4;MLH1;HNRNPA1;SMC6;TDP2;MCM2;HMCES;RAD51D;FUBP3
prerank,solute:sodium symporter activity (GO:0015370),-0.35630440568112676,-1.0925973082785312,0.33062330623306235,0.7184014663551523,1.0,3/27,8.29%,SLC4A10;SLC5A6;SLC4A8
prerank,microtubule binding (GO:0008017),-0.24110970369281653,-1.0920519486207014,0.18666666666666668,0.7140275531673603,1.0,58/222,20.44%,DNM3;MTUS1;SGIP1;MAP2;REEP1;NAV3;STARD9;CCDC88A;KIF26B;EML5;MID1;FMN1;KIF6;KIF13A;RPS3;KIF2A;ARHGEF2;FNTA;CDK5;KRIT1;SUN2;SYBU;RP1;RAB11A;PAFAH1B1;ARL3;CCDC61;KIF16B;NEFH;KIF20B;KIF1A;KIF15;POLB;DCTN1;GAS2L1;TRPV4;CCDC88C;CDK5RAP2;MAP1B;CEP57;KIF21A;CAPN6;DNM1;PRC1;GAS8;IRAG2;KIF23;KIF18A;REEP2;MTCL1;MAST1;CLASP1;KNSTRN;KIF5A;SPAG5;KIF18B;CCDC170;CLIP2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.47141925873146007,1.0917965467076225,0.3595890410958904,0.7619898424888536,1.0,2/16,1.82%,SLC1A5;SLC13A3
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.318478550292156,-1.0917357281354185,0.31666666666666665,0.7093657702953515,1.0,6/42,3.46%,YES1;PLCG2;SHE;SHC3;BCAR3;SHB
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3150375050243157,1.0916266604420592,0.27479338842975204,0.7585892610767155,1.0,83/346,18.74%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;RNF213;BFAR;BCOR;CDC42;ZNRF3;PML;CUL4B;RNF31;KCMF1;RNF10;TRIP12;CUL5;UBE2U;DTX4;FBXL3;TRAF7;RNF185;RNF139;RNF145;UBA7;UBR4;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;FBXO9;RSPRY1;FBXO11;ERCC8;FBXO4;BTRC;RNFT1;RNF217;MUL1;TNFAIP1;RNF19A;RC3H2;UBE2E2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;DZIP3;RNF2;NHLRC3;UBR5;UBE2R2;MSL2;RNF214;UBR3;UBE3B;RNF138;UBE3A;RNF135;PJA2;DTX3;TRIM45;RC3H1;RNF34;TRIM47;TRIM41;TRIM32
prerank,cardiolipin binding (GO:1901612),0.5227897413663527,1.0914853021096371,0.38421955403087477,0.7550647603371464,1.0,5/10,21.45%,GSDME;PLEKHN1;GSDMD;OPA1;STOML2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.3327194574500859,-1.0876400626914726,0.3322884012539185,0.7142067676937176,1.0,12/34,21.28%,UBE2G1;UBE2J1;UBE2H;TAF1;UBE2D3;UBE2K;UBE2B;UBE2G2;AKTIP;UBE2S;UBE2QL1;UBE2O
prerank,sialyltransferase activity (GO:0008373),-0.3856253921675732,-1.087497753898455,0.34704370179948585,0.709039511559164,1.0,4/20,0.97%,ST6GALNAC3;ST3GAL6;ST8SIA4;ST6GAL1
prerank,galactosyltransferase activity (GO:0008378),-0.46027998087731875,-1.0860224475409932,0.38461538461538464,0.7074279904242085,1.0,3/11,6.20%,B4GALT4;B4GALT5;B4GALT7
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4542368467381627,1.0838817374335177,0.361247947454844,0.7674746218756976,1.0,2/21,1.12%,CDK14;CDK8
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4542368467381627,1.0838817374335177,0.361247947454844,0.7674746218756976,1.0,2/21,1.12%,CDK14;CDK8
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3974092147392244,1.0823281614501155,0.3638928067700987,0.7677087444694246,1.0,17/40,26.34%,NNMT;DNMT3A;COMT;HNMT;LRTOMT;TPMT;THUMPD3;THUMPD2;METTL4;DNMT3B;PEMT;N6AMT1;DNMT1;CARNMT1;ARMT1;SETD3;RRP8
prerank,DNA polymerase activity (GO:0034061),-0.3624124876800126,-1.0821045825423783,0.3391812865497076,0.7119512142489961,1.0,9/22,20.66%,REV3L;POLM;POLH;POLE4;POLB;POLN;POLD4;POLQ;POLK
prerank,beta-tubulin binding (GO:0048487),0.41291014803867787,1.0809295473166,0.3584070796460177,0.7676345250309063,1.0,9/31,21.34%,GJB6;DLEC1;PDCD5;FGF13;EML4;IFT74;APPL1;HTT;TAOK1
prerank,single-stranded RNA binding (GO:0003727),0.39373428026574997,1.0786736216558344,0.3551912568306011,0.7697788732746804,1.0,5/43,11.00%,POLR2D;A1CF;DDX60;HNRNPA1;DDX3X
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2798371312655585,-1.077738048749418,0.336322869955157,0.7176556388842277,1.0,26/74,24.14%,NADK2;DGKB;DGKH;HK2;PANK3;DGKK;RFK;IPMK;ETNK1;FAM20C;DGKG;DGKQ;PIK3C2B;PIK3CA;CLP1;NOL9;NADK;TKFC;DGKZ;DGKI;KHK;PIK3CG;CHKA;PGM2L1;PKM;IDNK
prerank,metal ion transmembrane transporter activity (GO:0046873),0.41768646737508575,1.0762913851037732,0.36645962732919257,0.7722774501125813,1.0,3/27,6.48%,ITPR1;SLC41A1;SLC11A2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4664306554046057,1.0754780771961752,0.366723259762309,0.770651864249506,1.0,3/17,4.51%,ACOT11;ACOT6;ACOT2
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.38164109229232696,-1.0750450427878,0.3352272727272727,0.7189855083294326,1.0,5/20,10.52%,DLG2;TJP2;MAGI3;AK6;MPP1
prerank,protein kinase C activity (GO:0004697),-0.42630498239217557,-1.0749513078854267,0.38605898123324395,0.7139147108874828,1.0,4/14,17.55%,PRKCH;PKN1;PRKCZ;PRKCE
prerank,low-density lipoprotein particle binding (GO:0030169),-0.39661793341857354,-1.0733586329740135,0.380352644836272,0.7132647485295573,1.0,7/16,11.57%,PLTP;THBS1;SORL1;SCARF1;CDH13;SCARB1;STAB1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.4364592255190997,-1.0723785276120907,0.3811881188118812,0.710505904676285,1.0,5/12,17.95%,CISD2;CISD1;ISCU;SDHB;CIAPIN1
prerank,clathrin adaptor activity (GO:0035615),0.47318609196315914,1.0703688437966035,0.3941368078175896,0.7800003691083539,1.0,4/15,9.98%,STON1;DAB2;AP1G2;AP1M1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.4390834527765304,-1.0644909160767888,0.37220843672456577,0.7253404075761055,1.0,5/12,27.10%,TRAF5;TRAF1;TRAF2;BABAM2;TRAF6
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3562560564434324,1.062536585918689,0.38235294117647056,0.7964063250345971,1.0,8/70,10.10%,GXYLT2;B3GALT1;OGT;LARGE1;LARGE2;B4GALT1;B3GALNT1;EXT1
prerank,NADPH binding (GO:0070402),-0.4309046863672765,-1.061866036384996,0.4068627450980392,0.7270546678616908,1.0,10/13,37.61%,KCNAB1;DHFR;CBR3;HMGCR;GRHPR;MTRR;CBR4;LBR;NDOR1;DUS2
prerank,phospholipase C activity (GO:0004629),-0.3552540651640966,-1.0603434810379353,0.36716417910447763,0.7255516081255375,1.0,4/25,5.85%,PLCE1;EDNRA;PLCG2;CHRM3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.43892048620999047,-1.0601838921965718,0.40047961630695444,0.71572149029273,1.0,6/11,28.51%,BAG4;GRPEL1;HSPBP1;HSPH1;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.43892048620999047,-1.0601838921965718,0.40047961630695444,0.71572149029273,1.0,6/11,28.51%,BAG4;GRPEL1;HSPBP1;HSPH1;GRPEL2;BAG2
prerank,protein phosphatase 2A binding (GO:0051721),-0.3519752982510712,-1.0577289087316453,0.37057220708446864,0.717078866949032,1.0,8/23,15.79%,CTTNBP2NL;GRIN3A;ADCY8;STRN;PPME1;FOXO1;SMG7;STRN4
prerank,ion gated channel activity (GO:0022839),-0.3594320112167615,-1.0560341329590182,0.3287292817679558,0.7163050319844475,1.0,8/24,16.55%,ANO1;ANO4;TTYH2;ANO3;TMEM63C;ANO2;TMEM63B;ANO6
prerank,chloride channel regulator activity (GO:0017081),-0.41002851161467524,-1.0557680081092353,0.4047058823529412,0.7120325670250803,1.0,5/14,16.85%,VAMP8;SGK1;WNK2;CFTR;STX1A
prerank,cysteine-type peptidase activity (GO:0008234),0.3493522532304971,1.054364551039626,0.37707006369426754,0.8134165829633221,1.0,26/73,21.19%,USP11;SFRP1;CTSH;CTSF;USP47;USP20;USP35;USP24;USP48;ATG4A;CASP7;OTULINL;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;CASP9;CASP1;USP49;USP46;ATG4B;USP37;UCHL1
prerank,microtubule motor activity (GO:0003777),-0.3058478740152111,-1.053771953894866,0.3418181818181818,0.7117769096244689,1.0,19/51,22.51%,STARD9;KIF26B;KIF6;KIF13A;KIF2A;KIF16B;KIF20B;KIF1A;DYNLRB1;KIF15;KIFC3;KIF21A;KIF23;KIF18A;KIF5A;KIF18B;KIF22;KIF4A;KIF14
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.4953748764956039,1.0529835705343793,0.422680412371134,0.8131427666355063,1.0,2/12,8.00%,B3GALT1;B3GALNT1
prerank,exonuclease activity (GO:0004527),0.3761112390547599,1.0519689530677492,0.38482758620689655,0.8119974584296972,1.0,10/46,11.80%,ENPP1;REXO5;POLG;REXO4;DCLRE1C;DXO;EXOSC1;REXO2;ERI1;EXOSC7
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4812877502456413,1.0516323814567132,0.41968911917098445,0.808957037492081,1.0,4/13,9.59%,PDGFD;PDGFRA;PDGFRB;ITGB3
prerank,GTPase activity (GO:0003924),-0.23677228328734656,-1.0501395267775986,0.30120481927710846,0.7161875685519442,1.0,50/192,19.07%,DNM3;RAP1A;RIT2;RAB27A;KRAS;MFN1;GBP5;EEF2;RAB6A;GNA14;GBP4;RAB21;GBP7;GCH1;RAB3C;RAP1B;RAB5B;GNB2;RAB8B;GTPBP10;RHOB;RAB11A;EFTUD2;RAB27B;GTPBP1;ATL2;RASL12;ARHGDIB;GFM2;DIRAS2;GPN3;RALB;GNB1;RAB24;GNG5;RIT1;RAB6B;EEF1A1;RAB4A;GPN2;GNG11;GNA12;DNM1;GNA11;RAB3A;NKIRAS2;TBCC;RAB5C;GNAZ;GNA13
prerank,lipoprotein particle binding (GO:0071813),-0.37313380539145946,-1.0481964795171843,0.3793103448275862,0.7161837253650412,1.0,7/20,11.57%,PLTP;THBS1;SORL1;SCARF1;CDH13;SCARB1;STAB1
prerank,mannosyltransferase activity (GO:0000030),0.4368705525163322,1.0481701763921536,0.41626794258373206,0.8143513512767743,1.0,2/21,2.04%,TMTC1;TMTC4
prerank,phosphatidylinositol binding (GO:0035091),-0.26574488959551484,-1.0465276315317864,0.3575418994413408,0.7154028342602131,1.0,22/91,16.15%,PITPNC1;ESYT2;MCF2L;EPB41;DENND1B;CCDC88A;SNX13;PITPNA;WDFY3;TNFAIP8L3;SNX27;HIP1R;SNX1;ITPR3;SCARB1;EXOC8;FES;PHF12;PLEKHF2;GAP43;PIGU;PITPNB
prerank,Hsp70 protein binding (GO:0030544),-0.3297102515445266,-1.0454247161040922,0.37752161383285304,0.7133303572612016,1.0,11/31,23.48%,RPS3;DNAJB14;SACS;ERN1;NOD2;GPR37;DNAJC8;HIKESHI;PPID;DNAJB1;PPEF2
prerank,triglyceride lipase activity (GO:0004806),-0.3702471443297809,-1.0448842967062697,0.39195979899497485,0.7098604639155296,1.0,7/20,27.50%,LIPE;PNPLA3;PNPLA2;DAGLB;LIPH;LIPC;LPL
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.4059932142111883,-1.0427881152789307,0.43859649122807015,0.7101217366447141,1.0,5/15,17.20%,LPCAT1;AGPAT1;PNPLA3;AGPAT5;LPCAT2
prerank,hyaluronic acid binding (GO:0005540),0.4951794405688112,1.0425259414364234,0.4172661870503597,0.8249345168594374,1.0,3/10,14.28%,CEMIP;LYVE1;CHODL
prerank,microtubule minus-end binding (GO:0051011),0.46733250231125706,1.041823337324,0.4221824686940966,0.8229580000645174,1.0,4/13,19.34%,MACF1;HAUS7;CAMSAP1;NUMA1
prerank,3'-5' DNA helicase activity (GO:0043138),0.4607954692238501,1.0410135482807104,0.43327556325823224,0.8213388570323767,1.0,4/16,12.25%,NAV2;RECQL5;ASCC3;MCM2
prerank,GTPase binding (GO:0051020),0.31289925309729816,1.040666244412371,0.410913140311804,0.818543462195122,1.0,43/194,15.15%,MYCBP2;RHOH;RABGAP1L;RAPGEF4;ABCA1;DOCK4;USP6NL;OPTN;CDC42EP4;FGD1;IQGAP2;GOLGA4;FGD4;GNB3;RHOBTB3;STRN3;NDRG1;RANBP9;LRRK2;SPHK2;AFDN;MYO1C;ALS2;TRIP11;PICALM;ARFIP2;FMNL1;GGA2;BRAF;RNF152;RRAGD;FGD3;GOLGA5;WASF1;TNFAIP1;RAB3GAP1;TSC2;FLNA;AKAP13;RADIL;RAPGEF6;TBC1D20;HACE1
prerank,glutamate receptor binding (GO:0035254),-0.391026411727059,-1.0406546339317,0.4175257731958763,0.7104712867089824,1.0,6/17,16.80%,SHANK3;SHANK1;NSF;HOMER1;IGSF11;HOMER3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.46661002977670907,1.039706317741173,0.45107794361525705,0.8171382561683639,1.0,3/14,11.79%,AK1;AK8;NME6
prerank,RNA stem-loop binding (GO:0035613),0.4798111700141047,1.039228208653832,0.4371941272430669,0.8146206652273359,1.0,7/12,23.61%,MYH10;CPEB3;DDX3X;RC3H2;RC3H1;LARP6;METTL16
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2964445495814998,1.0377239779458092,0.41624365482233505,0.8146486686077575,1.0,83/431,17.44%,STK17B;DAPK2;ENPP1;RHOH;DAPK1;KSR1;ABCA1;ATP1A2;RHOD;BMPR1A;DMPK;RANBP17;MARK1;MLKL;PRKAG2;RHOBTB1;RRAS2;TGFBR1;MYO18A;MYH10;MYO1B;ACVR1;LIG4;MVK;OAS2;MRAS;RHOBTB3;MAP3K20;PDXK;CDC42;LRRK2;AKT3;RHOBTB2;SIK1;BRSK1;RAB22A;OXSR1;CLPX;MAST2;STK4;IRAK3;ARL2;MAP4K4;ARFIP2;ABCB9;STK11;RHOT1;ARL1;ANXA6;NEK6;PEX6;ABCE1;P2RX5;RRAGD;RHOQ;TLK1;WNK1;TUBB2B;INSR;RAP2A;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ARF4;ABCD2;RTEL1;GNL2;NLRC4;RND3;ARF6;TUBB2A;ARL5A;AGAP2;AKT1;RHOG;LONP1;PIM1;PTPA;ABCB6;RHOU;GCK
prerank,androgen receptor binding (GO:0050681),-0.3445643631642212,-1.0375243806783236,0.373134328358209,0.7134662154415277,1.0,10/25,19.13%,KDM1A;SNW1;FOXP1;PKN1;TMF1;TRIM68;ARID5A;EP300;RNF14;DDX5
prerank,methyl-CpG binding (GO:0008327),0.4208512440626548,1.0362620283850958,0.4133545310015898,0.8146848001524,1.0,7/22,14.94%,MBD2;ZBTB38;TET1;ZBTB4;CXXC5;MBD1;CXXC4
prerank,G protein-coupled receptor binding (GO:0001664),0.3231156580544192,1.0357464126252562,0.4268867924528302,0.8121667902016015,1.0,25/132,14.69%,GRK3;WNT8B;WNT4;GNAS;WNT6;CCL19;INSL3;FZD1;SFRP1;USP20;ZNRF3;WNT5B;AGTR1;TULP3;NPFF;ARRB1;ARHGEF11;PRKN;RYK;ADM;PTCH2;GNAO1;GPRASP2;FLNA;RSPO1
prerank,C-C chemokine receptor activity (GO:0016493),0.42881645960465475,1.034257107265511,0.416403785488959,0.8121141286178032,1.0,3/21,5.28%,XCR1;ACKR2;CCR9
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3258123781479725,-1.0326683680089008,0.3987915407854985,0.7208352953857723,1.0,7/33,10.96%,RNF144B;RNF144A;RNF125;SIAH1;RPS3;SIAH3;DCUN1D4
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.41239739534595576,1.0300730558505886,0.4362017804154303,0.8191787986745105,1.0,2/25,1.42%,MICAL3;CYP26B1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4881543595344332,1.0277881873531902,0.4283154121863799,0.8212358803339573,1.0,3/10,11.93%,ECHDC2;ECI1;ECHS1
prerank,transcription corepressor binding (GO:0001222),0.4028333947287963,1.023132870056666,0.4289940828402367,0.8292090510010719,1.0,7/27,12.01%,RORA;USP11;NR1D1;FAM89B;PHF1;NEK6;PER3
prerank,Hsp90 protein binding (GO:0051879),-0.3176854252385601,-1.0218694383239475,0.40853658536585363,0.7429568858440682,1.0,9/33,20.49%,SLC12A2;KDR;RPS3;UNC45B;ERN1;NOD2;HIF1A;PPID;USP19
prerank,WW domain binding (GO:0050699),0.4049813579955994,1.0217180472011773,0.4597156398104265,0.8288041309500706,1.0,5/26,11.36%,PMEPA1;RAPGEF2;TCEAL8;TCEAL1;NFE2
prerank,ubiquitin binding (GO:0043130),0.3431830678829853,1.0201064906193755,0.44174135723431496,0.8290324216570519,1.0,16/73,14.11%,SMAD3;NEDD4;FAF2;SPRTN;RNF31;SIRT2;UBXN2B;RNF185;CKS1B;UBXN11;PRKN;USPL1;OTULINL;RAE1;RNFT1;ADRM1
prerank,double-stranded RNA binding (GO:0003725),-0.2703416631062396,-1.0189453570307376,0.43333333333333335,0.7453583127383646,1.0,17/70,15.52%,STRBP;IFIH1;MBNL1;TFRC;LRRFIP1;VIM;HSP90AB1;TUBB4B;ELAVL1;EIF4A1;MSN;ADAR;SLC3A2;SUPV3L1;APTX;ADARB2;MRPL44
prerank,chloride channel inhibitor activity (GO:0019869),-0.43717355647826495,-1.0172653727412344,0.4501108647450111,0.7447471406395177,1.0,5/10,23.73%,VAMP8;WNK2;CFTR;STX1A;WNK4
prerank,ATPase activator activity (GO:0001671),0.43202587546661364,1.0169909775083132,0.4368770764119601,0.8330764422709717,1.0,4/20,16.37%,DNAJC1;ATP1B2;TOR1AIP1;TOR1AIP2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.41564741574508723,-1.01670268243623,0.4405594405594406,0.741173218104153,1.0,5/12,21.43%,CNOT6L;PAN3;PNLDC1;CNOT7;CNOT8
prerank,manganese ion binding (GO:0030145),0.35671254475512676,1.0161855622130873,0.44337016574585636,0.831371414381606,1.0,6/48,6.86%,ADCY2;MPPED2;LARGE1;ENDOU;LARGE2;B4GALT1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.43489181250638165,-1.0142043067384083,0.44883720930232557,0.7423057635930961,1.0,4/10,12.93%,SHANK3;SHANK1;NSF;IGSF11
prerank,proton transmembrane transporter activity (GO:0015078),-0.29871657978570565,-1.013492458013659,0.397212543554007,0.7394234616824361,1.0,15/39,25.88%,CLCN3;COX4I1;CLCN5;UQCRH;COX6A1;COX5B;COX5A;CLCN4;UQCR10;COX8A;UQCR11;ATP6V1F;UQCRQ;UQCRC1;UQCRFS1
prerank,phosphatase activity (GO:0016791),0.3375948941576477,1.0118540453476252,0.462406015037594,0.8381600942549718,1.0,5/73,3.00%,CILP;PLPP3;ATP1A2;PXYLP1;EPHX2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.31188513240103727,1.0113473843809446,0.44719101123595506,0.8357213429038783,1.0,41/147,16.64%,RIN2;MYCBP2;FARP1;RAPGEF4;DOCK4;DOCK10;RCBTB2;DOCK11;IQSEC2;DENND2A;FGD1;RAPGEF2;FGD4;DENND4A;ARFGEF2;ARHGEF17;DOCK5;DENND5A;ARHGEF18;ALS2;RGL1;ARHGEF11;RAPGEF1;EIF2B4;SBF2;LAMTOR2;ARHGEF10;FGD3;DENND1A;EGF;RAB3GAP1;EPS8L1;SERGEF;CCZ1;AKAP13;RAPGEF6;EIF2B3;RAB3IL1;ARFGEF1;FNIP1;DENND6A
prerank,ankyrin binding (GO:0030506),-0.3580040657769904,-1.0112776622378379,0.42933333333333334,0.7398312379924012,1.0,8/19,15.93%,CDH1;NRCAM;SPTBN1;SPTB;PLEC;CACNA1D;KCTD6;PTPRC
prerank,double-stranded DNA binding (GO:0003690),0.2863087338990819,1.0111681718741892,0.4539939332659252,0.8325883524940628,1.0,65/531,12.18%,TCF4;ZBTB20;RBMS1;TEAD1;PBX1;ARNT2;PKNOX2;GLI2;ZIC1;MAF;GLI3;THRB;NFIB;ASCL1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;MEOX2;MSC;RFX5;NEUROD1;KLF15;RARG;TBX3;HLF;BCL6;CUX2;TCF7;HES7;ZNF23;RAD51B;DMC1;NR5A1;SPRTN;BATF;DDX60;SREBF1;REXO4;NR1D1;OSR1;BBX;TCF7L1;FOXC2;KDM5B;EGFR;GMEB1;GLIS2;ARNT;CREB3L4;CREB3;FOXA1;NR1D2;MBD1;ZNF177;CEBPB;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;NR4A1;TERF2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.44508757829928114,-1.010449703234648,0.45274725274725275,0.7370499929005693,1.0,6/10,27.29%,USP22;NAA60;EP300;BRCA2;ATF2;HAT1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.44856833264867485,1.0090886331533115,0.4523364485981308,0.8339815451104943,1.0,1/13,0.60%,SLC7A2
prerank,titin binding (GO:0031432),0.44692393959252835,1.009068122161543,0.4623287671232877,0.8304613262921613,1.0,1/13,0.87%,ACTN2
prerank,filamin binding (GO:0031005),-0.4155326990264434,-1.0089919911136815,0.47391304347826085,0.7359920074584806,1.0,1/11,0.02%,NEBL
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.30339027741041613,-1.007947650567103,0.4622356495468278,0.7340260446788743,1.0,4/35,2.95%,PLCE1;GPCPD1;ENPP2;APEX2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4754499770377594,1.0078662924555915,0.4754653130287648,0.8297606160312693,1.0,1/11,0.27%,ITPR1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3743414069948541,1.0070804700445806,0.47153284671532847,0.8281829907770812,1.0,12/33,21.26%,AR;RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.48583830136940115,1.0064614886092005,0.45964912280701753,0.8261091466924211,1.0,3/10,10.79%,ASH1L;NSD1;SETD5
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.4072671880948057,1.0060093962443606,0.4784,0.823680940166243,1.0,3/22,9.04%,HSPG2;APOE;PICALM
prerank,voltage-gated cation channel activity (GO:0022843),-0.2527738017020258,-1.0042742161202352,0.49411764705882355,0.738131922678398,1.0,28/97,21.31%,KCNB2;PTK2B;KCNQ5;KCND2;GRIN2A;KCNMA1;KCND3;KCNQ1;KCNH7;KCNH5;KCNC2;GRIN2B;GRIN3A;CACNA2D2;KCNQ3;KCNA2;CACNA2D1;CACNA1D;KCNS3;CACNG3;CACHD1;CACNG4;CACNA1A;GRIN1;HCN1;CACNB3;HVCN1;KCNC1
prerank,AMP binding (GO:0016208),0.4690943406416447,1.0028204347969942,0.46397188049209137,0.8274795341840417,1.0,2/11,3.25%,MPPED2;PRKAG2
prerank,transaminase activity (GO:0008483),0.46698568315665895,1.0024233051277993,0.4788732394366197,0.8248853789947624,1.0,1/11,2.21%,ABAT
prerank,hexosaminidase activity (GO:0015929),0.4581798241918542,1.0019281886563542,0.46471600688468157,0.8225538265730749,1.0,1/12,0.72%,CEMIP
prerank,peptidoglycan binding (GO:0042834),-0.4335942320943892,-1.00102269401225,0.4751131221719457,0.7415304879727245,1.0,6/10,32.00%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,serotonin receptor activity (GO:0099589),-0.3366704520141967,-1.000038246671256,0.45454545454545453,0.7306975490504215,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.3366704520141967,-1.000038246671256,0.45454545454545453,0.7306975490504215,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.3366704520141967,-1.000038246671256,0.45454545454545453,0.7306975490504215,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,tubulin binding (GO:0015631),-0.21187281142714387,-0.9993120835178217,0.45652173913043476,0.7281897514591797,1.0,73/295,19.71%,DNM3;MTUS1;SGIP1;TTLL7;MAP2;UNC5C;TTLL5;REEP1;NAV3;STARD9;DIP2B;RABGAP1;CCDC88A;KIF26B;EML5;MID1;DIXDC1;FMN1;KIF6;KIF13A;RPS3;KIF2A;ARHGEF2;TBCE;FNTA;CDK5;KRIT1;SUN2;PAK1;SYBU;RP1;EFHC2;RAB11A;PAFAH1B1;ARL3;AGBL4;CCDC61;ALDOA;KIF16B;NEFH;KIF20B;KIF1A;PHF6;GIT1;KIF15;POLB;DCTN1;GAS2L1;TPPP3;TRPV4;CCDC88C;CDK5RAP2;EMD;MAP1B;CEP57;KIF21A;CAPN6;DNM1;PRC1;GAS8;CDK5R1;IRAG2;KIF23;BRCA2;KIF18A;REEP2;MTCL1;RAB11FIP5;MAST1;CLASP1;KIF5A;SPAG5;KIF18B
prerank,mRNA binding (GO:0003729),0.29547805934488497,0.9991370405131083,0.48628691983122363,0.8257003266220962,1.0,30/249,11.35%,CELF2;SAMD4A;RBMS1;RBMS3;A1CF;CSDC2;RBFOX1;RBMXL2;HNRNPLL;RBFOX2;MYH10;IGF2BP2;SNRNP70;CPEB1;ZFP36L1;THOC2;ACO1;SF1;CPEB3;DXO;RBMS2;HNRNPR;RBPMS;METTL14;PARN;EIF3A;NUP98;DDX3X;EIF2S2;SERBP1
prerank,serine-type peptidase activity (GO:0008236),0.3209900295949378,0.9961584503912998,0.4801920768307323,0.8290142932223338,1.0,11/96,11.77%,GZMK;MMP2;ENDOU;RHBDL3;CTSH;PRSS48;APEH;HTRA1;MASP1;CLPP;F2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4070939624226851,0.9959702542913114,0.46909667194928684,0.8260371738950746,1.0,3/21,10.17%,KL;FRS2;FGF2
prerank,protein phosphatase binding (GO:0019903),-0.24118985359682513,-0.9947398282315755,0.42771084337349397,0.7346857805535383,1.0,31/117,17.28%,PPP1R16B;CTTNBP2NL;ITGA1;IQGAP1;MET;KIFAP3;PXN;KCNQ1;ERBB2;PTPRT;FLT4;SIRPA;AP3B1;GRIN3A;ATP2B4;AKAP11;ANAPC7;GTF2F1;JUP;MTMR9;SKAP1;ADCY8;STRN;PPP1R3B;PPME1;CEACAM1;FOXO1;SMG7;STRN4;JAK3;RACK1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2821503428191496,-0.9940081565581004,0.4154929577464789,0.7319475584712419,1.0,19/49,25.31%,CPNE8;ESYT2;MCTP1;DYSF;CPNE3;SYT1;PCLO;PLA2G4C;SYT6;CPNE5;SYT4;ANXA1;SYT15;PLA2G4F;PLA2G4E;SYT5;ANXA8;ESYT3;CPNE9
prerank,C-C chemokine binding (GO:0019957),0.4076611195307191,0.9923620770733937,0.47318611987381703,0.8313806554824661,1.0,3/22,5.28%,XCR1;ACKR2;CCR9
prerank,NAD+ binding (GO:0070403),0.4547752245614688,0.9901438361333382,0.48342059336823734,0.8331994690166951,1.0,2/12,7.38%,CRYL1;SIRT2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.31573368625260134,-0.9817621180457465,0.5016501650165016,0.7559405223644007,1.0,6/29,14.91%,PTPRJ;GCH1;NFATC1;SIRT1;DUSP7;DUSP8
prerank,potassium:proton antiporter activity (GO:0015386),-0.41652308917247294,-0.9807711726089569,0.46875,0.753966222733401,1.0,3/10,8.53%,SLC9A2;SLC9A6;SLC9A7
prerank,N-acetyltransferase activity (GO:0008080),0.41121283832074224,0.9803038999415292,0.5106732348111659,0.8528492461316444,1.0,9/19,24.13%,KAT2B;SAT2;NAA80;NAT2;NAA50;SAT1;SMARCE1;NAT14;ESCO1
prerank,histone deacetylase activity (GO:0004407),0.4109456037213048,0.979501241985576,0.4858490566037736,0.8514443446768175,1.0,10/19,28.88%,SIRT2;HDAC8;HDAC4;SUDS3;MIER3;HDAC6;HDAC5;HDAC1;MIER1;SIRT7
prerank,phosphoric ester hydrolase activity (GO:0042578),0.35059581254828986,0.9787632751099643,0.4959349593495935,0.8496509826080774,1.0,4/49,3.00%,ATP1A2;PXYLP1;MPPED2;EPHX2
prerank,chemoattractant activity (GO:0042056),0.3856988213763,0.9780848737073318,0.4947049924357035,0.847695053996096,1.0,6/26,20.02%,GDNF;NTF3;FGF2;BMP4;CX3CL1;PGF
prerank,sodium channel regulator activity (GO:0017080),-0.29257781658786053,-0.9774722362094965,0.4952681388012618,0.7573053142466213,1.0,8/37,10.27%,NEDD4L;YWHAH;CAMK2D;FGF12;NOS1;ATP2B4;SGK1;GPLD1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2847693977307142,0.9740193233104479,0.5338983050847458,0.8536939599247253,1.0,53/254,18.21%,TCF4;NFIA;SMAD3;AR;MITF;RUNX1;PRRX1;SP7;NFIB;MLXIP;MEOX2;RLF;IRF1;RFX5;NEUROD1;KLF15;HLF;CEBPA;RBPJ;FOXC2;MZF1;SMAD1;GMEB1;GLIS2;CREB3;FOXA1;ZSCAN21;NKX2-8;NR4A1;STAT6;MYCN;SMARCD2;ETS1;TCF12;HOXC4;FOXK2;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;PLAG1;ATF5;TFDP1;SP1;MYBL1;GTF2I;IRF2;FOXJ3;ELF1;FOXO3;RFXANK;SOX11
prerank,pyrophosphatase activity (GO:0016462),0.3424414539487109,0.9738558623538817,0.505586592178771,0.8507499786912575,1.0,7/50,11.00%,CILP;ENPP1;NUDT7;DXO;DOLPP1;PLPP5;DDX3X
prerank,histone acetyltransferase binding (GO:0035035),0.40166405245483044,0.9733549122936436,0.48963317384370014,0.8486781826480728,1.0,5/21,12.95%,GLI3;EPAS1;SIRT2;KANSL1L;TRIP4
prerank,methyltransferase activity (GO:0008168),0.34858548486227553,0.9726278669175815,0.5095890410958904,0.84687676687156,1.0,13/46,21.26%,NNMT;COMT;BUD23;NSUN2;FTSJ3;LRTOMT;BCDIN3D;NSUN4;METTL4;DNMT3B;METTL3;N6AMT1;DNMT1
prerank,tropomyosin binding (GO:0005523),0.42114769226743687,0.9719649767038926,0.5132450331125827,0.8452630228468485,1.0,3/16,2.83%,CALD1;TMOD4;TNNT1
prerank,exopeptidase activity (GO:0008238),-0.27580389258923543,-0.9714735781758431,0.49812734082397003,0.7670223520590108,1.0,19/50,26.91%,DPP10;FAP;PRCP;XPNPEP3;ACE2;DPP6;MME;METAP2;BLMH;GGH;DPEP3;CPE;DPP4;NUDT16;RCE1;TRHDE;LNPEP;NPEPPS;CPB1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.3332017548620629,0.9712610139661947,0.49722991689750695,0.8435359305098179,1.0,14/55,16.48%,SLC7A2;SLC16A12;SLC13A3;SLC6A13;PDPN;SLC38A6;SLC22A4;SLC38A9;SLC16A3;SLC38A3;SLC7A6;SLC38A10;SLC38A2;SLC16A2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.46491260930956896,0.9697602339949556,0.5163636363636364,0.8434288964662102,1.0,2/10,6.67%,CACNB1;CACNA1C
prerank,GTPase inhibitor activity (GO:0005095),0.4434873455935341,0.9673861207169802,0.5044883303411131,0.8454052470548192,1.0,4/13,12.61%,RHOH;IQGAP2;ARL2;GPS1
prerank,nuclear receptor coactivator activity (GO:0030374),0.34333837219375246,0.9643804590294076,0.5348837209302325,0.8490173210351588,1.0,21/52,21.36%,NCOA2;BRD8;ATXN7L3;TACC1;MED14;ZMIZ1;ACTN4;FGF2;PSMC3IP;HELZ2;NCOA3;ETS1;SS18;NCOA7;CARM1;NCOA6;MED30;DCAF6;ACTN1;MED12;PRKCB
prerank,retinoid X receptor binding (GO:0046965),0.44318609788937585,0.9616121749724765,0.5221843003412969,0.8518606924798116,1.0,3/11,9.68%,RARG;TACC1;NSD1
prerank,voltage-gated anion channel activity (GO:0008308),-0.36027127405674675,-0.9615470770483375,0.5048309178743962,0.7860809151330328,1.0,3/15,8.88%,ANO1;CLCN3;CLCN5
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.42592953279374224,0.9604282664319932,0.5425709515859767,0.8512889845077632,1.0,5/14,14.63%,ACO1;EXO5;NUBPL;NFU1;ETFDH
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.289470465220715,-0.9603060477982529,0.5254777070063694,0.7802378961916836,1.0,15/34,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFB4;NDUFV2;NDUFV3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.289470465220715,-0.9603060477982529,0.5254777070063694,0.7802378961916836,1.0,15/34,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFB4;NDUFV2;NDUFV3
prerank,phosphate ion binding (GO:0042301),-0.4094783512960768,-0.9597941004992013,0.5345622119815668,0.7769875179099277,1.0,5/10,31.95%,PDE2A;PNP;MTHFD2;CHST14;ADSS2
prerank,glucuronosyltransferase activity (GO:0015020),0.4026881448541193,0.9591611274233682,0.5040387722132472,0.850742761746901,1.0,7/19,23.80%,LARGE1;LARGE2;EXT1;CHSY1;EXT2;B3GAT3;B4GAT1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.36697631876943526,0.9564005526851493,0.5419847328244275,0.853305216653139,1.0,5/30,6.97%,GAS6;CAST;MT3;CST3;DPEP1
prerank,phosphatidic acid binding (GO:0070300),-0.3429138169377396,-0.9542461040861743,0.4920212765957447,0.7855315098838268,1.0,2/19,0.74%,PITPNC1;PLTP
prerank,motor activity (GO:0003774),-0.26599523809410713,-0.952815293213018,0.5622641509433962,0.7844835522289021,1.0,19/60,22.51%,STARD9;KIF26B;KIF6;KIF13A;KIF2A;KIF16B;KIF20B;KIF1A;DYNLRB1;KIF15;KIFC3;KIF21A;KIF23;KIF18A;KIF5A;KIF18B;KIF22;KIF4A;KIF14
prerank,cAMP binding (GO:0030552),-0.40919832243383797,-0.9512404033473558,0.5341463414634147,0.7838533340132986,1.0,3/11,4.96%,PDE4D;PDE4B;PDE2A
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.20836812560211962,-0.9508798154959347,0.6923076923076923,0.7804014180902477,1.0,62/248,19.71%,DNM3;RAP1A;RIT2;RAB27A;KRAS;MFN1;VWA8;GBP5;EEF2;RAB6A;KIF2A;GNA14;GBP4;RAB21;GBP7;GCH1;RAB3C;RAP1B;RAB5B;GNB2;RAB8B;GTPBP10;RHOB;RAB11A;EFTUD2;RAB27B;GTPBP1;ATL2;RASL12;ARHGDIB;GFM2;KIF20B;DIRAS2;KIF1A;GPN3;RALB;GNB1;RAB24;GNG5;RIT1;KIF15;CFTR;RAB6B;EEF1A1;RAB4A;RUVBL1;GPN2;GNG11;GNA12;DNM1;GNA11;RAB3A;NKIRAS2;TBCC;CHD3;RAB5C;GNAZ;GNA13;KIF5A;CLU;DHX9;KIF18B
prerank,ephrin receptor binding (GO:0046875),0.393877644651562,0.9483331288632544,0.5193798449612403,0.8683062663779559,1.0,5/21,9.03%,LYN;EFNB2;SRC;EFNA2;EFNB1
prerank,phospholipase A2 activity (GO:0004623),-0.31534295671838797,-0.9426628560889394,0.5457063711911357,0.7951222898751651,1.0,14/26,37.21%,PLA2G7;PLAAT3;PNPLA8;PNPLA3;PLA2G4C;PLA2G4F;PLA2G4E;PLAAT1;PLA2G4B;PLA2G5;PLB1;PLA2G6;PLA2G3;PLAAT5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.45372983132317884,0.9419637028900674,0.5421245421245421,0.8791007552117767,1.0,2/10,6.97%,DPYSL3;DPEP1
prerank,death domain binding (GO:0070513),-0.39222761166503095,-0.9393497916691528,0.5552941176470588,0.7983549307316244,1.0,6/11,17.28%,CRADD;DAPL1;BCL2L1;MCL1;DAP;RACK1
prerank,actin monomer binding (GO:0003785),0.38793071063055445,0.9383391287077341,0.5664,0.8835191577606867,1.0,3/22,7.32%,MTSS1;LIMA1;MYL4
prerank,UDP-galactosyltransferase activity (GO:0035250),0.44625064355146504,0.9376014848027169,0.5410122164048866,0.8817645329669164,1.0,2/10,6.86%,B3GALT1;B4GALT1
prerank,tau protein binding (GO:0048156),0.3410869059963689,0.9342894087524626,0.5627644569816643,0.8855862890805056,1.0,6/40,10.44%,ROCK2;MARK1;APOE;BRSK1;PICALM;TTBK1
prerank,calcium channel regulator activity (GO:0005246),0.3372691482401427,0.9318051394067958,0.5557122708039492,0.8875605774636294,1.0,2/37,4.13%,ITPR1;STIM1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.3792856068418,-0.9302412249278514,0.5493273542600897,0.8145431959808043,1.0,3/12,6.54%,NOD1;BCL2L13;ATP2A3
prerank,endopeptidase activator activity (GO:0061133),0.4424085438780071,0.9286103351005536,0.5738007380073801,0.8911583207065265,1.0,4/10,19.70%,APH1B;ADRM1;NLRC4;PSME3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3939212766363106,-0.9260290762181689,0.54292343387471,0.8197514952060304,1.0,5/10,21.88%,SIRPA;JUP;CXADR;DSG2;DSP
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.39181578287447805,0.923058624406178,0.5534591194968553,0.899676615342345,1.0,7/18,21.94%,PIK3R1;WDR81;WDR91;PIK3R2;AGAP2;SOCS4;SOCS7
prerank,phosphatase binding (GO:0019902),0.2919419147769207,0.9228068321951574,0.605294825511432,0.8968513638279407,1.0,25/105,15.74%,PIK3R1;SMAD3;ANK1;CDH5;EIF2AK3;MAST2;MTMR3;EGFR;ANAPC5;VRK3;PPP1R3C;IKBKE;TBK1;CD33;RCAN3;WNK1;SYTL2;STAT6;TSC2;MVP;DLG4;CEP192;SPRED1;DZIP3;PIK3R2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.38960662581167893,0.9215063557910047,0.5599343185550082,0.896348729902941,1.0,7/18,22.80%,GAS6;MT3;DPEP1;NOL3;BIRC2;BIRC3;XIAP
prerank,protein kinase binding (GO:0019901),0.26384149444230204,0.9191141532058996,0.7224489795918367,0.897890982230486,1.0,93/479,17.04%,TCF7L2;NELL1;PDLIM5;ERRFI1;RHOH;GHR;SMAD3;SASH1;PRKCSH;IL31RA;GRK5;DACT1;RHOD;KIF13B;NEDD9;EPHA4;NBEAL1;CCNA2;CEP152;PRKAG2;RHOBTB1;PDGFRB;KIF20A;RFFL;CDK5RAP3;MAPK4;ACVR1;TOM1L2;PKIA;RHOBTB3;CDH5;SKI;CDC42;CD247;RHOBTB2;SIK1;NISCH;ERCC6L2;IL15RA;CKS1B;TOP2B;PARD6G;OXSR1;PARD6B;IRAK3;DNAJC3;KAT2B;ZBTB4;SPRY2;CCNK;SMAD1;PRKN;ITGAV;TELO2;PARN;SPRED3;KIZ;NEK6;ADRA2A;UFL1;RGCC;TNIP2;DUSP19;WNK1;MAP3K13;MAP2K6;TRIP4;DACT2;VDAC1;NOX4;MVP;FAM83F;LLGL1;PTPN23;IBTK;GATA6;CEP192;SUFU;BAG5;RNF13;SPRED1;RND3;TPCN2;MAPKAPK2;STX1B;CASP9;TBL2;AGAP2;RHOG;MAPK8IP3;CDKN2C;RNF138;ZC3HC1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3205044656386071,0.9177061600506345,0.5856950067476383,0.8975222429914397,1.0,16/53,23.14%,MICAL3;DPYD;MTHFR;DDO;SQOR;AIFM1;FOXRED2;NOX4;ETFDH;AOX1;CYB5R3;ETFA;PRODH;SDHA;LDHD;DLD
prerank,thioesterase binding (GO:0031996),0.4232506064763247,0.9161877463190741,0.5432525951557093,0.8975567836141731,1.0,4/11,15.37%,CDC42;ADRA2A;HAUS7;ARF6
prerank,MAP kinase activity (GO:0004707),-0.3589041544333938,-0.9155562470401931,0.5606796116504854,0.8392572089955628,1.0,7/14,24.26%,NLK;MAPK10;MAPK8;MAPK3;MAPK1;MAPK11;MAPK7
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3302734640483251,0.9136629295034199,0.5846153846153846,0.8997630971228793,1.0,6/46,11.82%,B3GALT1;OGT;LARGE1;B3GALNT1;EXT1;MGAT3
prerank,vinculin binding (GO:0017166),-0.3866151338538109,-0.9131050788224992,0.5570776255707762,0.8401412005443124,1.0,3/11,8.99%,UTRN;PXN;SORBS3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.36928127467773997,-0.9117254034361572,0.592964824120603,0.8388323791621807,1.0,5/12,36.20%,DUSP7;DUSP8;DUSP3;DUSP5;DUSP2
prerank,sodium channel activity (GO:0005272),0.33231282730028927,0.9092427252035946,0.5869872701555869,0.9056521437349712,1.0,3/37,5.58%,SCN7A;SHROOM2;GRIK5
prerank,protein phosphatase 1 binding (GO:0008157),-0.3258801046447845,-0.9060775053517317,0.5947368421052631,0.8467765357359527,1.0,9/21,31.21%,PPP1R16B;KCNQ1;AKAP11;PPP1R3B;PPP1R11;PPP1R16A;LILRB1;PPP1R3F;PHACTR4
prerank,chemokine receptor activity (GO:0004950),0.3634462993019095,0.9054189004533569,0.5803981623277182,0.9104255779871084,1.0,3/24,5.28%,XCR1;ACKR2;CCR9
prerank,histone deacetylase binding (GO:0042826),0.29003120384301784,0.9052108403654568,0.5992555831265509,0.907606615499521,1.0,23/88,17.76%,DACT1;GLI3;BCOR;BEX4;SIRT2;TOP2B;MTA2;NCOR1;ZMYND15;MTA3;KAT2B;BRMS1L;PRKN;NCOR2;BHLHE41;YWHAE;HDAC4;AKAP8L;SUDS3;CAMTA2;SP1;KPNA2;NIPBL
prerank,symporter activity (GO:0015293),-0.3908576833075147,-0.9045517478062061,0.592255125284738,0.8456455342172834,1.0,2/10,7.78%,SLC5A6;MFSD2A
prerank,protein phosphatase regulator activity (GO:0019888),0.3144211204649532,0.9045389461071897,0.6177285318559557,0.9056930387722036,1.0,8/53,13.48%,RCAN2;DMPK;RCAN1;PPP4R4;RCAN3;PPP2R5D;BOD1L1;IGBP1
prerank,hydro-lyase activity (GO:0016836),0.32471732473151504,0.9030530757979512,0.585195530726257,0.9055638157957074,1.0,5/41,8.03%,GMDS;ECHDC2;ACO1;ECI1;ENO2
prerank,hexosyltransferase activity (GO:0016758),0.2889701560541422,0.9028328264324027,0.6237980769230769,0.9028148707236956,1.0,9/101,8.30%,TMTC1;TMTC4;B3GALT1;OGT;LARGE1;LARGE2;B4GALT1;B3GALNT1;ALG5
prerank,hormone receptor binding (GO:0051427),-0.3496501385953755,-0.9026117779333243,0.5863874345549738,0.845556175526672,1.0,3/14,12.82%,SOCS2;JAK2;TYK2
prerank,phospholipase activity (GO:0004620),-0.2409000359388087,-0.9018306784369785,0.6444444444444445,0.8430847076275688,1.0,25/67,27.50%,PLCE1;ENPP2;MGLL;PNPLA7;PLAAT3;GPLD1;PNPLA8;PNPLA3;PLA2G4C;SMPDL3A;ABHD6;PITPNM3;PLD3;PNPLA6;LYPLA2;PLA2G4F;LYPLA1;PLA2G4E;GDPD1;LIPH;ABHD4;PLAAT1;LIPC;PLA2G4B;LPL
prerank,adenylyltransferase activity (GO:0070566),0.37218979615521736,0.9017946388260786,0.5853269537480064,0.9018500606884162,1.0,10/21,25.79%,OAS2;TENT4A;TENT4B;PAPOLG;NMNAT2;COASY;PAPOLA;NMNAT1;PAPOLB;ABL1
prerank,syntaxin binding (GO:0019905),0.30657403484816953,0.9017129700976049,0.6151832460732984,0.8988232284982433,1.0,8/61,7.85%,DAPK1;ABCA1;UNC13C;BAIAP3;STXBP3;STX16;LRRK2;SYT9
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3828112612269728,0.899715901951863,0.6095238095238096,0.8996637306074314,1.0,2/18,3.65%,PDLIM5;CNN3
prerank,cation channel activity (GO:0005261),0.2866891550274673,0.8984110071350022,0.6246973365617433,0.899121299035601,1.0,13/94,10.49%,SLC24A3;NALCN;TRPA1;CALHM5;SLC24A1;MCU;KCNK7;SLC24A5;PANX1;CUL5;KCNQ4;TRPM4;ANXA6
prerank,ribosomal small subunit binding (GO:0043024),0.38872625888308177,0.8953374121186483,0.6092150170648464,0.9022675918709211,1.0,6/17,20.07%,ERAL1;DDX3X;ABCE1;LARP1;PIM1;PTCD3
prerank,regulatory RNA binding (GO:0061980),0.3322996443869984,0.8947895573901172,0.5871156661786238,0.9002663268426228,1.0,12/38,24.47%,ZC3H7B;TUT7;PIWIL4;HNRNPA1;TUT4;ZNF346;RC3H1;DICER1;AGO4;RBM4;SOX2;AGO3
prerank,1-phosphatidylinositol binding (GO:0005545),-0.34611215303088205,-0.893173771400498,0.6004901960784313,0.8573530740535168,1.0,3/15,11.16%,EPB41;WDFY3;SCARB1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.37518584418332634,-0.8913865078759959,0.6025369978858351,0.857052322902947,1.0,5/10,10.68%,PRKAR1A;PKIB;PRKAR2B;PRKAR1B;PRKAR2A
prerank,kinase binding (GO:0019900),0.25530531505951015,0.8893073050165936,0.7617586912065439,0.9082311987937856,1.0,89/434,17.04%,TCF7L2;ERRFI1;RHOH;GHR;GSN;SMAD3;SASH1;IL31RA;RHOD;KIF13B;WWC2;NBEAL1;CCNA2;SP100;CEP152;PRKAG2;RHOBTB1;PDGFRB;KIF20A;RFFL;CDK5RAP3;MAPK4;TOM1L2;RHOBTB3;SKI;CDC42;SRC;RHOBTB2;PARP16;SIK1;CEBPA;NISCH;ERCC6L2;IL15RA;CKS1B;OXSR1;TTC28;IRAK3;DNAJC3;EGFR;KAT2B;ZBTB4;SPRY2;CCNK;SMAD1;PRKN;TELO2;PARN;SPRED3;KIZ;NEK6;TRIP6;ADRA2A;UFL1;RGCC;TNIP2;STRADA;WNK1;MAP3K13;MAP2K6;TRIP4;VDAC1;MYCN;MVP;FAM83F;LLGL1;DLG4;PTPN23;FLNA;IBTK;GATA6;CEP192;SUFU;BAG5;SPRED1;RND3;LAPTM4B;TPCN2;STX1B;CASP9;TBL2;AGAP2;SGO1;RHOG;ATF5;TNS2;CDKN2C;RNF138;ZC3HC1
prerank,ferrous iron binding (GO:0008198),-0.3029125375330308,-0.8869534537577344,0.6513513513513514,0.8623872158614192,1.0,5/21,12.33%,EGLN3;FTL;FTH1;EGLN2;ISCU
prerank,leucine zipper domain binding (GO:0043522),0.4344314322391576,0.8866329975272068,0.6098807495741057,0.9104872966984116,1.0,4/10,21.00%,PMF1;PAWR;AATF;DDIT3
prerank,nucleotidyltransferase activity (GO:0016779),0.36994204888616977,0.8859155072860538,0.5996860282574569,0.9088128222223207,1.0,8/19,21.39%,TUT7;TENT4A;TUT4;CRPPA;TENT4B;YRDC;PAPSS2;NUDT5
prerank,voltage-gated sodium channel activity (GO:0005248),0.35845005398918156,0.8852370795998862,0.5909822866344605,0.9070680736966569,1.0,1/22,0.69%,SCN7A
prerank,cholesterol transfer activity (GO:0120020),0.3766642667805804,0.882999137761265,0.6263910969793323,0.9081802105712896,1.0,5/16,15.44%,ABCA1;APOA1;MTTP;GRAMD1A;GRAMD1C
prerank,PDZ domain binding (GO:0030165),0.3027212201704666,0.8818919526015746,0.6251604621309371,0.9072582300239056,1.0,10/61,9.33%,TGFBR3;DOCK4;FZD2;ARHGAP29;SYNJ2;RAPGEF2;FZD1;PLEKHA2;SLC22A4;PRKN
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.40640541848605244,0.8799124310101765,0.6285714285714286,0.9079949674447667,1.0,7/12,23.23%,PHF2;KDM7A;PHF8;KDM3B;KDM4A;KDM4C;KDM3A
prerank,amyloid-beta binding (GO:0001540),0.29071047550377815,0.8785880082846654,0.6588089330024814,0.907572977251686,1.0,12/79,9.04%,LRP1;HSPG2;EPHA4;APOE;APOA1;LDLR;CST3;APBB2;TLR6;APBA1;EPHB2;PICALM
prerank,cholesterol binding (GO:0015485),0.3090177074885426,0.876978918260589,0.6505376344086021,0.9076298481166041,1.0,13/47,15.76%,ABCA1;APOA1;OSBPL8;STAR;SIDT1;ANXA6;TSPO;VDAC1;GRAMD1A;NR1H3;OSBPL5;GRAMD1C;NPC1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3206712033464239,0.8767109031206505,0.6204986149584487,0.9051540328950045,1.0,17/44,20.89%,SETD7;ASH1L;KMT5B;SETD1A;NSD1;WDR82;SETD5;SETD4;SMYD3;KMT2E;KMT2A;SETDB1;WDR5;SETD1B;CXXC1;RBBP5;N6AMT1
prerank,thyroid hormone receptor binding (GO:0046966),0.3356341413710375,0.8753014069922831,0.639344262295082,0.9048256075064605,1.0,10/28,18.82%,BRD8;TACC1;TRIP12;MED16;NCOR1;NSD1;TRIP6;NCOA3;NCOA6;MED30
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.36626452817534827,0.8729495598182372,0.6473354231974922,0.9061763198695121,1.0,8/21,18.50%,AKAP7;ARFGEF2;PRRC1;WASF1;AKAP8L;ARFGEF1;PJA2;PRKACA
prerank,syntaxin-1 binding (GO:0017075),0.3598252920445328,0.8720414654633911,0.6339563862928349,0.9048706938423383,1.0,4/22,6.60%,DAPK1;UNC13C;STXBP3;LRRK2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3286816984746527,-0.8681911611443965,0.654639175257732,0.8975989653836426,1.0,6/16,18.60%,MTMR2;INPP5F;MTMR9;SACM1L;MTMR6;SYNJ1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3305961085068483,-0.864370779211202,0.6439024390243903,0.9009351886512372,1.0,5/15,22.63%,COX4I1;COX6A1;COX5B;COX5A;COX8A
prerank,peptidase activator activity (GO:0016504),0.3584696936348203,0.8641544070444845,0.6360708534621579,0.916499194033062,1.0,7/22,15.33%,PCOLCE;PSME4;CLPX;APH1B;ADRM1;CASP8AP2;NLRC4
prerank,MAP kinase kinase activity (GO:0004708),0.3785843795775366,0.8634378961630497,0.6153846153846154,0.9147409116024722,1.0,3/15,12.85%,LRRK2;MAP2K1;MAP2K6
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3394410651774233,-0.8630685355391476,0.6618705035971223,0.8992156333125713,1.0,3/13,14.26%,PIP5K1B;PIK3C2B;PIK3CA
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.41687684700777583,0.862341744660384,0.6320582877959927,0.9138004993714676,1.0,1/10,3.80%,SLC6A13
prerank,peptide hormone receptor binding (GO:0051428),0.3972413321905961,0.8609144624157831,0.648506151142355,0.9135284446625375,1.0,1/11,5.57%,VIP
prerank,acetylcholine receptor activity (GO:0015464),-0.2958207777648158,-0.8593891037292015,0.6918918918918919,0.9029536571397972,1.0,13/22,46.84%,CHRM3;CHRM2;CHRM1;CHRNB1;HRH3;CHRM5;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;HRH4
prerank,water transmembrane transporter activity (GO:0005372),0.40109036103081136,0.8589145653587694,0.6408566721581549,0.9144072148532525,1.0,2/11,8.39%,PDPN;AQP6
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3327259589597802,0.858798564796028,0.6393939393939394,0.9116140914057853,1.0,6/32,9.73%,SLC1A5;SLC6A9;SFXN2;SLC38A6;SLC38A9;SLC43A1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3475275803607604,-0.858394928540783,0.6326034063260341,0.9002853952087458,1.0,3/12,12.53%,EIF4E;CYFIP2;EIF4E2
prerank,DNA replication origin binding (GO:0003688),-0.29211557870312815,-0.8582494476161583,0.6927374301675978,0.89619113641765,1.0,11/23,36.19%,ORC4;MCM8;MCM3;DHX9;MCM5;ORC5;GRWD1;CDC6;POLA1;MCM7;KAT7
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.3762119181049505,-0.8577466145196373,0.641860465116279,0.8929358617591286,1.0,5/10,29.65%,PIK3R3;PIK3C2B;PIK3CA;PIK3CG;PIK3CD
prerank,endonuclease activity (GO:0004519),0.2984301907194309,0.856272795337005,0.6807065217391305,0.9130656537604401,1.0,17/49,26.09%,SND1;OGG1;ENDOU;REXO4;PIWIL4;RNASEL;MBD4;TSNAX;DICER1;NOB1;APLF;RCL1;MRE11;AGO3;LACTB2;ANG;N4BP2
prerank,lysophospholipase activity (GO:0004622),0.35949062124283643,0.8560701104101078,0.6434494195688225,0.9104613261068015,1.0,3/20,6.13%,ASPG;PLA2G4A;LYPLAL1
prerank,endoribonuclease activity (GO:0004521),0.3214942990992181,0.8560096675032259,0.6695906432748538,0.9076339262884441,1.0,11/32,24.87%,SND1;ENDOU;PIWIL4;RNASEL;TSNAX;ENDOV;DICER1;NOB1;RCL1;AGO3;LACTB2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.4058560007409125,0.8555603369434707,0.6274509803921569,0.9054859321577323,1.0,4/11,16.26%,UBE4B;UBOX5;AMFR;UBR5
prerank,chemokine activity (GO:0008009),0.32104801360486734,0.854531461747329,0.662704309063893,0.904502196350853,1.0,3/31,6.12%,CCL19;CXCL16;CCL4
prerank,general transcription initiation factor binding (GO:0140296),-0.2902894108339395,-0.8533343345936516,0.6811989100817438,0.8977145597732594,1.0,11/25,23.25%,ESR1;TAF1B;TAF1;TBP;HHEX;GTF2A2;RUVBL1;YEATS2;THAP7;GTF2B;THRA
prerank,ribosomal large subunit binding (GO:0043023),-0.36428964043802325,-0.8525764734878741,0.6704035874439462,0.8948481703953176,1.0,6/11,26.42%,MRRF;MALSU1;NPM1;CPEB2;LTN1;CPSF6
prerank,ADP binding (GO:0043531),0.34120083456850825,0.8508927115197638,0.6617429837518464,0.9080416075408074,1.0,3/25,3.86%,PRKAG2;MYO18A;MYH10
prerank,snRNA binding (GO:0017069),0.3033240480372816,0.8506315736366523,0.6910569105691057,0.9055853844818448,1.0,15/42,23.68%,RBMXL2;SNRNP70;RBM22;HEXIM2;RNPC3;LSM8;RBM41;CCNT2;LSM10;HNRNPU;CCNT1;NCBP2;HEXIM1;PRPF8;TOE1
prerank,myosin binding (GO:0017022),0.2953721161296943,0.8501285594061458,0.6859838274932615,0.9037130653334339,1.0,3/55,1.20%,KIRREL1;CALD1;GSN
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.34271463033373945,-0.849405214658942,0.6498800959232613,0.8969355034092161,1.0,2/12,9.25%,SPPL3;BACE2
prerank,antiporter activity (GO:0015297),-0.2948141694945534,-0.8493074130334015,0.7014084507042253,0.892855168709835,1.0,10/20,31.76%,CLCN3;SLC35E4;SLC25A30;ATP1A3;SLC25A11;CLCN4;SLC35D1;SLC25A10;SLC25A14;SLC35D2
prerank,miRNA binding (GO:0035198),0.3280329265357118,0.8476487095670132,0.6576576576576577,0.9052807105083079,1.0,10/30,24.47%,ZC3H7B;TUT7;HNRNPA1;TUT4;ZNF346;RC3H1;AGO4;RBM4;SOX2;AGO3
prerank,Wnt-activated receptor activity (GO:0042813),0.3761102500402253,0.8470047662745596,0.6466666666666666,0.9035833421629749,1.0,4/15,10.18%,FZD2;FZD1;ROR1;RYK
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2719096736471819,0.8446963692902948,0.7106842737094838,0.9048384103244786,1.0,27/100,16.33%,MYO10;OGT;MYO1B;SH3PXD2B;IQGAP2;OSBPL8;PLA2G4A;ADAP2;PLEKHA8;ARHGAP9;ARFIP2;COMMD1;SNX12;GOLPH3L;SNX21;DENND1A;WIPI1;PLEKHN1;PIRT;PARD3;SAP30L;OSBPL5;GSDMD;LAPTM4B;GOLPH3;FCHSD2;AKT1
prerank,sterol transfer activity (GO:0120015),0.35437342770455976,0.843596329360361,0.6640253565768621,0.9039070696464627,1.0,5/17,15.44%,ABCA1;APOA1;MTTP;GRAMD1A;GRAMD1C
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2977932257254359,-0.8432633028156941,0.7386363636363636,0.9003479643073813,1.0,2/21,4.34%,GRIK2;P2RX7
prerank,chemokine receptor binding (GO:0042379),0.3079000368520549,0.8422567412081009,0.6803977272727273,0.903454912862772,1.0,5/35,13.54%,CCL19;CXCL16;CCL4;ITCH;CXCL13
prerank,protein homodimerization activity (GO:0042803),0.23785613960077942,0.841930981559688,0.9057750759878419,0.9012924754976901,1.0,96/589,15.74%,ENPP1;FBLN5;GHR;GDNF;SMAD3;CPQ;BCL2;NR2F2;CRYL1;TPM1;FGFR1;IL6R;BMPR1A;SLC30A8;IL17D;EPHX2;FGFR2;KIT;TPST1;FOXP2;PDGFRA;APOE;NPR3;IRAK2;CSF1;APPL2;MAPK4;DPYD;ACVR1;ZHX2;GSTM4;MIGA2;GSTM2;ADRA2C;ADRB3;PDXK;HOGA1;TNNC1;PML;LRRK2;KYNU;CEBPA;GUCY2D;ZBTB38;NAALADL1;MMUT;ALS2;STK4;IRAK3;RBPMS;ZBTB4;CBY1;COMMD1;ZBTB1;MZF1;ACTN4;CAMK2B;S100A11;ARNT;ABCB9;TIMM9;MASP1;EXT1;CARD9;SMIM1;SLC39A13;CEBPB;GALM;BHLHE41;ADRA2A;FBXO4;TERF2;CIP2A;PANK1;CDA;MAP3K13;RIPK2;ZNF318;TPM2;GOLGA5;KMT2A;TSC2;PSPH;ABCD2;FLNA;SNX9;DGAT2;NUDT16L1;CRPPA;PEX11B;GLIPR2;NLRC4;PRKRA;CYP2R1;CASR;HMGCS1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.34178700840109744,-0.8389915732265948,0.6758620689655173,0.9044056907764477,1.0,1/12,0.75%,SLC2A1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.36826229900800356,0.8372034579772325,0.6567164179104478,0.9068726597621831,1.0,1/15,1.19%,PIK3R1
prerank,solute:proton symporter activity (GO:0015295),0.36325817577838937,0.8369608436932283,0.6456953642384106,0.904511233155883,1.0,3/16,8.01%,SLC2A10;SLC11A2;SLC2A13
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3901467229388552,0.8325941770660215,0.6442477876106195,0.9091743352170855,1.0,2/11,19.34%,SLC22A4;SLC25A29
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2774809020414712,0.8307247860835444,0.7345132743362832,0.909574470476284,1.0,16/75,18.13%,CRYL1;DHRS3;H6PD;MDH2;HSD3B2;MDH1B;ADH1A;DCXR;AKR1B10;KDSR;BDH1;SORD;PHGDH;PGD;DHDH;ME3
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3346606019381853,-0.8298436948673968,0.6766917293233082,0.917839493439176,1.0,9/12,51.61%,RRH;OPN1MW3;OPN1MW;OPN3;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,G protein-coupled receptor activity (GO:0004930),0.24392968142095803,0.8288424327391616,0.8166311300639659,0.9099974955077066,1.0,19/239,8.34%,ADRA1B;PDGFRL;ADGRV1;LGR4;PDGFRB;ADGRL1;NPR3;LTB4R;GPR63;ADRA2C;LHCGR;ADRB3;BDKRB2;MTNR1A;AGTR1;GRM2;LPAR1;DRD3;MAS1
prerank,NADP binding (GO:0050661),-0.2601937930246057,-0.8270927918277633,0.7659574468085106,0.9189408631053402,1.0,18/32,28.95%,KCNAB1;NOS3;NOS1;ME1;DHFR;SPR;CBR3;HSD11B1;DHCR7;TM7SF2;HMGCR;CAT;GRHPR;NOX1;MTRR;CBR4;CRYZL1;NOS2
prerank,phosphatidate phosphatase activity (GO:0008195),0.3704841010386646,0.8261392697857878,0.6440972222222222,0.9117935855471055,1.0,6/13,26.43%,PLPP3;PLPP5;LPIN3;LPIN2;PLPPR2;LPIN1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.37574734658972053,0.8247085888790947,0.6860068259385665,0.9115719165344959,1.0,3/12,13.78%,CDK8;CCNK;CDK12
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2666313246843971,-0.8245510222096274,0.7269938650306749,0.9193533618911002,1.0,13/28,30.46%,EDC3;RPP14;POP4;RPP21;MRPL44;ELAC2;RNASEH1;NUDT16;EXO1;POP7;APEX1;FEN1;RPP40
prerank,carboxy-lyase activity (GO:0016831),-0.27795934356523166,-0.8239429170366472,0.7473684210526316,0.916244428147607,1.0,10/23,41.01%,ECHDC1;DDC;GAD1;BCKDHA;MLYCD;PPCDC;UXS1;AZIN1;PCK2;MVD
prerank,CARD domain binding (GO:0050700),-0.32293727422348717,-0.8232471205577394,0.7016317016317016,0.9133363882399005,1.0,4/14,15.20%,NOD1;CARD14;NOD2;CARD16
prerank,protein kinase inhibitor activity (GO:0004860),0.29623079746768083,0.8208674520221049,0.7059679767103348,0.9149400328906442,1.0,9/42,15.35%,PARVA;ITPRIP;DNAJC3;SPRY2;TAOK3;DUSP19;IBTK;CDKN1C;SPRED1
prerank,nuclear receptor binding (GO:0016922),0.2577133204012914,0.8208502242117468,0.7648456057007126,0.9121980885818501,1.0,21/111,15.03%,TCF7L2;SMAD3;NCOA2;BRD8;TACC1;MED14;TRIP12;MED16;NCOR1;STAT5B;ACTN4;NSD1;RNF6;NCOR2;TRIP6;NR4A1;WIPI1;TRIP4;NCOA3;TADA3;RXRA
prerank,acetyltransferase activity (GO:0016407),0.311112389680287,0.8180629640003781,0.723589001447178,0.9140545781450294,1.0,11/31,24.13%,DBT;KAT2B;LCAT;SAT2;NAA80;NAA50;SAT1;PAFAH2;SMARCE1;NAT14;ESCO1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.31317921931454096,0.8165224225460406,0.7061469265367316,0.9139283158447868,1.0,6/30,10.82%,SLC30A8;SLC25A37;SLC30A2;SLC11A2;SLC30A10;SLC39A13
prerank,Tat protein binding (GO:0030957),-0.34125252443090837,-0.810312457598572,0.7224770642201835,0.9321424690089177,1.0,5/10,31.61%,ACTB;NPM1;DLL1;SMARCA4;MDFIC
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.35038569957662163,0.8083634318550028,0.7056,0.924890938820684,1.0,3/17,11.79%,AK1;AK8;NME6
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3048453868473379,0.8068717859981323,0.7093023255813954,0.9245240936592667,1.0,7/34,9.07%,MYO10;OGT;MYO1B;IQGAP2;ADAP2;ARHGAP9;COMMD1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.35845676482537936,0.8040481386308401,0.7074829931972789,0.926406574849044,1.0,6/15,22.53%,SH3PXD2B;PLA2G4A;SAP30L;SESTD1;RUBCNL;LANCL2
prerank,ion channel inhibitor activity (GO:0008200),0.3029631591084642,0.8039397974809857,0.750728862973761,0.9238543314780485,1.0,2/35,4.27%,ITPR1;NEDD4
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2678359952240911,-0.8023532990202126,0.7822349570200573,0.9420843952380404,1.0,6/24,14.43%,RPL41;RPS14;RPS13;RPS7;RPL26;RPL5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3370266805666575,-0.8013015388319129,0.6937354988399071,0.9396074501055013,1.0,4/10,22.28%,APOBEC1;GDA;ADARB2;DCTD
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.3478516847713127,-0.7992559946407405,0.715962441314554,0.9388111211115948,1.0,3/10,22.95%,ANKRD13A;USP15;FAAP20
prerank,telomeric DNA binding (GO:0042162),-0.24418116953328023,-0.7936812920678501,0.801948051948052,0.9436939503446362,1.0,18/32,42.43%,KDM1A;HNRNPD;CTC1;HNRNPA2B1;ZBTB48;SMG7;TEN1;HMBOX1;APEX1;PIF1;TERT;STN1;PURA;TERF2IP;ACD;TINF2;UPF3A;XRCC6
prerank,myosin II binding (GO:0045159),0.37826809464917577,0.7928116433924034,0.6916376306620209,0.9388634624073836,1.0,2/10,7.32%,GSN;MYL4
prerank,NF-kappaB binding (GO:0051059),-0.2692685251756541,-0.7901690487044543,0.788135593220339,0.9451313429576264,1.0,8/24,21.95%,FAF1;NFKBIA;EP300;NPM1;HDAC3;PSMA6;COMMD7;GSK3B
prerank,nuclear localization sequence binding (GO:0008139),-0.2948695009165256,-0.7900294937988971,0.7780678851174935,0.9410754193396135,1.0,4/18,10.31%,NUP153;NFKBIA;IPO5;CABP1
prerank,kinesin binding (GO:0019894),-0.26003467222732496,-0.7895943604664751,0.7891737891737892,0.9376417581140962,1.0,10/27,27.94%,ACTB;SPAG9;KIFAP3;NEFH;PRC1;KIF18B;KIF1B;SPTBN5;RAB29;FAM83D
prerank,alpha-tubulin binding (GO:0043014),0.3020456121862691,0.7868384316792815,0.7526717557251908,0.9454182343466333,1.0,4/31,6.62%,DLEC1;EFHC1;INO80;BEX4
prerank,vitamin D receptor binding (GO:0042809),-0.303209417510805,-0.7858039829722542,0.7506053268765133,0.939221127905926,1.0,4/14,12.59%,MED1;MED4;SNW1;THRAP3
prerank,serine-type endopeptidase activity (GO:0004252),0.2592775708601897,0.7854347899406849,0.8124223602484472,0.9449475020399489,1.0,8/80,11.77%,MMP2;RHBDL3;CTSH;PRSS48;APEH;MASP1;CLPP;F2
prerank,histone methyltransferase binding (GO:1990226),-0.3251053002848752,-0.7827583748059048,0.7427884615384616,0.9399640607738687,1.0,2/11,6.87%,LCORL;HSP90AB1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3320790222523737,-0.7825951524196569,0.75,0.9319480498305308,1.0,2/10,14.91%,DUSP7;DUSP8
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3320790222523737,-0.7825951524196569,0.75,0.9319480498305308,1.0,2/10,14.91%,DUSP7;DUSP8
prerank,GABA receptor binding (GO:0050811),-0.33048356892999886,-0.7806725157318962,0.7348484848484849,0.9311200771056238,1.0,5/11,25.59%,PLCL2;TRAK2;JAKMIP1;GABARAP;AKAP5
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.2998136910372403,-0.7781624021215496,0.7716535433070866,0.9310822057959416,1.0,6/14,25.03%,RPP14;POP4;RPP21;ELAC2;TSEN34;POP7
prerank,neurexin family protein binding (GO:0042043),0.36733143561444215,0.776732723861556,0.7147887323943662,0.9558848029221217,1.0,2/10,12.45%,SYTL5;SYTL2
prerank,neuropeptide hormone activity (GO:0005184),0.3114842565436531,0.7719029488608062,0.7556221889055472,0.9604959175662929,1.0,3/22,15.66%,VIP;NPFF;NPY
prerank,ribonuclease activity (GO:0004540),0.2630207263854987,0.7716707585386557,0.8175937904269082,0.957977356506626,1.0,18/56,25.49%,SND1;ENDOU;RNASE12;EXOSC1;PIWIL4;RNASEL;RNASE7;EXOSC7;TSNAX;DICER1;NOB1;EXOSC2;RCL1;AGO3;LACTB2;EXOSC8;ANG;RNASE4
prerank,nucleosomal DNA binding (GO:0031492),0.31568348069332014,0.7704482919213432,0.7391304347826086,0.9570124648510726,1.0,6/21,16.85%,MBD2;SMARCC2;MTA2;SMARCD2;SMARCB1;HNRNPC
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3218523958194392,0.7699517273778982,0.7601957585644372,0.9549723541590674,1.0,9/20,24.06%,SLC30A8;SLC30A2;SLC30A10;SLC39A13;SLC39A1;SLC39A12;SLC39A6;SLC30A5;SLC30A4
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.31761964899747663,-0.7687674277648527,0.7541371158392435,0.9413794889650371,1.0,2/11,5.49%,APEX2;RPS3
prerank,methylation-dependent protein binding (GO:0140034),0.26446265502418104,0.7687007049382126,0.7984189723320159,0.9540084613407479,1.0,18/57,21.02%,ING3;ING5;PHF1;PHF2;L3MBTL1;L3MBTL2;KMT2E;JMJD7;WDR5;KDM7A;PHF8;CBX5;SPIN4;ATRX;KDM4A;CXXC1;RBBP5;KDM5A
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3080349737045571,0.7664734700708671,0.76049766718507,0.9545227145394124,1.0,5/22,11.61%,OPTN;SPRTN;WDR81;ZBTB1;IKBKE
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.3580081767269695,0.7664405018524103,0.7207207207207207,0.95181425887158,1.0,1/11,1.34%,SASH1
prerank,histone methyltransferase activity (GO:0042054),-0.2392220987469981,-0.7633331064941402,0.8660436137071651,0.9455039683369839,1.0,8/32,17.17%,EED;EZH2;PRMT7;SMYD2;SUV39H1;SMYD1;PRMT6;KMT5A
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.28934534268928724,0.7627298923973826,0.7943262411347518,0.9545187956037572,1.0,7/34,16.48%,SETD7;KMT5B;SETD4;SMYD3;KMT2E;SETDB1;EEF2KMT
prerank,deubiquitinase activity (GO:0101005),-0.19237609207856127,-0.7624390581281211,0.9609756097560975,0.9429019071403322,1.0,20/88,20.73%,USP53;OTUD7B;MINDY2;USP29;MINDY1;OTUD7A;OTUD4;USP31;YOD1;OTULIN;TNFAIP3;USP14;USP22;USP15;USP4;UFD1;EIF3F;OTUB1;USP19;TANK
prerank,histone acetyltransferase activity (GO:0004402),-0.24537860605677286,-0.7604481407627641,0.8508771929824561,0.941404376625298,1.0,10/30,19.17%,TAF1;KAT2A;TAF10;TADA2A;USP22;KAT6A;NAA60;EP300;BRCA2;MCM3AP
prerank,microtubule plus-end binding (GO:0051010),0.31018987818941696,0.7598762416302501,0.7741433021806854,0.9561214455043708,1.0,3/20,9.52%,STIM1;CLIP4;MAPRE2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.3352937592777321,0.7591846520156404,0.7191780821917808,0.9543995110446406,1.0,4/14,16.11%,AIFM1;CYB5R4;NOX4;NOX3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2221100338187228,0.7584388649970711,0.9414893617021277,0.9527109275968271,1.0,74/268,23.80%,TXNIP;SMAD3;BCL2;MOAP1;RFFL;CDK5RAP3;AXIN2;FAF2;SKI;DERL1;PML;CUL4B;RNF31;VCL;SNCAIP;CUL5;DBT;ARRB1;EGFR;UBOX5;PRKN;LTBR;STAT2;SMC6;ITCH;CKB;NEK6;IKBKE;RAD18;YWHAE;ACVR1B;TRIP4;MUL1;SYT11;GLMN;DIO2;HSPA9;SNX9;UBE2D1;BAG5;TMBIM6;HLTF;LAPTM4B;AUP1;SPART;SPOP;MAP1LC3A;BECN1;RNF34;PSMD1;PRKACA;KDM4A;SUMO1;UBE2T;PSMA3;PRDX6;UCHL1;CBS;TRIB1;SMAD2;JKAMP;TSG101;RNF20;BAG6;HDAC6;WFS1;AMBRA1;BRCA1;HSPA5;ATXN3;ERLIN2;UBXN7;CASC3;DET1
prerank,ribonuclease P RNA binding (GO:0033204),-0.32050744628298367,-0.7571294532342204,0.7880952380952381,0.942282589202219,1.0,5/10,30.46%,RPP14;POP4;RPP21;POP7;RPP40
prerank,voltage-gated ion channel activity (GO:0005244),-0.2860601675162934,-0.7551880114958778,0.795774647887324,0.9410809599830576,1.0,5/14,21.23%,KCND2;CACNA1H;ANO6;HCN1;HVCN1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2877630578892341,0.7519152228371898,0.7833827893175074,0.9591508312985917,1.0,6/29,9.97%,PRKAG2;PKIA;KAT2B;SPRY2;HEXIM2;INCA1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.25459061361912116,0.7516553334893807,0.8333333333333334,0.9567665762025959,1.0,11/69,16.70%,ASPG;PLA2G4A;DBT;LPGAT1;KAT2B;CERS6;CERS5;MOGAT3;DGAT2;CERS2;ZDHHC20
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.27683282233259915,0.7516176120724396,0.784570596797671,0.9541286789084215,1.0,13/35,28.27%,BCDIN3D;QRSL1;TRMT9B;TRMT13;DTWD1;ALKBH1;DUS3L;FTO;TRMT12;TYW3;PTRH2;TRIT1;QTRT2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.25599662949937946,-0.7504668555157548,0.8197674418604651,0.9438158075974202,1.0,7/23,21.93%,PLEKHA5;HIP1R;KIF16B;WDR45B;WIPI2;CLVS2;PLA2G4E
prerank,RNA polymerase II complex binding (GO:0000993),0.28324150991153824,0.7498885771599596,0.7769347496206374,0.953750309009515,1.0,11/32,21.26%,RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2370224920398849,-0.7470881923685415,0.8912386706948641,0.9443555403599655,1.0,9/29,23.97%,ACER3;ACER2;GANC;OVGP1;CTBS;NEU1;PARG;GLA;HPSE
prerank,SUMO binding (GO:0032183),0.33616302527760916,0.7457836854391698,0.7733333333333333,0.9568012323541073,1.0,4/13,14.33%,PML;USPL1;SERBP1;CASP8AP2
prerank,lysine-acetylated histone binding (GO:0070577),0.31325514832460444,0.742172377747667,0.7814029363784666,0.9562487445495834,1.0,4/20,6.93%,PSME4;PHIP;MLLT3;ATAD2B
prerank,acetylation-dependent protein binding (GO:0140033),0.31325514832460444,0.742172377747667,0.7814029363784666,0.9562487445495834,1.0,4/20,6.93%,PSME4;PHIP;MLLT3;ATAD2B
prerank,5'-3' exonuclease activity (GO:0008409),0.33320913032657284,0.740949288901253,0.7634782608695653,0.9551807962757929,1.0,6/14,24.39%,DCLRE1C;DXO;DCLRE1A;FAN1;XRN1;MRE11
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2985705186058588,0.7402455665047377,0.802130898021309,0.9535246068660667,1.0,1/24,1.26%,GLUL
prerank,transferrin receptor binding (GO:1990459),-0.3188748185184591,-0.7389729769302313,0.7991266375545851,0.9511805983386198,1.0,3/10,21.78%,SNX1;CD81;CHUK
prerank,retinoic acid receptor binding (GO:0042974),0.3175551848726669,0.737083041380014,0.7928802588996764,0.9550207901959136,1.0,4/17,9.68%,RARG;TACC1;ACTN4;NSD1
prerank,ubiquitin protein ligase binding (GO:0031625),0.2160103550214267,0.735789314879344,0.949678800856531,0.9540944212167842,1.0,70/253,23.80%,TXNIP;SMAD3;BCL2;MOAP1;RFFL;AXIN2;FAF2;SKI;DERL1;PML;CUL4B;RNF31;VCL;SNCAIP;CUL5;DBT;ARRB1;EGFR;UBOX5;PRKN;LTBR;SMC6;CKB;NEK6;IKBKE;RAD18;YWHAE;ACVR1B;MUL1;SYT11;GLMN;DIO2;HSPA9;SNX9;UBE2D1;BAG5;TMBIM6;HLTF;LAPTM4B;AUP1;SPART;SPOP;MAP1LC3A;BECN1;RNF34;PSMD1;PRKACA;KDM4A;SUMO1;UBE2T;PSMA3;PRDX6;UCHL1;CBS;TRIB1;SMAD2;JKAMP;TSG101;RNF20;BAG6;HDAC6;WFS1;AMBRA1;BRCA1;HSPA5;ATXN3;ERLIN2;UBXN7;CASC3;DET1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.28554551785019244,-0.7354499220342026,0.7783251231527094,0.951951375353358,1.0,9/14,51.45%,CAPNS1;CAPN6;CAPN3;CAPN11;CAPN2;CAPN12;CAPN8;CAPNS2;CAPN9
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.25687968157812,0.730151082121541,0.8379120879120879,0.9590076250571127,1.0,19/49,23.75%,OPTN;SPRTN;EPS15;WDR81;ZBTB1;TNIP2;IKBKE;RAD18;DZIP3;TNIP1;PSMD4;UIMC1;BRCC3;ZFAND6;ABRAXAS2;BAG6;HDAC6;PRPF8;PARP10
prerank,3'-5' exonuclease activity (GO:0008408),-0.2174633519340772,-0.7267451941854749,0.9259259259259259,0.958722018909927,1.0,12/45,21.43%,REV3L;CNOT6L;ANGEL2;PNPT1;PNLDC1;RAD1;TATDN1;DIS3L2;EXOSC5;CNOT7;USB1;CNOT8
prerank,mRNA methyltransferase activity (GO:0008174),0.3282550273332159,0.7256162972571251,0.7806563039723662,0.962315010774736,1.0,6/12,24.75%,NSUN2;METTL14;CMTR2;METTL3;METTL16;PCIF1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2931340208673285,0.7253090142981553,0.8041543026706232,0.960045746238199,1.0,3/26,8.00%,B3GALT1;GBGT1;B3GALNT1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3214619357543317,0.7240606069375886,0.8098471986417657,0.9589276497117465,1.0,5/13,20.57%,DNASE1L1;ENDOV;DICER1;ZGRF1;FAN1
prerank,GTP binding (GO:0005525),0.2149205723178748,0.7193155357960077,0.9372900335946248,0.962323284848639,1.0,29/172,16.63%,RHOH;RHOD;RANBP17;RHOBTB1;RRAS2;MRAS;RHOBTB3;CDC42;LRRK2;RHOBTB2;RAB22A;ARL2;ARFIP2;RHOT1;ARL1;ANXA6;RRAGD;RHOQ;TUBB2B;INSR;RAP2A;ARF4;GNL2;RND3;ARF6;TUBB2A;ARL5A;AGAP2;RHOG
prerank,CCR chemokine receptor binding (GO:0048020),0.2741294791855595,0.718581008325427,0.8365817091454273,0.9606462706189834,1.0,4/28,17.52%,CCL19;CCL4;CXCL13;CX3CL1
prerank,signal sequence binding (GO:0005048),0.2698897370836458,0.7168825998033285,0.8524822695035461,0.9600083390358682,1.0,11/35,24.73%,CEMIP;KPNA6;KDELR3;NUP214;KPNA2;KPNA1;KPNB1;SEC61A1;AP2B1;KDELR2;KPNA4
prerank,RNA polymerase binding (GO:0070063),0.3014246638812547,0.7146609059254407,0.8221859706362153,0.9602124952682207,1.0,7/18,23.00%,NEDD4;TCERG1;CCNT2;PKN2;SCAF8;CCNT1;BRCA1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3310318855134321,0.7141498554541883,0.7805755395683454,0.9582973838594806,1.0,11/11,66.92%,CHRNB2;CHRNA7;CHRNA4;CHRNA9;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNB1
prerank,tRNA binding (GO:0000049),-0.2156787313367174,-0.7138266822633059,0.9233576642335767,0.9704004409647929,1.0,20/43,35.65%,TRMT10A;PSTK;PTCD1;YARS2;EEF1A1;KARS1;FARS2;AIMP1;AARS2;EIF2AK4;NSUN6;TRMT10C;CTU1;TERT;HSD17B10;DALRD3;THG1L;TRMT10B;DARS2;ELP1
prerank,lysine N-methyltransferase activity (GO:0016278),0.2993490167307767,0.7134770556665464,0.827922077922078,0.9565184287096379,1.0,3/20,16.48%,SETD7;SETD4;EEF2KMT
prerank,phosphatase activator activity (GO:0019211),-0.27429342303385135,-0.7120196697270332,0.8456221198156681,0.9683910395144275,1.0,4/14,10.37%,PPP2R5A;GTF2F1;CALM1;CALM3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.2347445478108084,-0.7094284752807563,0.8818443804034583,0.9674598490688532,1.0,5/25,10.69%,ARAP3;HIP1R;PLEKHA1;KIF16B;PLEK
prerank,receptor antagonist activity (GO:0048019),0.3050456022136645,0.7082723594569136,0.8074324324324325,0.9601735546789837,1.0,4/17,23.25%,DKK3;IL18BP;FST;PXDN
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2590122674045582,0.708079524325899,0.8720238095238095,0.9578247091458069,1.0,3/38,6.60%,PIK3R1;FRS2;LRRK2
prerank,MHC class I protein binding (GO:0042288),0.31661526429420006,0.7055021013823108,0.8189655172413793,0.9582694319725592,1.0,4/13,20.91%,DERL1;ABCB9;TAPBP;TAP1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.23081155698775752,0.7004365524575725,0.912826899128269,0.9616758779709496,1.0,6/73,8.34%,LGR4;NPR3;LTB4R;LHCGR;BDKRB2;MAS1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21752734179041988,-0.6990179543728441,0.9453376205787781,0.9744454738692214,1.0,10/34,21.43%,CNOT6L;ANGEL2;PAN3;PNPT1;PNLDC1;DIS3L2;EXOSC5;CNOT7;USB1;CNOT8
prerank,RNA binding (GO:0003723),0.19672622391180966,0.6987075878898261,0.997997997997998,0.9610365767817334,1.0,276/1321,21.48%,POLR2D;CELF2;SAMD4A;RBMS1;BICC1;ROCK2;RBMS3;C1D;LRP1;DCN;TENT5A;A1CF;CSDC2;RBFOX1;RRBP1;SON;ADK;RBMXL2;MACF1;HNRNPLL;RBFOX2;FNDC3B;SPATS2L;SND1;RFTN1;MYO18A;MYH10;CDC42EP4;POLR1G;CAST;ZC3H7B;ENDOU;IGF2BP2;TNS1;GOLGB1;MDH2;NUDT7;OAS2;MAP3K20;SIDT1;SNRNP70;DYNC1H1;ZFP36L1;NPM3;TNRC6B;THOC2;ERI3;SERPINH1;RPUSD4;ACO1;SF1;CPEB3;BUD23;PNN;NPM2;DDX60;NUP42;SNTB2;DDX17;REXO4;RPP25L;TOP3B;DXO;HELZ;DNTTIP2;TUT7;EXOSC1;ERAL1;SAFB2;ZNF106;RBMS2;CHD2;TNRC6A;IBA57;RBM22;ALDH18A1;HNRNPR;NSUN2;RBPMS;METTL14;HNRNPA1;FLYWCH2;APEH;NONO;DDX39A;GFM1;ACTN4;EIF4A2;HEXIM2;DIMT1;RAVER2;ASCC3;ADAT1;PRRC2B;DDX19A;FTSJ3;RNASEL;WDR33;PARN;PPHLN1;TFAM;EIF3A;BYSL;RPUSD2;MANF;TRIP6;ERI1;NUP98;DDX3X;DDX31;EIF2S2;POLRMT;DDX23;PPP1R10;SERBP1;SUGP1;RBM19;RAE1;EIF5B;SUGP2;EXOSC7;MAGOHB;STXBP1;DDX50;WDR43;YWHAE;RCAN3;TUT4;LARP1;TRMT9B;HMGN5;SLC16A3;NMD3;GANAB;UTP23;DDX10;MTREX;TEFM;NOL3;ALDH6A1;USP10;USO1;IFIT2;RBM34;STAU1;HELZ2;ESF1;P4HB;GTF2E2;TIAL1;MARK2;SNRPD2;TEP1;HSPA9;RC3H2;NELFE;FLNA;NSUN5;TCERG1;SRP72;SRSF5;AKAP8L;NUDT16L1;RBM39;FASN;PCF11;GPKOW;GNL2;FUBP3;RBM5;RPP30;PRRC2C;HUWE1;CLK3;RRP7A;MRPL23;RBM6;HLTF;PRKRA;RBM4B;DDX52;DZIP3;PSPC1;RPP38;MRPL40;ELP5;EPPK1;COA6;EIF3I;DNAJC21;TBL2;LSM8;KTN1;TENT4B;SRRM2;DCP1A;SYNCRIP;HNRNPC;LONP1;NGDN;KPNA2;TRMT2A;TSNAX;PRPF6;PATL1;DDX4;NAF1;ZNF346;SF3B2;SF3B1;LSM10;RRP9;DARS1;SRSF10;ALKBH1;KHDC4;R3HDM2;PRRC2A;PPIE;CPSF2;DHX58;CKAP4;TRUB2;RC3H1;METTL3;EIF3C;DDX1;PARP12;TPR;ENDOV;TRIM32;KPNB1;FIP1L1;DICER1;SAP18;PSMD4;RSRC2;SUMO1;FASTKD3;DUS3L;NCOA5;ZGRF1;CCDC47;LARP6;YTHDF2;GPATCH8;PTCD3;AATF;UTP3;HNRNPU;AGO4;YRDC;HDLBP;ZFP36L2;GSPT1;FSCN1;ACTN1;DDX49;HNRNPH1;ZC3H15;MRPS28;MRPS35;DDX24;CEBPZ;PKN2;SCG3;BMS1;EIF4G2;SCAF8;UBFD1;SRSF3;RARS2;NOCT;NUDT5;SARS1;SARS2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.24458853769628677,-0.6946698215627188,0.9083769633507853,0.9748998130220876,1.0,13/21,51.68%,GRM5;GRM1;GRIA1;CHRNB1;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;DRD5;CHRNA1;DRD1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2848232014004955,0.691809075169201,0.8525641025641025,0.9661104619465847,1.0,11/24,22.53%,OSBPL8;PLA2G4A;PLEKHA8;ARFIP2;GOLPH3L;OSBPL5;GSDMD;GOLPH3;SESTD1;RUBCNL;LANCL2
prerank,guanyl ribonucleotide binding (GO:0032561),0.20400717024655857,0.6871969952799477,0.969060773480663,0.9685875518290028,1.0,31/196,16.63%,RHOH;RHOD;MPPED2;RANBP17;RHOBTB1;RRAS2;RAPGEF2;MRAS;RHOBTB3;CDC42;LRRK2;RHOBTB2;RAB22A;ARL2;ARFIP2;RHOT1;ARL1;ANXA6;RRAGD;RHOQ;TUBB2B;INSR;RAP2A;ARF4;GNL2;RND3;ARF6;TUBB2A;ARL5A;AGAP2;RHOG
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2819400536275172,0.6778658961825612,0.8642172523961661,0.9759002912034255,1.0,4/20,16.50%,USP47;OTULINL;USP9X;COPS2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.2078091256132704,-0.6729321568591544,0.9475308641975309,0.9917745373389557,1.0,10/33,21.43%,CNOT6L;ANGEL2;PNPT1;PNLDC1;DIS3L2;EXOSC5;CNOT7;DCP2;USB1;CNOT8
prerank,death receptor binding (GO:0005123),0.3004410542367702,0.6706690310459589,0.8428805237315876,0.9806325715324787,1.0,8/15,27.01%,NTF3;CASP8AP2;BDNF;FEM1B;MADD;MYD88;FADD;RIPK1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.25799309352844635,0.6705879092222892,0.8746355685131195,0.9781567936483062,1.0,7/28,21.22%,PRKAA2;LRRK2;MAP2K1;MAP2K6;AKT1;PRKACA;AURKA
prerank,O-acyltransferase activity (GO:0008374),-0.2177561879652305,-0.6680438551915292,0.9325513196480938,0.9922724465887548,1.0,6/30,17.20%,LPCAT1;MBOAT1;PLA2G4C;MBOAT7;LPCAT3;LPCAT2
prerank,ATPase regulator activity (GO:0060590),0.25231312921600774,0.6663444328435545,0.8989751098096632,0.9797376230394987,1.0,7/38,16.41%,DNAJC1;ATP1B2;KATNB1;TOR1AIP1;BAG5;TOR1AIP2;FNIP1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.23049769186129823,-0.6612118449606909,0.926605504587156,0.9939980650357623,1.0,10/22,36.20%,MTMR2;DUSP7;DUSP8;DUSP23;CDKN3;DUSP3;SBF1;PPM1F;DUSP5;DUSP2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.26733957312239237,-0.6600324297437017,0.9030023094688222,0.9910583315046921,1.0,6/12,28.52%,DHRS4;NDUFS7;CBR1;CBR4;CRYZL1;NQO1
prerank,protein phosphatase activator activity (GO:0072542),-0.26380713094817004,-0.6589895908476414,0.8935185185185185,0.9880124273208313,1.0,3/13,10.37%,PPP2R5A;CALM1;CALM3
prerank,methylated histone binding (GO:0035064),0.222928581134338,0.6570108440846023,0.9133247089262613,0.9860223325944695,1.0,18/62,21.02%,ING3;ING5;PHF1;PHF2;L3MBTL1;L3MBTL2;KMT2E;JMJD7;WDR5;KDM7A;PHF8;CBX5;SPIN4;ATRX;KDM4A;CXXC1;RBBP5;KDM5A
prerank,gamma-tubulin binding (GO:0043015),-0.23431031903953978,-0.6560217920984225,0.9072164948453608,0.9863276027711753,1.0,6/21,18.67%,DIXDC1;PAK1;GIT1;CDK5RAP2;BRCA2;RAB11FIP5
prerank,neuropeptide receptor binding (GO:0071855),-0.24939979070326596,-0.652094638009394,0.9102244389027432,0.985491804328362,1.0,2/14,18.38%,SHANK1;PPY
prerank,DNA secondary structure binding (GO:0000217),-0.20040041143670567,-0.6511153315815233,0.9444444444444444,0.9824489062048821,1.0,9/31,25.46%,MEF2C;YY1;RAD51C;HMGB2;HMGA2;MSH2;LIN54;RAD51AP1;GEN1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.24518199595573287,0.6504830590483778,0.8916913946587537,0.9890886854337627,1.0,12/33,21.53%,RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8;MAF1
prerank,translation initiation factor activity (GO:0003743),0.2423485543421771,0.6473242892233115,0.9072305593451568,0.989320823298049,1.0,9/36,18.43%,EIF4A2;EIF3A;EIF2B4;EIF2S2;EIF5B;EIF4E3;EIF2B3;EIF3I;EIF3C
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2677946367911537,0.645207819014878,0.8894308943089431,0.9885720471921027,1.0,4/20,14.61%,AGPAT3;LPGAT1;MOGAT3;DGAT2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.2699445355326805,-0.6443914093655502,0.9142857142857143,0.9833569601376454,1.0,6/11,46.30%,HCN1;HCN4;AQP1;CNGA2;CNGA4;CNGA3
prerank,palmitoyltransferase activity (GO:0016409),0.25268478468043687,0.6434196826586962,0.8928571428571429,0.9875384695242372,1.0,1/28,1.26%,GLUL
prerank,nuclear import signal receptor activity (GO:0061608),0.27433994822509855,0.6387044746913974,0.8885245901639345,0.9892949978800142,1.0,4/15,18.84%,KPNA6;KPNA2;KPNA1;KPNB1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2573999282316414,-0.6334069487132764,0.900709219858156,0.9869716369673813,1.0,5/12,22.00%,CCDC88A;VEGFA;VEGFC;DAB2IP;VEGFD
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.2338692000099983,0.6274445233036289,0.9154727793696275,0.9959575492008814,1.0,12/38,22.53%,SH3PXD2B;PLA2G4A;SNX12;SNX21;DENND1A;WIPI1;PARD3;ATG2B;WDR45;SESTD1;RUBCNL;LANCL2
prerank,aminopeptidase activity (GO:0004177),-0.20716216070009907,-0.6232058658570804,0.9473684210526315,0.9895230282479996,1.0,9/26,25.66%,XPNPEP3;MMP15;RNPEPL1;METAP2;BLMH;MMP16;TRHDE;LNPEP;NPEPPS
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3003342691212476,0.6166440548464804,0.9041591320072333,1.0,1.0,4/11,19.21%,NAA40;NAA20;NAA80;NAA50
prerank,damaged DNA binding (GO:0003684),0.21605161962705016,0.6163087184588479,0.9635854341736695,0.9993703206695741,1.0,6/44,11.92%,OGG1;CUL4B;DCLRE1C;SMC6;DCLRE1A;RAD18
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.21413419405460568,0.6144050294329821,0.9470827679782904,0.9981261945956118,1.0,17/54,25.21%,ASPG;ASPA;SIRT2;NGLY1;HDAC8;HDAC4;VNN1;SUDS3;AGA;DARS1;SIRT5;MIER3;HDAC6;HDAC5;ACER1;HDAC1;ACY1
prerank,exoribonuclease activity (GO:0004532),0.2751398138289619,0.6050403541569385,0.9018932874354562,1.0,1.0,5/12,27.35%,EXOSC1;EXOSC7;EXOSC2;EXOSC8;EXOSC9
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.25457221699167765,-0.603226269635559,0.9223744292237442,0.9973544489115657,1.0,7/11,30.25%,NUDT4;DCP2;NUDT11;DCPS;NUDT16;NUDT10;NUDT1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.2685369988501938,0.6028425493863585,0.9237147595356551,1.0,1.0,1/15,5.18%,PLA2G4A
prerank,glucose transmembrane transporter activity (GO:0005355),0.25970473478985034,0.6012367463440037,0.9197952218430034,0.9993624905735367,1.0,4/17,17.57%,SLC2A10;SLC5A3;SLC2A4;SLC2A8
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.24311733532871366,0.6004211142077477,0.9520958083832335,0.9973678153931154,1.0,3/24,11.79%,AK1;AK8;NME6
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19530961011252906,0.599478039944101,0.9874213836477987,0.9954800420207087,1.0,13/83,13.44%,USP11;USP47;USP20;USP35;USP24;USP48;USP30;USP9Y;USP32;USP10;USP9X;MINDY3;USP38
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.29509038635970064,0.598603898246947,0.906934306569343,0.9935971294804314,1.0,4/10,23.67%,PML;IDE;FAN1;ANKRD13D
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.25545729784210314,0.5981882950777955,0.9211356466876972,0.991338055810566,1.0,2/16,6.69%,NEIL1;ADPRH
prerank,ribonuclease P activity (GO:0004526),-0.23968472293622362,-0.5925086013397458,0.9311163895486936,0.9990835280298435,1.0,3/11,15.48%,RPP14;POP4;RPP21
prerank,CXCR chemokine receptor binding (GO:0045236),0.2780735238042382,0.5924884271430245,0.9060773480662984,0.9923846527444731,1.0,2/11,13.54%,ITCH;CXCL13
prerank,kinase activity (GO:0016301),0.18869589952416943,0.5913312173824178,0.9975669099756691,0.9905851509894871,1.0,24/109,21.36%,LYN;EPHA4;MVK;PDXK;LRRK2;SPHK2;MAP4K4;FN3KRP;CHKB;CKB;PI4KA;PANK1;CERK;AKT1;ITPKA;GK;CDC7;FN3K;NMRK1;COASY;BCKDK;PKN2;TAOK1;PAPSS2
prerank,omega peptidase activity (GO:0008242),0.1901914127661856,0.5900430934775989,0.992583436341162,0.9888697540396515,1.0,14/89,13.44%,USP11;USP47;USP20;USP35;USP24;USP48;APEH;USP30;USP9Y;USP32;USP10;USP9X;MINDY3;USP38
prerank,single-stranded DNA helicase activity (GO:0017116),-0.20815224025537704,-0.5871771885930355,0.9544303797468354,0.9978056304939914,1.0,9/19,29.49%,RAD51;DHX9;POLQ;WRNIP1;HELB;MCM5;DSCC1;CHTF18;PIF1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.18742107354868895,-0.5829217498300673,0.9815950920245399,0.9959232798568897,1.0,6/28,21.50%,TMBIM1;TRAF5;TRAF1;TRAF2;DAB2IP;BABAM2
prerank,cAMP response element binding (GO:0035497),-0.25162679062608595,-0.5792549779968869,0.944206008583691,0.9937715181479877,1.0,6/10,32.86%,CREB1;JUN;HMGA2;ATF2;NR4A3;E4F1
prerank,telomerase RNA binding (GO:0070034),0.2360838754683107,0.5704338771636466,0.948220064724919,0.997165820614666,1.0,6/22,20.16%,PARN;TEP1;TENT4B;HNRNPC;NAF1;HNRNPU
prerank,carbohydrate kinase activity (GO:0019200),-0.23394770719637065,-0.5669938038334914,0.9532710280373832,0.995125711949223,1.0,1/11,5.76%,HK2
prerank,phospholipase inhibitor activity (GO:0004859),0.26614495127780285,0.5623560110636269,0.929368029739777,0.9986002413694433,1.0,5/10,33.88%,ANXA5;ANXA2;ANXA4;ANXA9;ANGPTL3
prerank,ribosome binding (GO:0043022),0.19854485125069177,0.5611677296454392,0.9865047233468286,0.9966697499937723,1.0,11/46,22.35%,CPEB1;CPEB3;EIF6;ERI1;SERBP1;SRP72;EIF3C;CCDC47;SEC61A1;CPEB4;BAG6
prerank,MHC protein binding (GO:0042287),-0.1938381435870021,-0.5477884769088974,0.9778325123152709,0.9981638290457074,1.0,4/20,17.40%,ATP5F1A;TUBB4B;CD81;LAG3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.21481422832092384,-0.5432537999282658,0.9660633484162896,0.9958657688829635,1.0,6/13,36.37%,TRMT10A;TRMT1L;TRMT10C;TRMT10B;FTSJ1;TARBP1
prerank,DNA polymerase binding (GO:0070182),0.228114634967656,0.5428988310734909,0.9539170506912442,1.0,1.0,9/18,30.29%,FANCI;RTEL1;CDK2AP1;LONP1;NABP2;HMGB1;HSP90AA1;SMG6;PCNA
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.23489880252347362,0.5400457379284624,0.9519867549668874,1.0,1.0,3/17,17.02%,DPYD;DECR1;DECR2
prerank,aspartic-type peptidase activity (GO:0070001),-0.23054846853738004,-0.5361361405932616,0.9710144927536232,0.9942007889830811,1.0,2/10,24.07%,BACE2;CTSE
prerank,four-way junction DNA binding (GO:0000400),0.2304689840709555,0.5322476543658998,0.9563758389261745,1.0,1.0,7/17,26.39%,RAD51B;RAD51D;XRCC2;MSH6;HMGB3;ABL1;HMGB1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.18984341213256584,-0.5299981255277691,0.9777158774373259,0.9921436350448787,1.0,8/20,32.68%,RPS3;ZRANB3;EXO1;EXOG;APEX1;ENDOG;FEN1;ERCC5
prerank,single-stranded telomeric DNA binding (GO:0043047),0.24987759784650668,0.5289172302013232,0.9483985765124555,1.0,1.0,2/11,12.18%,HNRNPA1;TERF2
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.20398704411242494,-0.5277538097204496,0.9845758354755784,0.9890137994824063,1.0,6/15,29.65%,PIK3R3;PIK3C2B;PIK3CA;PIK3CG;PI4K2B;PIK3CD
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2439533963470108,0.5246224469124096,0.953405017921147,0.9992177759911267,1.0,3/11,18.70%,FBXO11;PRMT9;CARM1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.24476991950858457,0.5193460342123475,0.9471890971039182,0.9984636746463561,1.0,2/10,11.73%,DCLRE1C;DCLRE1A
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2353572334996441,0.5141387091247418,0.9798657718120806,0.9975820769294221,1.0,3/14,13.80%,MTMR3;MTMR7;PTEN
prerank,snoRNA binding (GO:0030515),0.19036364114716087,0.49110589598105664,0.9895988112927192,1.0,1.0,9/30,27.03%,NUDT7;BYSL;NUDT16L1;RRP9;BMS1;NUDT5;NOP14;HEATR1;TBL3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.20853341999087732,0.4809192920987296,0.9838187702265372,1.0,1.0,1/18,5.29%,HSD3B2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.20391957268147143,-0.4795966156023259,0.988399071925754,0.9954644738390894,1.0,6/10,40.76%,NCF2;NOX1;NCF1;NCF4;DUOX1;CYBA
prerank,peptide N-acetyltransferase activity (GO:0034212),0.2253681310945915,0.4619546972495224,0.9730700179533214,1.0,1.0,3/10,19.21%,NAA20;NAA80;NAA50
prerank,U6 snRNA binding (GO:0017070),0.20186296380598936,0.45392966216301944,0.9836065573770492,1.0,1.0,4/14,23.61%,RBM22;LSM8;PRPF8;METTL16
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.16934618851621114,-0.45012864462319296,0.9924433249370277,0.9955854448761472,1.0,9/15,45.92%,P2RX7;P2RY14;PTAFR;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,Toll-like receptor binding (GO:0035325),0.20291689195608062,0.4299129943140986,0.9808695652173913,1.0,1.0,3/11,21.73%,TLR6;TIRAP;MYD88
prerank,deoxyribonuclease activity (GO:0004536),0.185886517236043,0.41975167585474793,0.9983136593591906,1.0,1.0,5/14,26.01%,DNASE1L1;MBD4;APLF;MRE11;MAP1S
prerank,SUMO transferase activity (GO:0019789),0.17360457085452344,0.4041685823867262,0.9887820512820513,0.999412631575231,1.0,16/16,82.66%,MUL1;HDAC4;NSMCE2;PIAS3;MDM2;RNF212;PIAS4;UBE2I;PIAS1;EGR2;RNF212B;PIAS2;TOPORS;TRIM28;CBX4;RANBP2
prerank,N-acyltransferase activity (GO:0016410),0.1505666553841806,0.3906862077302941,0.9985380116959064,0.9979589478114295,1.0,10/32,24.13%,CERS6;CERS5;CERS2;SAT2;NAA80;NAA50;SAT1;SMARCE1;NAT14;ESCO1
